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0.1 Foreword 
 
Coordination Chemistry is the chemistry of metal complexes (or coordination compounds) 
which consist of a central metal ion surrounded by a certain number of molecules or ions, 
called ligands.  
The ligands are bounded via dative or coordinative bonds to the central metal ion and the total 
number of the sites occupied by them identifies the coordination number of the metal.  
In some cases, more than one of these sites is occupied by the same ligand when the ligand 
acts as polydentate ligand.  
The role of a metal complex used in a reaction as catalyst is fundamental, since many 
processes only take place when the catalyst offer new reaction pathways. 
In the last decades many have been the problems that chemists tried to overcome, from both 
scientific and industrially point of view; such as the need to simplify the way of synthesis of 
the ligands, and the possibility to apply a combinatorial approach in order to find suitable 
catalysts in a easier and faster way.  
Supramolecular Chemistry answers these needs.
1
 
One of the cornerstone of Supramolecular Chemistry is that ligands contain, besides the 
atom(s) coordinated to the catalytic metal center, an additional functionality capable of non-
covalent interactions which can play the following roles: 
 allow monondentate ligands to self-assemble into the so-called “supramolecular 
polydentate ligands”,  
 bind the substrate(s) in proximity to the catalytic metal center, in analogy to 
metalloenzymes.  
In both cases, this approach causes reduced degrees of freedom in the metal coordination 
complexes, which are thus expected to result in more pre-organized systems with a better 
capacity of controlling the metal-catalyzed reaction. 
In chapter 1 and 2 will be highlighted the use of hydrogen bonding as non-covalent force able 
to create supramolecular bidentate ligands.  
In the last few years, indeed, several powerful supramolecular bidentate ligands with 
outstanding reactivity and selectivity have been described, but unfortunately this concept has 
so far been exclusively confined to the use of phosphorus ligands.  
                                                                
1 S. Carboni, C. Gennari, L. Pignataro, U. Piarulli, Dalton Trans. 2011, 40, 4355. 
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So it will be described the hydrogen bonds-induced formation, characterization and 
application to transition metal catalyzed transformations, of supramolecular bis(oxazoline) 
and phosphinooxazoline ligands (Figure 0.1 and Figure 0.2). 
 
 
 
Figure 0.1 
 
 
  
Figure 0.2 
 
The formation of our transition metal complexes (Cu
2+
, Pd
2+
, Zn
2+
 and Ir
+
) was investigated 
by complexation studies through the use of different techniques, such as mass spectrometry, 
UV/Vis and NMR spectroscopy.  
 
In addition, recently, particular attention has been paid to solve another drawback of the 
application of metal-complexes, the majority of which contains expensive noble metals (Ru, 
Rh, Ir, Pd, Pt). It concerns the high cost of the metals, which has serious affect on the 
application in industrial scale. Therefore, quite obviously, the replacement of precious metals 
with cheap first-row transition metals turns out in a great breakthrough.
2
  
Among the possible suitable metals, we chose iron, in particular Fe(II), because it owns 
important advantages: iron is a physiologically and environmentally friendly metal and it is 
abundant and cheap.  
                                                                
2 Iron Catalysis in Organic Chemistry: Reactions and Applications, Wiley-VCH, 2008; R. H. Morris, Chem. Soc. 
Rev. 2009, 38, 2282; R. M. Bullock, Catalysis without Precious Metals, Wiley-VCH, 2010. 
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Regrettably, Fe(II)-complexes cannot be often considered robust catalyst. Indeed Fe(II) is 
very prone to oxidation to Fe(III).  
Polydentate nitrogen ligands, are expected to stabilize Fe(II) and, therefore, we paid attention 
on tridentate N3-ligands and tetradentate N4-ligands in order to form iron(II)-complexes 
(Figure 0.3). 
The formation of our complexes will be discussed in chapter 3. 
 
 
Figure 0.3 
 
The characterization of the iron(II)-complexes that we prepared, mainly relied on mass 
spectrometry, since the NMR spectroscopy appeared quite often as not a suitable technique, 
due to the paramagnetism of the Fe(II)-species.  
Preliminary attempts in order to study the application of the complexes in hydrogenation and 
epoxidation reactions were done and described in chapter 3, although studies are still 
underway in our laboratory. 
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Bisoxazoline Ligands 
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1.1     Asymmetric catalysis 
 
The biological activity of many pharmaceutical compounds, agrochemicals, flavors, and 
fragrances is associated with absolute molecular configuration. 
Since van’t Hoff  and Le Bel around 140 years ago introduced the tetrahedral model of the 
carbon atom to explain the optical activity of organic molecules, providing a structural basis 
for molecular stereochemistry, scientists have been fascinated by the challenge to achieve 
absolute stereocontrol in chemical transformations starting from achiral compounds.  
Chirality has been denoted as “signature of life”, and it is not unexpected that questions on 
the origin, control and amplification of homochirality are intimately associated with chemical 
evolution and the origin of life. 
In spite of the incredible importance, asymmetric catalysis has not been considered as a 
fundamental research area until 1968.  
Besides enzymatic processes, only few examples of enantioselective catalytic reactions were 
known at that time and, in view of the generally low enantiomeric excesses, many chemists 
actually doubted that synthetic chiral catalysts would had ever played an important role in 
asymmetric synthesis.  
Soon the situation dramatically changed, when impressive progresses were made in the 
rhodium-catalyzed hydrogenation of olefins by Knowles,
3 
Horner
4
, Kagan
5
 and Noyori,
6
 
culminating in the famous Monsanto process for L-DOPA and in the selective epoxidation
7
 
and dihydroxilation
8
 of olefins by Sharpless. 
The demand for chiral compounds, predominantly as single enantiomers, has sharply 
escalated in recent years, particularly driven by the demands of the pharmaceutical industry, 
but also by other applications, including agricultural chemicals, flavors, fragrances, and 
materials.  
We have only to realize that two-thirds of prescription drugs are chiral, with the majority of 
new chiral drugs being single enantiomers, especially since when, in 1992, the Food and Drug 
                                                                
3 W. S. Knowles, M. J. Sabacky, Chem. Commun. 1968, 22, 1445; W. S. Knowles, M. J. Sabacky, B. D. Vineyard, J. 
Chem. Soc., Chem. Commun. 1972, 10; B. D. Vineyard, W. S. Knowles, M. J. Sabacky, G. L. Bachman, D. J. 
Weinkauff, J. Am. Chem. Soc. 1977, 99, 5946; W. S. Knowles, Angew. Chem. Int. Ed. 2002, 41, 1998. 
4 L. Horner, H. Siegel, H. Büthe, Angew. Chem., Int. Ed. Engl. 1968, 7, 941. 
5 H. B. Kagan, T. P. Dang, J. Am. Chem. Soc. 1972, 94, 6429. 
6 R. Noyori, Adv. Synth. Cat. 2003, 345, 15. 
7 Y. Gao, R. M. Hanson, J. M. Klunder, S. Y. Ko, H. Masamune, K. B. Sharpless, J. Am. Chem. Soc. 1987, 109, 
5765; M. G. Finn, K. B. Sharpless, J. Am. Chem. Soc. 1991, 113, 113. 
8 H. C. Kolb, M. S. van Nieuwenhze, K. B. Sharpless, Chem. Rev., 1994, 94, 2483. 
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Administration of the USA published a policy statement for the development of the new 
stereoisomeric drugs.
9
  
In the last two decades, the number of new chiral compounds submitted for approval to 
various regulatory bodies as single enantiomers, rather than as racemic mixtures, has been 
rapidly increasing and the trend for future drug developments is evident. The need to 
synthesize active pharmaceutical ingredients (API) as a single isomer has promoted a variety 
of methodologies to achieve the goal.
10
 
Among the numerous variables, cost usually plays a key role in the decision of the best route, 
as well as environmental and safety issues.  
Although bio-related applications are the most obvious, materials science also relies on the 
properties imparted by chirality, notably in chiral polymers and liquid crystals.  
Asymmetric catalysis is an integrated chemical approach in which the maximum chiral 
efficiency can be obtained only by a combination of suitable molecular design with proper 
reaction conditions. The reaction must proceed with high turnover number (TON) and high 
turnover frequency (TOF), while the enantioselectivity range is between 50:50 (nonselective) 
and 100:0 (perfectly selective).  
By now it is, in principle, the most efficient strategy for the production of enantiopure 
compounds, requiring only catalytic amounts of chirally modified metal complexes formed 
by a metal source and one or more chiral ligands. Chiral ligands modify intrinsically the 
metal atoms. They must possess suitable three-dimensional structure and functionality to 
generate sufficient reactivity and the desired stereoselectivity. In this way, a chiral catalyst 
can permit kinetically precise discrimination among the enantiotopic atoms, groups or faces 
in chiral molecules.
11
 
Two significant challenges pertain to asymmetric catalysis: discovering new catalytic 
reactions and inventing effective chiral catalysts.  
Thousands of chiral ligands have been prepared so far, although a relatively small number of 
structural classes stand out because of their broad applicability. A survey of their structures 
reveals that, at first sight, a surprisingly large number of them possess C2 symmetry, such as 
for instance, the C2-symmetric ligand DIOP, introduced by Dang and Kagan in 1971.
12
  
                                                                
9 http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm122883.htm 
10 V. Farina, J. T. Reeves, C. H. Senanayake, J. J. Song, Chem. Rev. 2006, 106, 2734. 
11 P. Espinet, K. Soulantica, Coord. Chem. Rev. 1999, 193-195, 499. 
12 T. P. Dang, H. B. Kagan, J. Chem. Soc. Chem. Commun. 1971, 481. 
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The reason of choosing a C2-symmetric ligand is generally related to the reduction of the 
number of possible isomeric metal complexes, as well as the number of different substrate-
catalyst arrangements and reaction pathways, if compared with a non-symmetrical ligand.  
Because fewer reaction intermediates must be taken into account, C2-symmetry is of 
particular advantage in mechanistic studies because it facilitates the analysis of ligand-
substrate interactions that may be responsible of the enantioselection. Initially, chiral ligands 
were developed containing mainly phosphorus donor atoms; later the concept of C2-symmetry 
was successfully applied also to other ligand classes with N or O donor atoms.
13
 
 
1.2     Supramolecular approach  
 
At the turn of the 20th century, the concept of supramolecular chemistry was introduced 
for the first time.  
Emil Fischer, a German chemist, studying the reaction of an enzyme with a substrate, came 
up with the conclusion that the shape of a substrate molecule needed to be complementary 
with the shape of its receptor site in order to recognize it and then react. For this finding, he 
was awarded the Nobel Prize in Chemistry in 1902. This principle led to an increasing 
understanding of many biological processes, such as the structure of the proteins and the 
elucidation of the DNA double helical interaction. Nearly 100 years later, chemists were able 
to take these concepts and apply them to synthetic systems.  
In particular, Jean-Marie Lehn, Nobel Prize in Chemistry in 1987, provided the concept of 
supramolecular chemistry as “chemistry beyond the molecule”, whereby organized entities of 
higher complexity result from the association of two or more chemical species held together 
by intermolecular additive and cooperative forces including hydrogen bonding, coordination, 
hydrophobic interactions, π-π interactions, electrostatic interactions of a reversible nature. 
Of remarkable impact was to realize that the final properties of a supramolecular molecule are 
different from the sum of the properties of each individual component. 
 
Supramolecular chemistry is a multidisciplinary field which impinges on various 
disciplines, such as the traditional areas of organic and inorganic chemistry, needed to 
synthesize the precursors for a supramolecule, physical chemistry, to understand the 
                                                                
13 A. Pfaltz, Acc. Chem. Res. 1993, 26, 339; A. K. Ghosh, P. Mathivanan, J. Cappiello, Tetrahedron: Asymmetry 
1998, 9, 1; Y. Chen, S. Yekta, A. K. Yudin, Chem. Rev. 2003, 103, 3155. 
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properties of supramolecular systems and computational modeling to understand 
supramolecular complex behavior.  
Supramolecular chemistry can be split into two big categories, arbitrarily named host-guest 
chemistry and self-assembly chemistry.  
In the host-guest chemistry the host is the largest molecule and the guest the smallest. The 
host molecule recognizes the best guest molecules among those containing the array of 
binding sites and steric features that complement those of the host. Thus, guest and host must 
be compatible with respect to the shape if they must be complexed. This family includes 
many biological systems, among them it is worth mentioning the system enzyme-substrate. 
Where there is no significant difference in size and no species is acting as a host for another, 
the non-covalent joining is named self-assembly. Specifically, the self-assembly is the 
equilibrium between two or more molecular components to produce an aggregate with a 
structure dependent only on the characteristic of the chemical building blocks. 
Hereunder, self-assembly chemistry will be exclusively discussed, since it is the approach that 
SupraBox formation is based upon. 
 
1.3     Self-assembly chemistry 
 
Examples of self-assembly can be found in different fields, from chemistry to biology, 
biochemistry or nanotechnologies.  
It consists in the spontaneous association of two or more species to create a larger aggregate 
through the formation of reversible, supramolecular interactions.  
DNA double-helix is probably the best-known self-assembled structure in biological system. 
It is made of complementary strands entwined via hydrogen bonds and π-π stacking. The 
strands recognize each other and join together to form the most thermodynamically stable 
assembly product.  
Folding process of proteins to give rise to secondary, tertiary and quaternary structures, as 
well as hydrophobic effect in the formation and activity of lipid membranes, or RNA 
interactions in the structure of Virus, like tobacco mosaic virus (TMV), operate in a broadly 
similar manner. 
Such biological examples have provided a powerful incentive for researchers to explore 
molecular associations more broadly and also giving birth to the supramolecular chemistry, a 
rapidly expanding field of chemistry.  
15 
 
Synthetic self-assembly systems are based on the ability of the chemists to design molecules 
containing complementary functionalities. A chemist has in principle no direct control over 
the assembly process otherwise it would not be termed self-assembly. However it is possible 
to induce the chemical system to rearrange to the most thermodynamically stable (and 
desired) product, by a careful and judicious choice of the different parts of the system. 
 
1.4     Formation of synthetic bidentate ligands by self-assembly  
 
The use of non-covalent supramolecular ligand–ligand interaction in transition metal-
catalyzed transformations is a new, rapidly emerging area of research. The basic idea is to use 
two monodentate ligands, which can imitate the situation of a bidentate ligand at the 
catalytically active metal center through non-covalent connections between the two respective 
binding sites. For this reason, besides the atom coordinating the catalytic metal, the 
monodentate ligands need additional functionalities capable of ligand–ligand bonding via 
non-covalent interactions, such as hydrogen bonding, dipole-dipole, charge transfer, van der 
Waals, - stacking, and inclusion compounds.14 This approach offers the advantage of an 
easier synthesis, compared to the synthesis of covalent bidentate ligands, and of reduced 
degrees of freedom in the respective metal coordination complexes, compared to the analogs 
complexes based on monodentate ligands. This is expected to result in a more pre-organized 
systems with a better capacity of controlling the metal-catalyzed reaction, thus imparting 
higher activity and chemo-, regio-, and stereoselectivity to the corresponding transition metal 
complexes in a number of catalytic applications.
15
 
 
1.5     Self-assembly through hydrogen bonding 
 
The concept of hydrogen bonding was firstly introduced in the literature in 1920 by 
Latimer and Rodebush to describe the nature of association in the liquid state of water.
16
 
Indeed, a footnote in their paper credited: "Mr. Huggins (a first-year graduated student of this 
                                                                
14 Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem., 2012, 108, 292; Annu. Rep. Prog. Chem., Sect. B:Org. Chem., 
2012, 108, 171. 
15 B. Breit, Angew. Chem. Int. Ed. 2005, 44, 6816; M. J. Wilkinson, P. W. N. M. van Leeuwen, J. N. H. Reek, Org. 
Biomol. Chem. 2005, 3, 2371; A. J. Sandee, J. N. H. Reek, Dalton Trans. 2006, 3385; P. W. N. M. van Leeuwen, 
Supramolecular Catalysis, Wiley-VCH, Weinheim, 2008; P. E. Goudriaan, P. W. N. M. van Leeuwen, M.-N. 
Birkholz, J. N. H. Reek, Eur. J. Inorg. Chem. 2008, 2939; G. Gasparini, M. Dal Molin, L. J. Prins, Eur. J. Org. 
Chem. 2010, 2429; J. Meeuwissen, J. N. H. Reek, Nat. Chem. 2010, 2, 615–621;C. Gennari, U. Piarulli, Dalton 
Trans. 2011, 40, 4355; J. N. H. Reek, Org. Biomol. Chem. 2011, 9, 1704. 
16 W. M. Latimer, W. H. Rodebush,, J. Am. Chem. Soc., 1920, 42, 1419. 
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laboratory) has used the idea of a hydrogen kernel held between two atoms as a theory in 
regard to certain organic compounds".  
Among the different kinds of non-covalent interactions used so far for the self-assembly, 
hydrogen bonds are arguably the most practical and efficient for several reasons:  
 functional groups capable of hydrogen bonding (e.g. ureas, amides, guanidines) are 
stable and relatively easy to introduce;  
 hydrogen bonds are created dynamically and reversibly in the reaction medium, thus 
being able to self-repair when broken; 
 often coexist with other interactions in a ‘non-invasive’ manner.  
The interaction can be of two different nature: complementary or non complementary, 
depending on the nature of the groups responsible of the hydrogen bonds formation. (Scheme 
1.1). 
 
DoDo
M
Non-covalent, complementary
interaction
= donor atom = catalytic metalDo M
DoDo
M
Non-covalent, non complementary
interaction
= donor atom = catalytic metalDo M
 
Scheme 1.1 
 
In case of complementary interactions, one of the two ligands has functionalities which make 
it able to act as hydrogen-bond donor while the other one as hydrogen-bond acceptor. In case 
the interaction is non complementary, both ligands can act as hydrogen bond acceptor and 
donor. 
Hereafter is reported a brief introduction on some common examples of supramolecular 
synthetic organic systems through hydrogen bonding. 
 
1.5.1     Hydrogen bonding among amido groups 
    
Peptides are the class that probably possesses the best known functionality capable of 
intermolecular and intramolecular backbone interaction by hydrogen bonding. 
17 
 
Breit recently developed a library of phosphines 1 and phosphites 2,
17
 that mimic the well-
known PhanePhos ligand.
18
 Meta-carboxypeptidyl-substituted triarylphosphines or phosphites 
were employed to construct PhanePhos-like structures by means of an inter-ligand helical 
hydrogen-bonding network. The latter, in turn, induces a planar -stacking arrangement of the 
two meta-substituted arene rings which resembles the planar stereogenic element present in 
PhanePhos, as it was demonstrated by X-ray and NMR analysis of Pt- and Rh-complexes. 
The homocombinations of ligands 1 and 2, in the presence of [Rh(cod)2BF4], were tested in 
the enantioselective hydrogenation of methyl 2-acetamido acrylate, methyl (Z)-2-acetamido 
cinnamate and dimethyl itaconate. The best combinations gave enantioselectivity levels 
comparable with those of PhanePhos ligands (75- 99% ee).  
 
 
 
The concept of utilizing peptide-functionalized P-ligands was further developed and 
expanded to the formation of heterocomplexes.
19
 Indeed, when C-linked peptides 1 were 
combined with N-linked peptides 3 in the presence of Pt(II) and Rh(I) salts, a two-stranded, 
antiparallel -sheet structure was formed (Scheme 1.2), which served as basis for the 
generation of a heterobidentate ligand library.  
 
                                                                
17 A. C. Laungani, B. Breit, Chem. Commun. 2008, 844. 
18 P. J. Pye, K. Rossen, R. A. Reamer, N. N. Tsou, R. P. Volante, P. J. Reider, J. Am. Chem. Soc., 1997, 119, 6207; P. 
J. Pye, K. Rossen, R. A. Reamer, R. P. Volante, P. J. Reider, Tetrahedron Lett., 1998, 39, 4441. 
19 A. C. Laungani, J. M. Slattery, I. Krossing, B. Breit, Chem.–Eur. J. 2008, 14, 4488. 
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Scheme 1.2 
 
These heterocomplexes were screened in the enantioselective hydroformylation of styrene. 
Remarkably, the stereocenters of the peptide chains could induce a moderate selectivity, 
although they were remote from the catalytic metal centre. 
In a recent project developed by the group of Gennari and our group, the formation of a new 
supramolecular bidentate phosphorous ligands was investigated, starting from a new class of 
chiral monodentate phosphite ligands 4, named PhtalaPhos, which contain a phthalic acid 
secondary diamide moiety.
20
  
 
 
 
Phtalamidic group displays both donor and acceptor hydrogen-bonding properties that, in 
principle, can give rise to supramolecular interactions between the two ligands and with the 
substrate of the reaction.  
These ligands were applied to the rhodium-catalyzed enantioselective hydrogenation of 
olefins with excellent results and enantioselectivities (up to >99%). Computational studies 
were also made to investigate the real structure of the precatalyst and the effective double 
hydrogen bond array. (Scheme 1.3)  
 
                                                                
20 L. Pignataro, S. Carboni, M. Civera, R. Colombo, U. Piarulli, C. Gennari, Angew. Chem. Int. Ed. 2010, 49, 6633. 
19 
 
 
Scheme 1.3 
 
1.5.2     Hydrogen bonding among heterocycles 
 
   The first example concerning the in situ generation of bidentate ligands based on self-
assembly through hydrogen bonding of monodentate ligands in the coordination sphere of a 
metal center is attributed to Breit and Seiche.
21
  
They developed a number of phosphines 5-9 using as hydrogen bond source the already well-
known
 
equilibrium between the two tautomeric forms of the 2-hydroxypyridine derivatives.
22
 
(Scheme 1.4) 
 
 
 
Scheme 1.4 
                                                                
21 B. Breit, W. Seiche, J. Am. Chem. Soc. 2003, 125, 6608; W. Seiche, A. Schuschkowski, B. Breit, Adv. Synth. 
Catal. 2005, 347, 1488; B. Breit, W. Seiche, Pure and Appl. Chem. 2006, 78, 249: B. Breit, W. Seiche, Angew. 
Chem. Int. Ed., 2005, 44, 1640. 
22 K. Mashima, H. Nakano, A. Nakamura, J. Am. Chem. Soc. 1993, 115, 11632; K. Mashima, M. Tanaka, K. Tani, H. 
Nakano, A. Nakamura, Inorg. Chem. 1996, 35, 5244. 
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Ligands 5-9 were used in Rhodium-catalyzed hydrogenation of olefins with enantioselectivity 
up to 99%.  
The importance of the tautomeric equilibrium was settled by the poor results obtained with 
ligand 6, unable to self-assemble. Moreover, they observed that the hydrogen-bonding 
network of the ligands, and thus the chelating binding mode, can be disrupted by employing 
either temperatures above 110°C or protic solvents such as methanol and acetic acid. 
Breit also explored the possibility to exploit tautomeric interactions in a combinatorial 
fashion. Inspired by DNA base pairing, the method enables rapid generation of catalyst 
libraries by simple mixing of the components without additional synthetic steps, and so 
allowing access towards structurally diverse and meaningful ligand libraries 
The DNA approach, or rather a non-tautomeric system based on Adenine-Thymine interplay, 
was used to overcome the problem of statistic mixture (Figure 1.1).
23
  
 
 
Figure 1.1 
 
A library of 8 building blocks were synthesized to obtain heterocomplexes, which form stable 
hydrogen bonding even in protic solvents such as methanol. Tautomeric and non-tautomeric 
systems were then used in a various list of reactions like hydrogenation,
24
 anti-Markovnikov 
hydration of terminal alkynes,
25
 hydration of nitriles,
26
 allylic amination
27
 and hydrocyanation 
of alkenes.
28
 
Phosphonites 10 and 11 were then introduced using a BINOL moiety in order to create the 
chiral ligand donor group and tested in the hydrogenation of olefins.
29
 
 
                                                                
23 C. Waloch, J. Wieland, M. Keller, B. Breit, Angew. Chem. Int. Ed. 2007, 46, 3037. 
24 M-N. Birkholz, N. V. Dubrovina, H. Jiao, D. Michalik, J. Holz, R. Paciello, B. Breit, A. Borner, Chem. Eur. J., 
2007, 13, 5896. 
25 F. Chevallier, B. Breit, Angew. Chem. Int. Ed., 2006, 45, 1599. 
26 T. Smejkal, B. Breit, Organometallics, 2007, 26, 2461. 
27 M-N. Birkholz, N. V. Dubrovina, I. A. Shuklov, J. Holz, R. Paciello, C. Waloch, B. Breit, A. Borner, Tetrahedon: 
Asymmetry, 2007, 18, 2055. I. Usui, S. Schmidt, M. Keller, B. Breit, Org. Lett., 2008, 10, 1207. 
28 M. De Greef, B. Breit,  Angew. Chem. Int. Ed., 2009, 48, 551. 
29 M. Weis, C. Waloch, W. Seiche, B. Breit, J. Am. Chem. Soc. 2006, 128, 4188. 
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1.5.3     Hydrogen bonding between urea functionalities 
 
Ureas are functionalities well known to form network of hydrogen bonds, and have been 
used over the last years as additional interacting functionalities for the formation of 
supramolecular bidentate ligands. The groups of Love
30
 and Reek
31
 had a key-player role in 
this field.  
They firstly, independently described the formation of transition metal complexes containing 
urea-phosphine ligands 12 in the presence of a palladium source. 
In particular, with ligand 12a Love observed the formation of a species assumed to have a 
polymeric nature with intermolecular hydrogen bonding due to its insolubility in commonly 
used solvents; whereas Reek, with ligand 12b, reported the formation of a trans complex. 
In addition, in the presence of a metal source and tetrabutylammonium chloride, symmetric 
supramolecular metal complexes were obtained, where a chloride ion was accommodated 
between the two urea groups through a network of four hydrogen bonding (Scheme 1.5). 
 
 
Scheme 1.5 
                                                                
30 P. A. Duckmanton, A. J. Blake, J. B. Love, Inorg. Chem. 2005, 44, 7708. 
31 L. K. Knight, Z. Freixa, P. W. N. M. van Leeuwen, J. N. H., Reek, Organometallics 2006, 25, 954. 
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Later, Reek and co-workers developed a new class of chiral urea-functionalized phosphite 
and phosphoramidite ligands 13-28 called UREAphos, capable of self-assembling in the 
presence of a rhodium source for the formation supramolecular homocomplexes, as 
confirmed by NMR studies. 
The rhodium complexes of the UREAphos ligands were screened in the enantioselective 
hydrogenation of both benchmark substrates and challenging, industrially relevant olefins.
32
 
 
 
 
Recently, 6 phosphinourea ligands were used in a combinational fashion to form 14 
supramolecular rhodium catalysts: 6 homocomplexes and 8 heterocomplexes (Scheme 1.6).
33
  
                                                                
32 A. J. Sandee, A. M. van der Burg, J. N. H. Reek, Chem. Commun. 2007, 864; J. Meeuwissen, M. Kuil, A. M. van 
der Burg, A. J. Sandee, J. N. H. Reek, Chem. Eur. J. 2009, 15, 10272. 
33 J. Meeuwissen, A. J. Sandee, B. de Bruin, M. A. Siegler, A. L. Spek, J. N. H. Reek, Organometallics 2010, 29, 
2413. 
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Scheme 1.6 
 
Due to the presence of only one NH in the urea moiety, the interaction between the two 
ligands during the formation of the complexes occurs in a different way from those 
mentioned before. The complexes formed, were finally investigated in rhodium-catalyzed 
hydroformilation reaction of styrene. 
 
1.6     Oxazoline-containing chiral ligands 
 
As it can be appreciated by the above overview, supramolecular bidentate ligands have 
been prepared, containing essentially phosphorus donor atoms.  
Notwithstanding, nitrogen ligands have played important roles in asymmetric catalysis, and 
among the most widespread nitrogen ligands (e.g. amines, Schiff bases, oxazolines, etc.) 
bis(oxazolines) are the most successful ligands.  
Starting from the first report by Wimmer in 1986 of the use of chiral oxazoline as ligands in 
asymmetric catalysis,
34
 a wide range of ligands having one, two, or more oxazoline 
incorporating various heteroatoms, additional chiral motifs, and specific structural features 
have been used with great success in many asymmetric reactions, also because of the 
versatility of this ring, which is able to act as protector group, coordinating ligand, and 
activation moiety. 
Oxazolines are five-membered cyclic and, although the oxazoline cycle was for the first time 
prepared in 1884,
35
 it is starting from the 1970s that ligands containing oxazoline groups have 
been extensively applied. 
Compounds containing chiral oxazolinic rings have become one of the most versatile and 
commonly used class of ligands for asymmetric catalysis.
36
  
                                                                
34 H. Brunner, U. Obermann, P. Wimmer, J. Organomet. Chem. 1986, 316, C1. 
35 R. Andreasch, Monatsh. Chem. 1884, 5, 33. 
36 A. K. Ghosh, P. Mathivanan,  J. Cappiello, Tetrahedron: Asymmetry 1998, 9, 1; G. Helmchen, A. Pfaltz, Acc. 
Chem. Res. 2000, 33, 336; O. B. Sutcliffe, M. R. Bryce, Tetrahedron: Asymmetry 2003, 14, 2297. 
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In chiral oxazolines, the stereocenter lies close to the metal sphere in the catalytic species, 
since next to the nitrogen atom, thus having a direct influence on the stereochemical outcome 
of the reaction. 
The ligands can be easily prepared from natural available aminoacids or synthetic 
aminoalcohols.  
 
1.7     Bis(oxazolines)  
 
Bis(oxazolines) have developed into one of the most useful ligand class for asymmetric 
catalysis thanks to their ability to coordinate a large variety of metal ions as well as the 
excellent results in terms of activity and selectivity which can be attained in a number of 
enantioselective reactions.
37
 
For bidentate ligands, of great importance is the concept of bite-angle, that is easily defined as 
the angle formed by two bonds existing between a metal center and two ligand atoms, 
therefore strongly dependent on the linker between the two donor groups.  
It is well known that catalytic activity of the final catalyst is depending on the bite angle, so 
bidentate ligands can have a preference for a specific geometry and reactivity. Many 
pioneering studies have been undertaken in order to understand how exactly reactions are 
affected by the variation of the bite angle
38
 but, although the progress in studying this concept 
and in the field of theoretical and computation chemistry, it is still not totally possible to 
predict the activity and selectivity of a catalytic system.  
Nowadays, catalyst development still relies on a combination of intuition, laborious work 
and, quite often, in serendipity. 
 
In 1986 Pfaltz and co-workers developed semicorrins 29,
39
 a new class of bidentate ligands 
having a rigid scaffold defined by the planar π-system and the two heterocycles. This feature 
makes them attractive as ligand for asymmetric metal catalysis. 
                                                                
37 G. C. Hargaden, P. J. Guiry, Chem. Rev. 2009, 109, 2505; R. Rasappan, D. Laventine, O. Reiser, Coord. Chem. 
Rev., 2008, 252, 702. 
38 S. Otsuka, J. Organomet. Chem. 1980, 200, 191;  J. J. Low, W. A. Goddard, J. Am. Chem. Soc. 1984, 106, 6928; P. 
Hofmann, H. Heiss, G. Müller, Z. Naturforsch. B, 1987, 42, 395; P. Dierkes, P. W. N. M. van Leeuwen, J. Chem. 
Soc. Dalton Trans. 1999, 1519; Z. Freixa, P. W. N. M. van Leeuwen, Dalton Trans. 2003, 1890; R. Fazaeli, A. 
Ariafard, S. Jamshidi, E. S. Tabatabaie, K. A. Pishro, J. Organomet. Chem. 2007, 692, 3984; V. P. Ananikov, D. G. 
Musaev, K. Morokuma, Eur. J. Inorg. Chem. 2007, 5390. 
39 H. Fritschi, U. Leutenegger, A. Pfaltz, Angew. Chem. Int. Ed. 1986, 25, 1005. 
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These complexes showed a very high enantioselectivity in copper-catalyzed asymmetric 
cyclopropanation of olefins
40
 and the cobalt-catalyzed conjugate addition of α,β-unsaturated 
esters and amides.
41
 
The electron-rich vinylogous amidine group imparts an electron donating character to the 
ligands, reducing the electrophilicity of the metal center. For some reactivity, it is preferable 
to have a weak electron donating character or even a π-acceptor ligand.42 In order to decrease 
this effect, in the early 90’s neutral analogs of the semicorrins 29, the (bis)oxazolines 30, 
were independently developed by several groups.
43
  
 
 
 
Bis(oxazolines), commonly called BOX, were then successfully applied with excellent results 
to a wide range of reactions including cyclopropanation of olefins and Diels-Alder reactions. 
Over the years, the popularity of these ligands rapidly increased due to two factors: the ease 
of synthesis and the catalytic activity.  
Modification on the nature, size and flexibility of the linker and substituents on the two 
oxazolines, have led to the development of a plethora of BOX ligands which have been used 
in various reactions such as Diels-Alder, aziridination, cyclopropanation, allylic substitution, 
Mukayama, Michael, and many others.
44
 
 
The bidentate bis(oxazoline) ligands of C2-symmetry are constructed by two homochiral 
oxazoline rings connected to a central structure A (spacer) (Figure 1.2). In these ligands the 
coordination to the metal occurs through two nitrogen atoms. The degree of substitution of 
the two oxazoline rings and the metal employed in the catalyst construction are crucial factors 
governing the efficiency and the applicability of these ligands in asymmetric catalysis.  
                                                                
40 A. Pfaltz, Acc. Chem. Res. 1993, 26, 339. 
41 U. Leutenegger, A. Madin, A. Pfaltz, Angew. Chem. Int. Ed. 1989, 28, 60; P. von Matt,  A. Pfaltz, Tetrahedron: 
Asymmetry 1991, 2, 691. 
42 U. Leutenegger, G. Umbricht, C. Fahrni, P. von Matt, A. Pfaltz, Tetrahedron 1992, 48, 2143. 
43 D. A. Evans, K. A. Woerpel, M. M. Hinman, M. M. Faul, J. Am. Chem. Soc. 1991, 113, 726; E. J. Corey, N. Imai, 
H-Y Zhang, J. Am. Chem. Soc. 1991, 113, 728. 
44 G. Desimoni, G. Faita, K. A. Jørgensen, Chem. Rev. 2006, 106, 3561; R. Rasappan, D. Laventine, O. Reiser, 
Coord. Chem. Rev. 2008, 252, 702. 
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Figure 1.2 
 
Here below, examples of some bis(oxazolines) employed in catalysis, will be list on the base 
of different typology of spacer A. 
 
1.7.1     Bis(oxazoline) ligands separated by one carbon 
 
   (Bis)oxazolines with a carbon spacer between the two oxazolinic rings are the most 
frequently used, affording high selectivity in a wide range of metal-catalyzed reactions. 
 
 
 
For instance, ligand 31 has found several applications in asymmetric transformations. 
 
        
 
Sibi reported the application of 31c in enantioselective Diels-Alder reaction, achieving 95% 
of ee (Scheme 1.7).
45
  
 
 
Scheme 1.7 
 
                                                                
45 M. P. Sibi, S. Manyem, H. Palencia, J. Am. Chem. Soc. 2006, 128, 13660. 
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Cu(OTf)2 complexes of 31d were successfully applied by Yamazaki in the Friedel-Crafts 
reaction of a range of ethenetricarboxylates with various indoles in yields up to 87% and 
e.e.’s up to 95%.46 
Ligands 31c and 31e were used for enantioselective Mannich-type reactions of imines in the 
presence of Lewis acids (Scheme 1.8).
47
 
 
 
Scheme 1.8 
 
In 1998 Desimoni developed ligand 32, bearing a bulky 2-naphthyl groups in 4-position of 
the oxazolines, in an attempt to increase the selectivity of 31a. The goal was achieved using 
different metal salts in the Lewis acid-catalyzed Diels-Alder reaction of cyclopentadiene and 
N-alkenoyl-oxazolidin-2-ones (Scheme 1.7).
48
 
Ligand 33 was compared to 31 by Rutjes, who used the corresponding Cu(II)-complexes in 
Mukaiyama aldol reactions and Diels-Alder reactions. With ligand 33 the enantioselection 
achieved was higher than with the use of ligand 31a, but significantly lower than with 31b, 
the ligand tert-butyl-substituted.
49
 
 
 
 
(Bis)oxazoline ligands which possess hydroxy groups at the stereogenic 4-position of the 
oxazoline rings, have been deeply studied by Reiser, who developed ligands 34, suitable for 
both copper and zinc coordination. 
                                                                
46 S. Yamazaki, Y. Iwata, J. Org. Chem. 2006, 71, 739. 
47 S. Nakamura, H. Sano, H. Nakashima, K. Kubo, N. Shibata, T. Toru, Tetrahedron Lett. 2007, 48, 5565. 
48 S. Crosignani, G. Desimoni, G. Faita, P. Righetti, Tetrahedron 1998, 54, 15721. 
49 H. L. van Lingen, J. K. W. van de Mortel, K. F. W. Hekking, F. L. van Delft, T. Sonke, F. P. J. T. Rutjes. Eur. J. 
Org. Chem. 2003, 317. 
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The ligands were tested in copper(II)-catalyzed conjugate addition of diethylzinc to cyclic 
enones and in asymmetric addition of diethyl zinc to a range of aldehydes with good results 
(Scheme 1.9).
50
  
 
 
Scheme 1.9 
 
 
 
In 2003 Reiser investigated the use of ligands 34 and 35, which possess secondary binding 
sites, in the copper(I)-catalyzed cyclopropanation.
51
 In this work, the authors proposed that 
the hydrogen bond donor groups of the oxazolines 4-substituents are able to form hydrogen 
bonding with the substrate, controlling the direction of the attack.   
The dihydroxy bis(oxazoline) ligands 34a and 36 were applied in the palladium-catalyzed 
allylic alkylation of 1,3-diphenylpropenyl acetate with dimethyl malonate using sodium 
hydride as the base by Aït-Haddou. Ligand 36 was the most selective, affording the product 
in 95% yield and  97% ee.
52
 
Sibi applied the indene-derived ligand 37, which contains a cyclopropyl linkage, in the 1,3-
dipolar cycloaddition of nitrones and nitrile oxides with excellent results, obtaining 
enantioselectivities of 98% and 99%, respectively.
53
  
                                                                
50 M. Schinneri, M. Seitz, A. Kaiser, O. Reiser, Org. Lett. 2001, 3, 4259.  
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699.  
53 M. P. Sibi, M. L. Stanley, X. Nie, L. Venkatraman, M. Liu, C. P. Jasperse, J. Am. Chem. Soc. 2007, 129, 395. 
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Ligand 38 was used by Ma in the copper-catalyzed enantioselective addition of different 
activated terminal alkynes to 1-acylpyridinium salts affording the final product in yield up to 
81% and ee up to 99% (Scheme 1.10).
54
  
 
 
Scheme 1.10 
 
1.7.2     Bis(oxazoline) ligands separated by heteroatoms  
 
BOX with a range of bridges linking the chiral oxazoline rings have been developed and 
applied in metal-catalyzed asymmetric transformations. A peculiarity of this class is that they 
can be neutral, but also ionic, depending on the heteroatoms. 
Reiser reported an interesting variant of ligands 30 where the central atom was replaced by a 
nitrogen atom, giving rise to the so called aza-bis(oxazolines).  
 
 
 
                                                                
54 Z. Sun, S. Yu, Z. Ding, D. Ma, J. Am. Chem. Soc. 2007, 129, 9300. 
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Ligands 39 were tested in palladium-catalyzed allylic alkylations and copper-catalyzed 
cyclopropanations affording very interesting results.
55
 Afterward, Reiser proposed an 
interesting variant of these ligands, in which the aza-bis(oxazolines) were linked to a polimer. 
The novel bisbenzyl-substituted aza-bis(oxazoline) ligand proved to be very effective when 
immobilized to insoluble polymers.
56
 
Nishiyama prepared ligands 40, bearing a pyridine ring between the two oxazolines, and 
applied them in enantioselective aldol reductions (Scheme 1.11).
57
 The reactions were 
complete within 30 min and in all cases afforded the aldol products in high yields (93-97%). 
The syn/anti ratio obtained was between 15:85 and 12:88 and the highest ee% achieved 87%.  
 
 
Scheme 1.11 
 
Ligand 41, belongs to the class of PyBOXs, as ligand 40, was used in enantioselective Diels 
Alder reactions (Scheme 1.12).
58
 The best result obtained was with FeBr3 and AgSbF6 in a 1:2 
ratio, using 41c as ligand that allowed the formation of the final product in 75% yield and 
92% ee. 
 
 
Scheme 1.12 
 
Zhang used ligand 42 in Ru(II)-catalyzed transfer hydrogenation of aromatic ketones,
59
 
demonstrating the importance of the central NH, by comparing the excellent results achived 
with ligand 42 with the poor selectivity obtained with the use of the N-metylated analog. 
A special type of heterotridentate bis(oxazolines), 43, was recently reported by Willis, in 
which the two oxazoline rings are linked by a dibenzofuran moiety. The ligand was used in 
                                                                
55 M. Glos, O. Reiser, Org. Lett. 2000, 2, 2045. 
56 H. Werner, C. I. Herrerías, M. Glos, A. Gissibl, J. M. Fraile, I. Pérez, J. A. Mayoral, O. Reisera, Adv. Synth. Catal. 
2006, 348, 125. 
57 T. Shiomi, J. Ito, Y. Yamamoto, H. Nishiyama, Eur. J. Org. Chem 2006, 5594. 
58 H. Usuda, A. Kuramochi, M. Kanai, . Shibasaki, Org, Lett. 2004, 6, 4287. 
59 Y. Jiang, Q. Jiang, X.  Zhang, J. Am. Chem. Soc. 1998, 120, 3817. 
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the Mannich reaction
60
 and in the addition of nitrones to cyclopropanes
61
 with excellent 
enantioselectivity in both cases. 
 
 
 
A class of anaionic bis(oxazoline) ligands 44, known as boraBOX, was instead used by Pfaltz 
in the enantioselective cyclopropanation of styrene (Scheme 1.13).
62
 The boraBOX 
complexes showed similar reactivity of the corresponding BOX complexes.  
Bulkier substituents at the boron atom induced higher enantioselectivities. Ligand 44e 
provided the best results with a cis/trans ratio of 28:72. 
 
 
Scheme 1.13 
 
1.7.3     Bis(oxazoline) ligands separated by a stereo-axis 
 
Ligands with biphenyl and binaphthyl backbone were the first stereoaxis-containing 
bis(oxazolines) to be employed in a wide range of asymmetric reactions.
63,64
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Rippert prepared a numerous library of bis(phenyl) analogs 45 and investigated their 
characteristics in the copper(I)-catalyzed cyclopropanation of styrene with ethyl diazoacetate 
finding out an enantioselectivity dependence on the steric hindrance at the 5-position of the 
oxazoline ring.
 65
 
A binaphthyl skeleton was used by Hayashi to prepare ligands 46 for applications to Pd(II)-
catalyzed Wacker-type cyclizations.
66
  
 
 
 
An interesting class of bis(oxazolines), the chiral spiro ligand 47, was introduced by Sasai in 
2004 and employed in a range of asymmetric reactions,
67
 and lateron refined by Zhou.  
In this contest, Zhou reported also the synthesis of ligands 48 and their application to the 
catalytic asymmetric N-H insertion of amines with diazoesters,
68
 and to the enantioselective 
insertion of carbenoids into the O-H bonds of phenols,
69
 (Scheme 1.14), describing very 
recently the intramolecular phenolic O-H bond insertion.
70
 (Scheme 1.15) 
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Scheme 1.14 
 
 
Scheme 1.15 
 
Cu(I)-catalyzed cyclopropanation of styrene with ligand 49, characterized by the 3,3’-
bithiophene backbone, was able to give the final product in 81%, 67% of ee, and with a 
trans/cis ratio of 67:33.
71
 (Scheme 1.13)  
 
 
 
1.7.4     Bis(oxazoline) ligands separated by a stereo-plane 
 
A class of bis(oxazolines) that is worth mentioning consists in the ferrocenyl derivatives. 
In these ligands a stereo-plane replaces the usual stereocenters, in order to optimize the 
enantioselectivity of the tested reactions. 
Ikeda prepared several tetrasubstituted oxazolinylferrocenes 50 and 51, reaching yields up to 
97% and ee up to 93% in asymmetric alkylation of benzaldehyde with diethylzinc (Scheme 
1.16).
72
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Scheme 1.16 
 
1.7.5     Bis(oxazoline) ligands formed by supramolecular interaction  
 
In 2008, Schultz published, to the best of our knowledge, the only example reported in 
literature for supramolecular bis(oxazoline) ligands formed via charge transfer interaction of 
two monodentate oxazolines. She reported the synthesis of mono(oxazoline) ligands from 
three different amino alcohols and bearing either an electron-rich anthracene group 52 or an 
electron-poor trinitrofluorenone substituent 53. In the presence of copper triflate as pre-
catalyst, all the ligand combinations were tested, proving to give rise to active catalysts for 
the Diels–Alder reaction between cyclopentadiene and 3-but-2-enoyl-oxazolidin-2-one, albeit 
only poorly enantioselective (Scheme 1.17).
73
  
 
 
Scheme 1.17 
 
However, the best results in terms of enantioselectivity were obtained with the homocomplex 
formed from two electron-poor trinitrofluorenone oxazolines (therefore not able to form a  
supramolecular catalyst), for either the endo or the exo product.  
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1.8 Development of a new class of supramolecular bidentate nitrogen ligands. 
 
As discussed in the introduction, the concept of self-assembly of ligands through hydrogen 
bonding for combinatorial homogeneous catalysis was recently introduced, and several 
powerful supramolecular ligands were described with outstanding reactivity and selectivity. 
However, this methodology developed has been exclusively confined to the use of 
phosphorus ligands.
74
  
Therefore, we decided to extend this concept to nitrogen ligands for the synthesis of the first 
supramolecular bisoxazoline ligands, that we called SupraBox (Figure 1.3).  
In our approach, a covalent linker is replaced by a hydrogen-bond interaction between two 
urea moieties that are connected to the oxazoline rings via different spacers. Transition metal 
complexes with SupraBox were formed and applied to asymmetric transformations.  
In particular, the Zn(II)-complexes were used as catalysts for the Friedel-Crafts alkylation of 
the indole with fuctionalized alkenes, while the Cu(II)-complexes for kinetic resolution and 
desymmetrization of 1,2-diol.
75  
 
 
Figure 1.3 
 
1.8.1     Synthesis of the ligands  
 
In general terms a class of ligands suitable for a combinatorial exploitation should be 
accessed in a limited number of steps, through a highly modular synthesis which allows the 
creation of a wide diversity from a limited number of building blocks. 
The SupraBox ligands possess three possible tunable sites:  
 the oxazoline moiety,  
 the spacer,   
 the urea substituents,  
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which can be coupled in three straightforward synthetic steps involving only two 
chromatographic purifications (Scheme 1.18).  
 
 
Scheme 1.18 
 
Three different isocyanates (phenyl, cyclohexyl and 2-nitrophenyl isocyanate) were included 
in the screening to vary the H-bond forming properties of the ligands.  
The formation of the urea is probably the limiting step in terms of total yield of the synthesis, 
the main problem being due to the low solubility of the different amino acids used in the 
reaction. In general THF proved to be the a good solvent even if the solubility of products 
was not optimal. In one case the almost total insolubility of the 2-amino-isobutyric acid 
necessitated the use of a 2M NaOH solution as solvent, anyway leading low yield.   
Four different linkers, namely -alanine, 2-amino-isobutyric acid, L- and D-aspartic acid 
-pyrrolidinamide and 3-aminobenzoic acid, were used to impart different conformational 
rigidity to the ligands and hence influence the global conformation of the complexes (Scheme 
1.19).  
 
 
Scheme 1.19 
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Achiral linkers were readily available commercial products, whereas the chiral linker was 
synthesized ad hoc starting from aspartic acid (Scheme 1.20). In particular, the presence of 
stereocenters at the α-position of carboxylic groups (and hence of oxazolines) were deemed 
dangerous in terms of the stereo-integrity of the final ligand. Oxazolines in fact are known  to 
be susceptible of epimerization during the coupling of the starting carboxylic acid with the 
amino alcohols and the subsequent cyclization. On the other hand commercial enantiopure 3-
homo amino acids are very expensive and, despite several published synthetic protocols, 
suffer from difficult availability in multigram quantities. 
 
 
Scheme 1.20 
 
Coupling of the amino alcohols gave no particular problems using standard procedures, but  
chromatographic purification of the resulting amides was complicated by the use of DIPEA. 
An acidic work-up would be theoretically sufficient to remove the base, however the 
tendency of the product to be soluble in aqueous phases made this procedure not 
recommended.       
Different substituents on the oxazoline ring lead obviously to a different chemical 
environment around the catalyst metal and consequently different levels of steric hindrance 
can modify the selectivity of the catalyst. Due to the synthetic strategy the stereochemistry 
and the nature of the substituent is related to the starting amino alcohol (Scheme 1.21).  
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Scheme 1.21 
 
Cyclization reactions to give the oxazoline ring were carried out using diethylaminosulfur 
trifluoride (DAST) at -78°C. Due to the presence in the molecule of other nucleophilic 
oxygen atoms, an excess of DAST (2.2 equiv.) was necessary to obtain the cyclized product 
in good yieldsc(Scheme 1.22).  
 
 
Scheme 1.22 
 
Due to the modularity of the synthesis, a small library of 16 ligands Ox 1-16 was prepared for 
testing them in metal complex-catalyzed transformations.  
In addition, one monooxazoline Ox-0, devoid of the functionality capable of hydrogen bonds, 
was added to validate the importance of the supramolecular interactions.  
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1.8.2     Formation of the metal complexes and complexation studies 
 
Before screening the library in catalytic applications we decided to investigate the 
formation of transition metal complexes of our ligands.  
Bis(oxazolines) have been developed into one of the most useful ligand classes due to their 
ability to coordinate different metals and also to impart specific coordination geometries to 
these metal ions. 
The resulting chiral complexes display a C2-axis, a feature that has proven most beneficial in 
designing asymmetric processes due, in general, to the reduction of possible transition states 
caused by the equivalency of structures upon rotation by 180° (Figure 1.4).  
40 
 
 
Figure 1.4 
 
In the majority of bis(oxazoline) complexes, the metal is a four to six coordinated species; 
therefore, besides the two coordination sites occupied by the bidentate ligand, substrates, 
solvent molecules or counter anions, occupied the other available sites. The geometry of the 
complexes is a result of many factors and affects the outcome of a given reaction. 
Copper is known to be one of the metals with more coordination geometries, forming tri- 
tetra- penta- and hexacoordinate complexes. 
Tricoordinated complexes are almost exclusively prerogative of Cu(I), and in particular of 
copper(I)-carbene complexes as intermediates in cyclopropanations of alkenes with 
diazoacetates.
76
 
The two main geometries possible for tetracoordinated bis(oxazoline) complexes are square-
planar and tetrahedral. These are indeed widely found with varying degrees of distortion.  
Zinc(II), nickel(II) and iron(II) chloride complexes have proven to form distorted tetrahedral 
complexes, meanwhile with copper(II) chloride, coordinations are considerably more 
distorted towards a square-planar geometry.  
Quite obviously, the chloride ligands, when present, orient themselves away from the ligand 
quadrants blocked by the sterically demanding substituent and in general it is possible to say 
that the degree of distortion from the ideal tetrahedral geometry increases with the steric bulk 
of the oxazoline substitution (Scheme 1.23-A).
77
  
A similar trend is present for square-planar Cu(II)-complexes, which is a marked preferred 
geometry for hydroxyl- or carbonyl-containing ligands (Scheme 1.23-B).
78
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Scheme 1.23 
 
Hexacoordinated complexes are almost absent with bis(oxazoline) ligands, meanwhile 
pentacoordinated are more diffused.  
 
We focused our attention on copper- and zinc-complexes. 
The copper(II)-complex of ligand Ox-3 was obtained treating the ligand with CuCl2 in 
CH2Cl2, followed by recrystallization from CH2Cl2/hexanes. Its molecular composition was 
assessed by ESI-MS spectrometry and revealed one principal peak at m/z 613.3, 
corresponding to a copper atom coordinated to two molecules of ligand [Cu(Ox-3)2]
+
 (Figure 
1.5).  
The reduction of Cu
2+
 to Cu
+
 has been already reported to occur using ESI as ionization 
source, in which the electron counterflow between the counterelectrode and the capillary 
causes an increase of the Cu(I) species.
79
 In particular, the reduction of Cu(II) species can be 
induced by direct electron capture in the atmospheric pressure region of the source, before the 
entrance in the glass capillary.  
 
 
Figure 1.5 
 
                                                                                                                                                                       
Kozlowski, C. W. Downey, J. S. Tedrow, J. Am. Chem. Soc. 2000, 122, 9134; D. A. Evans, T. Rovis, M. C. 
Kozlowski, J. S. Tedrow, J. Am. Chem. Soc. 1999, 121, 1994. 
79 Lavanant, H.; Virelizier, H.; Hoppilliard, Y. J. J Am Soc Mass Spectrom 1998, 9, 1217. 
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Another interesting technique that allowed us to determine the formation of the desired 
complex, was the Yoe–Jones analysis.  
In general, when we deal with reactions based on the coordination of ligands to a metal 
source to give a complex MxLn, absorption spectroscopy is a powerful tool for exploring the 
complexation.  
Two general approaches to study the composition of complexes are typically used: 
 
 Method of Continuous Variations (Job's Method) 
In this method, the metal cation and ligand solutions with identical concentrations are mixed 
in different amounts such that the total volume of the mixture solutions and the total moles of 
reactants in each mixture is constant. This procedure causes the mole ratio of reactants to be 
varied across the set of mixture solutions. The absorbance of each solution is then measured 
and plotted versus the volume fraction of one of the reactants (M or L).  
 
 Mole-Ratio Method (Yoe-Jones Method) 
In this method, a series of solutions is prepared in which the concentration of one reactant is 
held constant while that of the other is varied. The absorbance of each solution is measured 
and plotted versus the mole ratio of the reactants. Assuming the complex absorbs more than 
the reactants, this plot will produce an increasing absorbance up to the combining ratio. At 
this point, further addition of reactant will produce less increase in absorbance. Thus a break 
in the slope of the curve occurs at the mole ratio corresponding to the combining ratio of the 
complex.
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Both techniques provide interesting information about the coordination processes of the 
ligand to metal, and also about the global stability constant of complexes.
80
 
For our complexation studies, we focus the attention on the Yoe-Jones method.  
In a typical representation, the analytical signal increases with the ligand mole ratio until a 
maximum is reached; from this point the analytical signal is maintained constant. The 
maximum value of the curve corresponds to the maximum formation of the complex and it 
indicates the stoichiometry of the complex . 
The curvature of the line obtained depends on the stability of the complex; the more stable it 
is, the closer the lateral segments of the experimental curve approach a straight line, and it 
means that the formation of the complex is practically total. For weak complexes, the 
experimental curve does not present any straight segments. 
In our experiments, we chose Ox-13 as ligand and we measured the absorbance (MAX = 741 
nm) as a function of the ligand/metal ratio, and a linear increase up to two equivalents of 
ligands added was observed, suggesting the presence of only one species ascribable to one 
copper coordinated to two molecule of ligands.  
The procedure required multiple and constant additions to CuCl2 in dichloromethane of a 
stock solution of the ligand, directly in the glass cuvette used for the analysis. 
Initially the solution was clear and colorless with CuCl2 insoluble as residue. The solution 
started to become greener and greener at each addition, as soon as the first portion of ligand 
was added. It is necessary to stress that, only when the amount of ligand added reached 2 
equivalents, the insoluble residue of CuCl2 totally disappeared.  
According to this type of analysis, the stochiometry of the complex is estimated from the 
point in which the curve changes its slope.  
All the observations led us to assumed the unique formation of the desired product Cu(Ox-
13)2Cl2 (Scheme 1.24).  
 
 
                                                                
80 E. J. Olson, P. Bühlmann, J. Org. Chem. 2011, 76, 8406. 
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Scheme 1.24 
 
Besides, we decided to explore the complexation of ligand Ox-0, the oxazoline devoid of the 
urea group. As for Ox-13, we measured once again the absorbance (MAX = 757 nm) as a 
function of the ligand/metal ratio. 
 
 
Scheme 1.25 
 
Again, a linear increase for each portion of ligand added was observed but, this time, the 
absorbance increased until the amount of ligand added was 2.5 equivalents, and still a slight 
portion of solid CuCl2 remained undissolved even after that was reached a constant value of 
absorbance (Scheme 1.25).  
Our explanation is that probably a series of equilibria occur and the formation of the final 
complex is a bit arduous to obtain; whereas the presence of the urea moiety in Ox-13, lead 
most likely to the immediately formation of a supramolecular bidentate ligands, hence 
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helping the formation of the desired complex and avoiding the possibility of the inconvenient 
mixture of equilibria. Moreover, the deviation from linearity could depend on the stability of 
the complex with respect to ligand dissociation:
81
 the more stable the complex is, the closer 
the experimental curve approaches a straight line. 
The paramagnetism of Cu(II) hampers the use of NMR spectroscopy for the characterization 
of the complex. Thus, palladium was chosen.  
Bis(acetonitrile)dichloropalladium(II) and two equivalents of ligand Ox-3 were stirred in 
dichloromethane and the complex [Pd(Ox-3)2Cl2] was isolated by precipitation with hexanes 
(Scheme 1.26).  
 
 
Scheme 1.26 
 
The formation of the supramolecular bidentate species was then studied by 
1
H-NMR.  
The attention was mainly focused on NH protons, the more representative signals. While 
coordination of the oxazolines to the metal ion is quite certain, coordination of two ligands on 
the same atom and moreover an interaction between them is far from obvious. So, a study of 
the chemical shifts of protons, which should give rise to H-bonding, should provide important 
information.  
The hydrogen bonding status of the NH protons for both the free ligand and the Pd(II)-
complex was then studied by 
1
H-NMR spectroscopy. In particular, the correlation between 
the variation of the chemical shift of the NH signals and the variation of the concentration 
was considered for both the ligand and the complex, and finally reported in the plot here 
below. This trend, if present, is important for showing a possible chemically different 
behavior of the NHs. 
 
 
 
 
                                                                
81 C. D. Chriswell, A. A. Schilt, Analytical Chem. 1975, 9, 1623. 
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(S) Ox-3 NHA NHB 
concentration (mM)    
5 5,62 0,00 6,80 0,00 
10 5,65 0,03 6,88 0,08 
20 5,78 0,16 7,19 0,39 
40 5,89 0,27 7,48 0,68 
 
     
Homocomplex NHA NHB 
concentration (mM)    
5 5,74 0,00 7,03 0,00 
10 5,76 0,02 7,05 0,02 
20 5,80 0,06 7,09 0,06 
40 5,84 0,10 7,13 0,10 
 
 
 
The results clearly show that the ligand alone behaves differently from when it is in a 
complex.  
The downfield shift of the chemical shifts of the two NH protons of the complex is not 
depending on the concentration as much as those of the free ligands. NHA and NHB proton 
signals of the homocomplex can better be considered fairly independent from the 
concentration.  
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What now seems curious is the lack of different sets of signals. Since one ligand acts as donor 
and the other as acceptor, two different sets of chemical shift should be present. So, we 
decided to investigate the behavior of the complex as a function of temperature and we found 
out that at temperature lower than 268K two signals appeared.  
This experiment, commonly used to differentiate between random-coil peptides and peptides 
in hydrogen bonded conformations, together with previous observations, indicates that the 
two ligands coordinated to the metal atom interact intramolecularly via hydrogen bonds. 
In order to verify complexation with zinc, only preliminary studies were done and they 
confirmed the formation of a supramolecular bidentate complex. 
Ligand Ox-3 was chosen and reacted with Zinc(II)trifluoromethanesulfonate in 
dichloromethane. The resulting [Zn(Ox-3)2(OTf)2] complex was isolated by precipitation 
with hexanes (Scheme 1.27).  
 
 
Scheme 1.27 
 
The downfiled shift of the urea protons in the 
1
H-NMR spectrum is consistent with the 
formation of the supramolecular bidentate complex: NHA signal for Ox-3 is at 5.62 ppm, 
while in the complex at 6.04ppm. On the other hand, NHB signal for Ox-3 is at 6.80 ppm, 
while in the complex at 7.05ppm. 
This trend, if present, is important to show a possible chemically different behavior of the 
NHs, that in our case would indicate the presence of hydrogen bonding. 
 
1.8.3     Catalytic applications 
 
1.8.3.1     Friedel-Crafts alkylation of indoles  
 
Lewis acid-catalyzed Friedel-Crafts alkylation reaction is a powerful carbon-carbon bond-
forming process in organic chemistry. The asymmetric version of this reaction can provide a 
very useful approach to the enantiomerically enriched alkylated arene products. 
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Examples of this reaction in literature mainly foresee the use of covalent bis(oxazolines) as 
ligands. Optically active indole derivatives have attracted significant attention in organic 
synthesis because they are important building blocks in a variety of interesting natural 
products and potential medicinal agents.
82
  
The asymmetric Friedel-Crafts reaction is one of the most powerful carbon-carbon bond-
forming reactions in synthetic organic chemistry; for this reason, Friedel–Crafts alkylation of 
indoles
83
 has shown promise as a synthetic methodology towards functionalized indoles.  
,-unsaturated carbonyl compounds are very suitable substrates for this reactions and they 
have been overwhelmingly investigated over the last years. 
On the other hand, the use of nitroalkenes is more recent but the easy transformation of the 
nitro group into a range of different functionalities makes their use even more attractive. 
Nitroalkenes are very active Michael acceptors,
84
 and the products of the alkylations of 
indoles with nitroalkenes can be applied to the synthesis of many biologically active 
compounds.  
In 2001, Jørgensen reported the first example of this reaction using a C2-symmetric chiral 
bis(oxazolines)-copper(II) complex as catalyst.
85
 Subsequently, other authors employed 
bis(oxazolines)-complexes to promote the reactions and, later on, Reiser examined the 
oxazoline/metal ratio influence on the enantioselectivity.
86
  
Reactions with ,-unsaturated carbonyl compounds, such as alkylidene malonate, are almost 
completely confined to the use of Cu(II)–bis(oxazolines) complexes.  
However, recently, the knowledge that these substrates are able to chelate a series of Lewis 
acids in many asymmetric reactions,
87
 has lead to the employment of different Lewis acids in 
the reactions. In the case of nitroalkenes, Zn(II)-complexes have mainly been used as 
catalysts reported in leterature.
88
 
                                                                
82 J. P. Kutney, The Total Synthesis of Natural Products: The Synthesis of Indole Alkaloids (Ed.: J. ApSimon), Wiley-
Interscience, New York, 1977; A.-u. -Rahman, A. Basha, Indole Alkaloids, Harwood Academic, Chichester, 1998; D. 
J. Faulkner, Nat. Prod. Rep. 2002, 19, 1. 
83 M. Bandini, A. Melloni, A. Umani-Ronchi, Angew. Chem. Int. Ed. 2004, 43, 550; D. A. Evans, K. R. Fandrick, H.-
J. Song, K. A. Scheidt, R. S. Xu, J. Am. Chem. Soc. 2007, 129, 10029; T. B. Poulsen, K. A. Jørgensen, Chem. Rev. 
2008, 108, 2903. 
84 O. M. Berner, L. Tedeschi, D. Enders, Eur. J. Org. Chem. 2002, 1877. 
85 W. Zhang, T. Hansen, K. A. Jørgensen, Chem. Commun. 2001, 347. 
86 R. Rasappan, M. Hager, A. Gissibl, O. Reiser, Org. Lett. 2006, 8, 6099; A. Schtz, R. Rasappan, M. Hager, A. 
Gissibl, O. Reiser, Chem. Eur. J. 2008, 14, 7259. 
87 J. Zhou, Y. Tang, J. Am. Chem. Soc. 2002, 124, 9030, D. A. Evans, T. Rovis, M. C. Kozlowski, C. W. Downey, J. 
S. Tedrow, J. Am. Chem. Soc. 2000, 122, 9134. 
88 S-F. Lu, D-M Du, J. Xu, Org. Lett. 2006, 8, 2115; Y-X. Jia, S-F. Zhu, Y. Yang, Q-L. Zhou, J. Org. Chem. 2006, 
71, 75; H. Liu, D-M. Du, Eur. J. Org. Chem. 2010, 2121.  
49 
 
In view of the above considerations, we decided to screen some of our ligands in the Friedel-
Crafts alkylation of indole.  
We started with benzylidenemalonate. The reactions were carried out in dichloromethane 
using one equivalent of alkylidene malonate, 2 equivalents of indole, 5 mol% of Cu(OTf)2 
and 10 mol% of the chosen ligand (Table 1.1).  
 
 
 
 
 
 
 
 
 
 
 
a Isolated by flash chromatography. Eluent: EDP/AcOEt 5:1 
enantiomerc excess determined by HPLC: Column Chiracel OD-H, Hex/IPA 88:12, flow 0,8 mL/min  
Table 1.1 
 
First of all, the reaction was catalyzed by the precatalyst Cu(OTf)2, affording the final product 
in 30% yield after 3 days; while the formation of the catalyst with Ox-0, the ligand void of 
the urea moiety, led to lower conversion. The SupraBox Cu(II)-complexes showed activity, 
even though not always giving better results comparing with those from the use of Cu(OTf)2 
itself. Phenyl substitution on the oxazoline ring gave no conversion at all, independently from 
the spacer (entries 5 and 7). Complex of Ox-13 (entry 8) showed good activity in terms of 
conversion, affording the final product in 63% yield.  
Unfortunatelly no promising data were obtained with respect to enantioselection. This lack in 
enantioselectivity hampered us from further investigation.  
Better results were achieved in the Friedel-Crafts alkylation of indole with trans--
nitrostyrene.The screening results are reported in Table 1.2 here below. 
Entry Ligand  Yielda (%) 
1 none 30 
2 Ox-0 10 
3 Ox-2 13 
4 Ox-3 34 
5 Ox-4 n.r. 
6 Ox-6 21 
7 Ox-7 26 
8 Ox-13 63 
9 Ox-15 n.r. 
10 Ox-16 12 
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Entry Metal source Time Yielda (%) eeb (%) 
1 Cu(OTf)2 4 days 41 rac 
2 Zn(OTf)2 24 h 90 8 
 
 
Entry Ligand Temp (°C) Solvent Time Yielda (%) eeb (%) 
3 Ox-3 15 CH2Cl2 17 h 63 8 
4 Ox-3 15 Toluene/CH2Cl2 1:1 17 h 83 8 
5 Ox-3 15 Toluene 17 h 42 8 
6 none 0 Toluene/ CH2Cl2 1:1 3 days 30 rac 
7 Ox-0 0 Toluene/ CH2Cl2 1:1 3 days 90 10 
8 Ox-2 0 Toluene/ CH2Cl2 1:1 3 days 43 rac 
9 Ox-3 0 Toluene/ CH2Cl2 1:1 3 days 75 10 
10 Ox-4 0 Toluene/ CH2Cl2 1:1 3 days 72 10 
11 Ox-7 0 Toluene/ CH2Cl2 1:1 3 days 16 rac 
12 Ox-12 0 Toluene/ CH2Cl2 1:1 3 days 75 20 
13 Ox-13 0 Toluene/ CH2Cl2 1:1 3 days 14 10 
14 Ox-14 0 Toluene/ CH2Cl2 1:1 3 days 96 rac 
15 Ox-15 0 Toluene/ CH2Cl2 1:1 3 days 82 15 
16 Ox-16 0 Toluene/ CH2Cl2 1:1 3 days 33 10 
a Isolated by flash chromatography. Eluent: EDP/AcOEt 3:1 
b Determined by HPLC. Column Chiracel OD-H, Hex/IPA 88:12, flow 0,8 mL/min 
Table 1.2 
 
First of all we compared Cu(OTf)2 with Zn(OTf)2 as metal source in dichloromethane at 15°C 
and, as expected,
89
 for this substrate zinc(II) proved to be a better catalyst than copper(II) 
(entries 1 and 2). 
                                                                
89 S-F. Lu, D-M Du, J. Xu, Org. Lett. 2006, 8, 2115; Y-X. Jia, S-F. Zhu, Y. Yang, Q-L. Zhou, J. Org. Chem. 2006, 
71, 75. 
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The following step was based on the choice of the best solvent. Toluene, which is reported to 
be the best solvent, did not work in our case due to the insolubility of our complexes in this 
solvent, whereas a mixture of toluene/dichloromethane in a 1:1 ratio turned out to be the best 
compromise. 
Once the solvent was defined, we proceeded with the investigation of the ligands library, 
using 5 mol% of catalyst, stirring the reaction at 0°C for 3 days. 
From the library of SupraBox, some representative ligands were chosen and tested. 
Zn(OTf)2 itself catalyzed the reaction, affording the desired product in a 30% yield (entry 6). 
In addition, also the complex formed from Ox-0, the ligand devoid of urea group, had a very 
good activity, leading to the final product in 90% yield (entry 7). With some complexes, 
higher conversions than entry 6 were obtained and in some cases (Ox-12 and Ox-15) a 
glimmer of enantiodiscrimination was obtained (entries 12 and 15). To confirm the presence 
of supramolecular bidentate ligand in the reaction we compared the reaction outcome using 5 
mol% Zn(OTf)2 and either 5 mol% of ligand Ox-12 (in a 1:1 ratio) or 10 mol% of the same 
ligand (in a 1:2 ratio). In the latter case the ee% was higher than in the first experiment, where 
a racemate was formed in the same yield of entry 6 (where Zn(OTf)2 itself was the catalyst). 
The levels of ee% reached were, unfortunately, considered not so satisfactory to lead us in 
continuing with further investigations. 
 
1.8.3.2     Kinetic resolution of racemic diols and desymmetrization of meso diols  
 
The importance of chirality is well recognized, mainly in connection with the fact that 
nearly all natural products are chiral and their physiological or pharmacological properties 
depend upon their recognition by chiral receptors, which interact only with molecules of the 
proper absolute configuration. Thus, the use of chiral drugs in enantiopure form is now a 
standard requirement for virtually every new chemical entity and the development of new 
synthetic methods to obtain enantiopure compounds has become a key goal for 
pharmaceutical companies. The broad utility of synthetic chiral molecules as single-
enantiomer pharmaceuticals, as well as components in electronic and optical devices or in 
polymers with novel properties and lastly as probes of biological function, has made 
asymmetric synthesis a prominent area of investigation.  
In pharmaceuticals, as well as in related industries, asymmetry plays an important role, since 
both enantiomers of a specific drug do not necessarily have the same activity. Although  
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tremendous advances have been made in asymmetric synthesis, resolution of racemates is still 
the most important industrial approach to the synthesis of enantiomerically pure compounds.  
A kinetic resolution is defined as a process where the two enantiomers of a racemate are 
transformed to products at different rates. If the kinetic resolution is efficient, one of the 
enantiomers of the racemic mixture is transformed into the desired product while the other is 
recovered unchanged.  
Copper bis(oxazoline) complexes have been shown to be efficient catalysts in the kinetic 
resolution of racemic diols and in particular hydrobenzoin. 
For this reason we decided to screen our small library of ligands in this reaction (Table 1.3).  
The catalytic reactions were carried out by pre-formation of the complexes by stirring a 
suspension of CuCl2 in a solution of the ligand in CH2Cl2, until all of the highly insoluble 
copper salt becomes soluble by complexation (formation of a deeply colored solution) with 
the ligand. 
 
 
Entry Ligand Yielda (%) eeb (%) (conf.) Selectivityc (s) (%) 
1 Ox-0 40 0 1 
2 Ox-1 45 86 (S,S) 28 
3 Ox-2 43 70 (R,R) 9.5 
4 Ox-3 44 86 (R,R) 27 
5 Ox-4 47 20 (S,S) 1.8 
6 Ox-5 45 2 (R,R) 1.1 
7 Ox-6 41 44 (R,R) 3.4 
8 Ox-7 44 64 (R,R) 7.4 
9 Ox-8 26 56 (S,S) 4.3 
10 Ox-9 37 22 (R,R) 1.8 
11 Ox-10 43 70 (R,R) 9.5 
12 Ox-11 35 0 1 
13 Ox-12 38 34 (R,R) 2.5 
14 Ox-13 17 12 (R,R) 1.3 
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15 Ox-14 39 14 (R,R) 1.4 
16 Ox-15 28 14 (S,S) 1.4 
17 Ox-16 34 20 (R,R) 1.7 
a Isolated by flash chromatography. Eluent: Hex/AcOEt 3:1 
b Determined by HPLC. Column Chiralpak AS-H, Hex/IPA 90:10, flow 0,5 mL/min 
c Determined according ref. 90 
Table 1.3 
 
Despite structural similarities between Ox 1-16, their performance in the asymmetric 
benzoylation varied considerably, and rather surprisingly, best selectivities were obtained 
with ligands Ox-1 and Ox-3, while ligands Ox-2 and Ox-4, having benzyl and phenyl 
substitution at the stereocenters, that had proven most successful in the title reaction with 
bis(oxazolines), gave inferior results.
91
  
From a closer inspection of the selectivities, the importance of a fine balance of 
conformational flexibility, steric hindrance, and electronic properties becomes evident. In 
particular, the meta-disubstituted aromatic linker (entries 14-16) and the C-tetrasubstituted 
amino acid (Aib) hamper enantioselectivity, probably because of the high rigidity which does 
not allow an efficient docking of the two urea functionalities. In fact, the use of a -alanine 
linker (entries 1-7), which is best combined with an iso-propyl or ethyl substitution at the 
oxazoline moiety, results in a significant increase of selectivity (entries 2 and 4). Finally, no 
selectivity was obtained with the monodentate ligand Ox-0, which is not capable of 
supramolecular interactions (entry 1). 
The asymmetric catalytic acylation with copper(II) complexes has also been applied to the 
desymmetrization of meso-diols,
92
 although with lower ees than the kinetic resolution (ee = 
58% in the asymmetric benzoylation of meso-hydrobenzoin
93
). We tested a selection of 
ligands in the desymmetrization of meso-hydrobenzoin by benzoylation and the results are 
collected in Table 1.4. 
 
                                                                
90 H. B. Kagan, J. C. Fiaud, Top. Stereochem. 1988, 18, 249; J. M. Keith, J. F. Larrow, E. N. Jacobsen, Adv. Synth. 
Catal. 2001, 343, 5. 
91 Y. Matsumura, T. Maki, K. Tsurumaki, O. Onomura, Tetrahedron Lett. 2004, 45, 9131; C. Mazet, S. Roseblade, V. 
Köhler, A. Pfaltz, Org. Lett. 2006, 8, 1879; Y. Matsumura, T. Maki, S. Murakami, O. Onomura, J. Am. Chem. Soc. 
2003, 125, 2052; A. Gissibl, M. G. Finn, O. Reiser, Org. Lett. 2005, 7, 2325; A. Gissibl, C. Padié, M. Hager, F. 
Jaroschik, R. Rasappan, E. Cuevas-Yañez, C.-O. Turrin, A.-M. Caminade, J.-P. Majoral, O. Reiser, Org. Lett. 2007, 
9, 2895; A. Schätz, M. Hager, O. Reiser, Adv. Funct. Mater. 2009, 19, 2109; A. Schätz, R. N. Grass, Q. Kainz, W. J. 
Stark, O. Reiser, Chem. Mater. 2010, 22, 305. 
92 C. Mazet, V. Köhler, A. Pfaltz, Angew. Chem. Int. Ed. 2005, 44, 4888; D. Nakamura, K. Kakiuchi, K. Koga, R. 
Shirai Org. Lett. 2006, 8, 6139; Y. Demizu, K. Matsumoto, O. Onomura, Y Matsumura, Tetrahedron Lett. 2007, 48, 
7605. 
93 C. Mazet, V. Köhler, A. Pfaltz, Angew. Chem. Int. Ed. 2005, 44, 4888. 
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Entry Ligand Yielda (%) eeb (%) (conf.) 
1 Ox-0 73 0 
2 Ox-1 92 78 (1S,2R) 
3 Ox-2 77 6 (1R,2S) 
4 Ox-3 44 88 (1R,2S) 
5 Ox-4 70 24 (1S,2R) 
6 Ox-6 89 38 (1R,2S) 
7 Ox-7 88 68 (1R,2S) 
8 Ox-8 99 26 (1S,2R) 
9 Ox-9 68 40 (1R,2S) 
10 Ox-10 62 20 (1R,2S) 
11 Ox-13 68 2 (1R,2S) 
12 Ox-15 74 7 (1S,2R) 
a Isolated by flash chromatography. Eluent: Hex/AcOEt 3:1  
b Determined by HPLC. Column Chiralpak AS-H, Hex/IPA 90:10, flow 0,5 mL/min 
Table 1.4 
 
Once again satisfactory results were obtained with ligands Ox-1 and Ox-3 (entries 2 and 4). 
Notably, the SupraBox ligands outperform the classical methylene-bridged bis(oxazolines) 
and the aza-bis(oxazolines), probably because the flexibility of the linker allows these meso-
substrates to be accommodated in the copper(II) coordination sphere. On the contrary, the 
rigidity of the classical bis(oxazolines) creates a cavity where the C2-symmetric (D,L)-vic-
diols can fit better than the -symmetric meso-diols. Also in this case, ligand Ox-0, devoid of 
functionalities acting as hydrogen bond donors, catalyzed the benzoylation in an unselective 
way (entry 1). 
 
1.9     Conclusions 
 
In this chapter we reported the synthesis of a new class of supramolecular bis(oxazolines), 
called SupraBox, using the urea moiety as self-assembly inducer. 
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A library of 16 ligands, with different degrees of structural diversity  was prepared by a 3-step 
modular synthesis starting from readily available starting materials. Zinc(II)-, palladium(II)- 
and copper(II)-complexes were characterized by NMR spectroscopy, UV-Vis spectroscopy 
and Mass-spectrometry in order to investigate their structures and properties. 
Zinc(II)-complexes were used as catalysts in asymmetric Friedel-Crafts alkylations of indole 
as well as copper(II)-complexes; whereas for kinetic resolutions of racemic diols and for the 
desymmetrization of meso diols only copper(II)-complexes were applied. 
Complexes of SupraBox ligands proved to be active catalysts in the Friedel-Crafts alkylation 
of indole, but not entirely satisfactory results have been archived so far.  
Complexes of SupraBox ligands proved to give best results in the asymmetric benzoylation of 
hydrobenzoin and good enantiomeric excesses were achieved with both racemic and meso 
substrates. This unusual property, and the selectivity itself, proved to be correlate to the 
ligand structure, and in general the more flexible ligands gave better results. We hypothesized 
that the above mentioned flexibility, peculiar of our system but not of classical Box and aza-
Box, best fit to the structure of meso compounds, thus leading better results (Scheme 1.28).  
In case of racemic substrates, the two enantiomers have different affinity with the catalyst, 
while with meso substrates, only one hydroxy group is available for the reactivity. 
 
RACEMIC SUBSTRATES                                    MESO SUBSTATES 
                                 
Scheme 1.28 
 
1.10     Experimental section 
 
General Remarks  
 
All reactions were carried out under a nitrogen atmosphere, using standard Schlenk 
techniques. The reactions were performed with distilled solvents. CH2Cl2 was distilled from 
CaH2 and toluene was distilled from Na under nitrogen.  
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Kinetic resolution and desimmetrization of diols were performed using dry solvents (over 
molecular sieves in bottles with crown caps) purchased from Sigma–Aldrich and stored under 
nitrogen. 
Air sensitive liquids and solutions were transferred via a gas-tight syringe or cannula. 
Removal of solvents was accomplished by evaporation on a Buchi rotary evaporator (water 
bath 40°C).  
The reactions were monitored by analytical thin-layer chromatography (TLC) using silica gel 
60 F254 pre-coated glass plates (0.25 mm thickness). Visualisation was accomplished by 
irradiation with a UV lamp and/or staining with a potassium permanganate alkaline solution 
or a nynhidrine solution. Flash column chromatography was performed using silica gel (60 Å, 
particle size 40-64 μm) as stationary phase, following the procedure by Still and co-workers.94 
1
H- and 
13
C-NMR spectra were recorded measured on a Bruker DRX 400MHz. Chemical 
shifts are reported in ppm with the solvent reference relative to tetramethylsilane (TMS) 
employed as the internal standard (CDCl3 δ = 7.26 ppm). 
13
C NMR spectra were recorded 
with a 400 MHz spectrometer operating at 100.56 MHz with complete proton decoupling. 
Chemical shifts are reported in ppm relative to TMS with the respective solvent resonance as 
the internal standard (CDCl3, δ = 77.23 ppm). Mass spectra were measured with a Fourier 
Transform Ion Cyclotron Resonance (FT-ICR) Mass Spectrometer APEX II & Xmass 
software (Bruker Daltonics)-4.7 T Magnet (Magnex) equipped with ESI source. Chiral HPLC 
analysis were performed with a Shimadzu instrument equipped with a Diode Array detector. 
Commercially available reagents were used as received without, unless indicated otherwise. 
 
1.10.1    Synthesis of the ligand relative precursors 
 
3-(3-phenylureido)propanoic acid (54a) 
 
Phenylisocyanate (5.0mL, 44 mmol, 1.0 equiv.) was dissolved in 220 mL THF and then β-
alanine (3.92 g, 44 mmol, 1.0 equiv.) was added and the reaction mixture stirred at room 
temperature for 3 days. The mixture was treated with cold Et2O to provide the precipitation of 
the product. After filtration the crude product was purified by flash chromatography eluting 
                                                                
94 W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923. 
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with 3→10% MeOH in DCM to yield product 54a as fine white powder (8.33g, 40 mmol, 
91%). 
Rf = 0.24 (DCM/MeOH 95:5) - m.p.160-161°C  - 
1
H NMR (400 MHz, CD3OD, 25°C): δ = 
2.55 (t, 2H, J= 6.3 Hz), 3.47 (t, 2H, J= 6.3 Hz), 6.98 (t, 1H, J= 6.8 Hz), 7.25 (dd, 2H, J=  8.4, 
7.4 Hz), 7.33 (m, 2H). - 
13
C NMR (100.6 MHz, CDCl3, 25°C): δ = 34.1, 35.2, 119.0, 122.0, 
128.4, 139.5, 156.8, 174.3. - IR: ν = 3584, 3329, 2725, 1694, 1638, 1571, 1108. - C10H12N2O3 
(208.21): calcd. C 57.68, H 5.81, N 13.45; found C 57.73, H 5.57, N 13.81.  
 
3-(3-(2-nitrophenyl)ureido)propanoic acid (54b) 
 
2-nitro-phenylisocyanate (1.000 g, 6.09 mmol, 1.0 equiv.) was dissolved in 30 mL THF and 
then β-alanine (1.085 g, 12.18 mmol, 2.0 equiv.) was added and the reaction mixture stirred at 
room temperature for 3 days. The mixture was treated with cold Et2O to provide the 
precipitation of the product. After filtration the crude product was purified by flash 
chromatography eluting with 3→5% MeOH in DCM to yield product 54b as fine yellow 
powder (1.077g, 4.25 mmol, 67%). 
Rf= 0.41 (DCM/MeOH 95:5) - m.p.160-161°C - 
1
H NMR (400 MHz, CDCl3, 25°C): δ = 2.56 
(t, 2H, J= 6.6 Hz), 3.48 (t, 2H, J= 6.6 Hz), 7.13 (ddd, 1H, J= 8.5, 7.2, 1.3), 7.61 (ddd, 1H, J= 
8.6, 7.2, 1.6), 8.12 (dd, 1H, J= 8.5, 1.6 Hz), 8.35 (dd, 1H, J= 8.6, 1.3 Hz). - 
13
C NMR (100.6 
MHz, CD3OD, 25°C): δ = 33.8, 35.5, 121.4, 122.1, 125.1, 134.6, 135.7, 137.1, 155.4, 174.0. - 
IR: ν = 3583, 3393, 3330, 2753, 2360, 1694, 1611, 1582, 1539, 1342, 1258, 1142, 1085, 798. 
- C10H11N3O5 (253.21): calcd. C 47.43; H 4.38; N 16.59; found C 47.62, 4.23, 16.2 
 
3-(3-cyclohexylureido)propanoic acid (54c) 
 
Cyclohexylisocyanate (2.86 mL, 22 mmol, 1.0 equiv.) was dissolved in 150 mL THF and 
then β-alanine (2.00 g, 22.4 mmol, 1.0 equiv.) was added and the reaction mixture stirred at 
room temperature for 3 days. The mixture was treated with cold Et2O to provide the 
precipitation of the product. After filtration the crude product was purified by flash 
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chromatography eluting with 5→15% MeOH in DCM to yield product 54c as fine white 
powder (3.60 g, 16.8 mmol, 76%). 
Rf= 0.23 (DCM/MeOH 95:5) - m.p.159-160°C  - 
1
H NMR (400 MHz, DMSO, 25°C): δ = 
0.97-1.16 (m, 3H), 1.18-1.30 (m, 2H), 1.50 (m, 1H), 1.61 (m, 1H), 1.70 (m, 1H), 2.31 (t, 2H, 
J= 6.5 Hz), 3.15 (q, 2H, J= 6.5 Hz), 5.74 (t, 1H, J= 5.8 Hz), 5.83 (d, 1H, 7.9 Hz), 12.17 
(s,1H). - 
13
C NMR (100.6 MHz, DMSO, 25°C): δ = 24.9, 25.8, 33.7, 35.5, 35.7, 48.1, 157.7, 
173.9. - IR: ν = 3335, 1699, 1626, 1580, 1535, 1307, 1248, 1222, 1080, 921. - C10H18N2O3 
(214.26): calcd. C 56.06; H 8.47; N 13.07; found C 55.87, H 8.62, N 12.72. 
 
2-methyl-2-(3-phenylureido)propanoic acid (54d) 
 
2-aminoisobutyric acid (3.0 g, 29 mmol, 1.3 equiv) was suspended in 10 mL of 2M NaOH 
then phenylisocyanate (2.37 mL, 22 mmol, 1.0equiv) was added and the mixture reaction was 
stirred for 60 minutes at room temperature. The mixture was filtered and the product was 
precipitated from solution by slow addition of 1M HCl. The white solid was dissolved in 10 
mL of 1M NaOH and the solution washed with DCM.  Addition of 1M HCl provides the 
precipitation of product 54d as fine white powder (1.73 g, 7.78 mmol, 35%). 
Rf= 0.37 (DCM/MeOH 95:5) - m.p.157-158°C  - 
1
H NMR (400 MHz, CD3OH, 25°C): δ = 
1.53 (s, 6H), 6.41 (s, 1H), 6.95 (m, 1H), 7.24 (m, 2H), 7.30 (m, 2H), 8.19 (s, 1H). - 
13
C NMR 
(100.6 MHz, CD3OD, 25°C): δ = 24.6, 55.3, 118.6, 121.9, 128.3, 139.4, 155.7, 177.3. - IR: 
ν= 3381, 2724, 1704, 1648, 1544, 1308, 1158, 1069. - C11H14N2O3 (222.24): calcd. C 59.45; 
H 6.35; N 12.60; found C 59.55, H 5.55, N 12.61. 
 
4-(allyloxy)-4-oxo-2-(3-phenylureido)butanoic acid (56a-56b) 
 
4-(allyloxy)-2-amino-4-oxobutanoic acid hydrochloride (1.20 g, 5.72 mmol, 1.0 equiv.) was 
suspended in 57 mLTHF and triethylamine (0.79 mL, 5.72 mmol, 1.0 equiv) added dropwise. 
The reaction mixture was vigorously stirred for 30 minutes then phenylisocyanate (0.65 mL, 
5.72 mmol, 1.0 equiv) added and stirred for 3 days at room temperature. The mixture was 
treated with acold Et2O to provide the precipitation of a white powder. The solid was washed 
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with KHSO4 1M to obtain product 56a and 56b as fine white powder (S-enantiomer: 1.407 g, 
4.81 mmol, 84%, R-enantiomer: 1.394 g, 4.77 mmol, 83%.). 
Rf= 0.28 (DCM/MeOH 95:5) - m.p.186-187°C  - 
1
H NMR (400 MHz, CDCl3, 25°C): δ = 
2.86 (bs, 2H), 4.54 (bs, 2H), 4.78 (bs, 1H), 5.19 (d, 1H, J= 10.4 Hz), 5.26 (d, 1H, J= 17.1 
Hz), 5.84 (m, 1H), 6.8 (bs, 1H), 6.96 (t, 1H, J= 6.8 Hz), 7.20 (t, 2H, J= 7.1 Hz), 7.39 (d, 2H, 
J= 7.0 Hz), 8.46 (bs, 1H), 11.23 (bs, 1H). - 
13
C NMR (100.6 MHz, CDCl3, 25°C): δ = 36.5, 
49.9, 65.6, 118.4, 119.4, 122.6, 128.8, 131.8, 139.1, 156.5, 170.9. - IR: ν = 3311, 2738, 2603, 
2531, 2496, 1716, 1702, 1596, 1547, 1397, 1172, 1072, 1036, 851, 807. - C14H16N2O5 
(292.29): calcd. C 57.53; H 5.52; N 9.58; found C 57.89, H 5.87, N 9.34. 
  
allyl 4-oxo-3-(3-phenylureido)-4-(pyrrolidin-1-yl)butanoate (57a-57b) 
 
4-(allyloxy)-4-oxo-2-(3-phenylureido)butanoic acid (1.300 g, 4.45 mmol, 1.0 equiv) and N,N-
diisopropylethylamine (1.90 mL, 11.1 mmol, 2.5 equiv.) were dissolved in 45 mL DMF and 
the solution cooled at 0°C. HBTU (1.3equiv) was added and the solution stirred at the same 
temperature for 30 minutes, then pirrolidine (0.44 mL, 5.34 mmol, 1.2 equiv.)  was added and 
the reaction mixture stirred at 0°C for 60 minutes and overnight at room temperature. 
The solvent was evaporated under reduced pressure and the mixture separated by flash 
chromatography eluting with MeOH (gradient from 2 to 6%) in DCM to yield the products 4a 
and 4b as pale yellow oil (S-enantiomer: 1.199 g, 3.47 mmol, 78%, R-enantiomer: 1.122 g, 
3.24 mmol, 73%.). 
Rf= 0.28 (DCM/MeOH 95:5) - 
1
H NMR (400 MHz, CDCl3, 25°C): δ = 1.88 (m, 2H), 1.99 
(m, 2H), 2.68 (dd, 1H, J= 15.8, 6.7 Hz), 2.89 (dd, 1H, J= 15.8, 7.4 Hz), 3.42 (m, 2H), 3.67 
(m, 1H), 3.78 (m, 1H), 4.59 (t, 1H, J= 1.3 Hz), 4.61 (t, 1H, J= 1.3 Hz), 5.01 (t, 1H, J= 7.0 
Hz), 5.20 (ddd, 1H, J= 10.5, 2.7, 1.2 Hz), 5.31 (ddd, 1H, J= 17.2, 3.0, 1.6 Hz), 5.92 (m, 1H), 
6.98 (m, 1H), 7.24 (m, 2H), 7.34 (dd, 2H, J= 8.8, 1.0 Hz).  - 
13
C NMR (100.6 MHz, CDCl3, 
25°C): δ = 23.7, 25.5, 36.6, 46.0, 46.5, 48.2, 65.1, 117.2, 118.8, 122.3, 128.4, 132.1, 139.2, 
155.7, 170.2, 170.4. - IR: ν = 2721, 2656, 2512, 2345, 1721, 1678, 1600, 1329, 1178, 1109, 
1074, 997, 856.  - C18H23N3O4 (345.39): calcd. C 62.59; H 6.71; N 12.17; found C 62.33, H 
6.57, N 11.99. 
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4-oxo-3-(3-phenylureido)-4-(pyrrolidin-1-yl)butanoic acid (54e-54f) 
 
allyl 4-oxo-3-(3-phenylureido)-4-(pyrrolidin-1-yl)butanoate (1.10g, 3.18mmol, 1.0 equiv) 
was dissolved in 30mL DCM and the solution cooled at 0°C. Pyrrolidine (0.31 mL, 3.82 
mmol, 1.2 equiv.), triphenylphosphane (0.149 g, 0.57 mmol, 0.18 equiv.) and 
tetrakis(triphenylphosphane) palladium(0) (0.147 g, 0.13 mmol, 0.04 equiv.)  were added and 
the reaction mixture stirred for 1 hour at 0°C. The mixture was poured into AcOEt (200mL) 
and extracted with satd. NHCO3  solution (5x 30mL). Organic layers were acidified to pH 2 
with 1M KHSO4 solution. The acidified aqueous solutions was extracted with DCM (3x 
25mL) and the combined organic layers were dried with Na2SO4 and concentrated under 
reduced pressure. The crude product was purified by flash chromatography eluting with 6% 
MeOH in DCM to yield the product as yellow solid (S-enantiomer 0.778 g, 2.55 mmol, 80%, 
R-enantiomer 0.754 g, 2.47 mmol, 77%.). 
Rf= 0.30 (DCM/MeOH 95:5) - m.p.168-169°C  - 
1
H NMR (400 MHz, CDCl3, 25°C): δ = 
1.85 (m, 2H), 1.96 (m, 2H), 2.73 (dd, 1H, J= 15.7, 6.2 Hz), 2.84, (dd, 1H, J= 15.7, 6.1 Hz), 
3.44 (m, 2H), 3.62 (m, 1H), 3.80 (m, 1H), 5.13 (m, 1H), 6.75 (d, 1H, J= 8.8 Hz), 6.97 (t, 1H, 
J= 7.5 Hz), 7.21 (t, 2H, J= 7.5 Hz), 7.34 (d, 2H, J= 7.7 Hz), 8.08 (s, 1H). - 
13
C NMR (100.6 
MHz, CDCl3, 25°C): δ = 24.1, 25.9, 37.5, 46.6, 47.1, 48.2, 119.5, 122.7, 128.8, 139.1, 155.4, 
170.6, 173.7. - IR: ν = 3347, 3202, 3145, 1728, 1685, 1615, 1553, 1518, 1481, 1312, 1203, 
1119, 1046, 997. - C15H19N3O4 (305.33): calcd. C 59.01; H 6.27; N 13.76; found C 59.34, H 
5.99, N 13.44. 
 
3-(3-phenylureido)benzoic acid (54g) 
 
Phenylisocyanate (1.59  mL, 14.5 mmol, 1.0 equiv.) and 3-aminobenzoic acid (2.0 g, 14.5 
mmol, 1.0 equiv) were dissolved in 80 mL THF and the reaction mixture stirred at room 
temperature for 3 days. The mixture was treated with cold Et2O to provide the precipitation of 
the product as fine white powder (2.34 g, 9.15 mmol, 63%). 
Rf= 0.35 (DCM/MeOH 95:5) - m.p.152-1531°C - 
1
H NMR (400 MHz, CD3OD, 25°C): δ = 
7.03 (m, 1H), 7.30 (m, 2H), 7.37-7.46 (m, 3H), 7.68 (ddd, 1H, J= 7.7, 1.5, 1.1 Hz), 7.73 (ddd, 
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1H, J= 8.0, 2.3, 1.1 Hz), 8.08 (t, 1H, J= 1.7 Hz). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ = 
119.1, 119.9, 122.6, 123.2, 123.5, 128.4, 128.6, 131.2, 139.0, 139.5, 151.1, 168.2. - IR: ν = 
3354, 2724, 1738, 1680, 1649, 1556, 1310, 1156, 1066. - C14H12N2O3 (256.26): calcd. C 
65.62; H 4.72; N 10.93; found C 63.38, 4.44, 10.81. 
 
3-(3-(2-nitrophenyl)ureido)benzoic acid (54h) 
 
2-nitrophenyl isocyanate (1.0 g, 6.09 mmol, 1.0 equiv.) and 3-aminobenzoic acid (0.84 g, 
6.09 mmol, 1.0 equiv) were dissolved in 60 mL THF and the reaction mixture stirred at room 
temperature for 3 days. The mixture was treated with cold Et2O to provide the precipitation of 
the product as fine yellow powder (1.36 g, 4.50 mmol, 74%). 
Rf= 0.26 (DCM/MeOH 95:5) - m.p.174-175°C - 
1
H NMR (400 MHz, DMSO, 25°C): δ = 
7.22 (ddd, 1H, J= 8.4, 7.2, 1.2 Hz), 7.42 (t, 1H, J= 7.8 Hz), 7.59 (dt, 1H, J=7.7, 1.2 Hz), 7.66-
7.73 (m, 2H), 8.09 (dd, 1H, J= 8.4, 1.6 Hz), 8.15 (t, 1H, J= 1.8 Hz), 8.29 (dd, 1H, J= 8.5, 1.2 
Hz), 9.61 (s, 1H), 10.03 (s, 1H), 12.93 (s, 1H). - 
13
C NMR (100.6 MHz, DMSO, 25°C): δ = 
119.7, 122.8, 123.0, 123.7, 125.8, 129.6, 131.9, 135.2, 135.4, 138.3, 140.0, 152.3, 167.6. - 
IR: ν = 3354, 3281, 2724, 1829, 1739, 1652, 1543, 1310, 1155, 1073, 949. - C14H11N3O5 
(301.25): calcd. C 55.82; H 3.68; N 13.95; found C 55.54, H 3.34, N 14.30. 
 
1.10.2   General procedure for the synthesis of compounds 58 
 
Carboxylic acid (1.1 equiv) and N,N-Diisopropylethylamine (3.0 equiv) were dissolved in 
DCM (0.1M solution) and the solution cooled at 0°C. HBTU (1.3 equiv) was added and the 
solution stirred at the same temperature for 30 minutes, then the aminoalcohol (1.0 equiv) 
was added and the reaction mixture stirred at 0°C for 60 minutes and overnight at room 
temperature. 
The solvent was evaporated under reduced pressure and the mixture separated by flash 
chromatography eluting with MeOH (gradient from 2 to 10%) in DCM to yield the product.   
 
(R)-N-(1-hydroxybutan-2-yl)-3-(3-phenylureido)propanamide (58a) 
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According to the general procedure product 58a was yielded as white solid (0.604 g, 2.16 
mmol, 99%) starting from acid 54a (0.500g, 2.4mmol) and coupled with (R)-2-aminobutan-1-
ol. 
Rf= 0.23 (DCM/MeOH 94:6) - m.p. 131-132°C -  [α]20D = +32.01(c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 0.93 (t, 3H, J= 7.4 Hz), 1.42 (m, 1H), 1.63 (m, 1H), 2.46 (m, 
2H), 3.43-3.52 (m, 4H), 3.80 (m, 1H), 6.97 (m, 1H), 7.23 (m, 2H), 7.33 (m, 2H). - 
13
C NMR 
(100.6 MHz, CD3OD, 25°C): δ = 18.6, 23.9, 36.5, 37.3, 53.9, 64.8, 119.8, 123.0, 128.9, 138.9, 
157.0, 173.3. -  IR: ν = 3327, 3265, 2724, 1738, 1647, 1557, 1307, 1154, 1070. - C14H21N3O3 
(279.33): calcd. C 60.20; H 7.58; N 15.04; found C 60.42, H 7.59, N 14.79. 
 
(S)-N-(1-hydroxy-3-phenylpropan-2-yl)-3-(3-phenylureido)propanamide (58b) 
 
According to the general procedure product 58b was yielded as white solid (0.802 g, 2.35 
mmol, 98%) starting from acid 54a (0.500 g, 2.4 mmol) and coupled with (S)-2-amino-3-
phenylpropan-1-ol. 
Rf= 0.30 (DCM/MeOH 95:5). - m.p. 131-132°C - [α]20D = -34.68 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 2.38 (t, 2H, J= 6.4 Hz), 2.71 (dd, 1H, J= 13.8, 8.1), 2.90 (dd, 
1H, J= 13.8, 6.2 Hz), 3.38 (m, 2H), 3.53 (m, 2H), 4.12 (m, 1H), 6.97 (m, 1H), 7.15 (m, 1H), 
7.21-7.27 (m, 6H), 7.33 (m, 2H). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 35.9, 36.1, 
36.6, 52.8, 62.9, 118.8, 122.1, 125.9, 126.9, 127.9, 128.4, 128.9, 138.4, 139.5, 156.8, 172.5. - 
IR: ν = 3320, 2724, 2453, 1829, 1738, 1625, 1545, 1308, 1263, 1156, 1071, 1036. -  
C19H23N3O3 (341.40): calcd. C 66.84; H 6.79; N 12.31; found C 67.01, H 6.46, N 12.37. 
 
 (S)-N-(1-hydroxy-3-methylbutan-2-yl)-3-(3-phenylureido)propanamide (58c) 
 
According to the general procedure product 58c was yielded as white solid solid (0.569 g, 
1.94 mmol, 89%) starting from the acid 54a (0.500 g, 2.4 mmol) and coupled with L-valinol. 
Rf= 0.22 (DCM/MeOH 95:5). - m.p. 121-122°C - [α]20D = -31.01(c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CDCl3, 25°C): δ = 0.89 (d, 3H, J= 6.8 Hz), 0.91 (d, 3H, J= 6.8 Hz), 1.83 (m, 1H), 
2.57 (m, 2H), 2.90 (bs, 1H), 3.47-3.59 (m, 3H), 3.67 (dd, 1H, J= 11.6, 3.2 Hz), 3.75 (m, 1H), 
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6.85 (d, 1H, J= 8.5 Hz), 6.98 (m, 1H), 7.21 (m, 2H), 7.28 (m, 1H), 7.44 (m, 1H), 7.55 (m, 
1H), 7.86 (bs, 1H). - 
13
C NMR (100.6 MHz, CDCl3, 25°C): δ = 18.9, 19.4, 29.1, 36.5, 37.2, 
57.4, 63.3, 119.8, 123.1, 128.9, 138.7, 156.9, 173.4. - IR: ν = 3337, 3243, 3087,2478, 2419, 
1670, 1632, 1560, 1503, 1354, 1295, 1260, 1141, 1117, 1063, 1029, 970, 760. - C15H23N3O3 
(293.36): calcd. C 61.41; H 7.90; N 14.32; found C 61.21, H 8.02, N 14.72. 
 
 (R)-N-(2-hydroxy-1-phenylethyl)-3-(3-phenylureido)propanamide (58d) 
 
According to the general procedure product 58d was yielded as white solid (0.505 g, 1.54 
mmol, 64%) starting from acid 54a (0.500 g, 2.4 mmol) and coupled with (R)-2-amino-2-
phenylethanol. 
Rf= 0.31 (DCM/MeOH 95:5). - m.p. 119-120°C - [α]20D = -37.23 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 2.53 (m, 2H), 3.47 (t, 2H, J= 6.5 Hz), 3.77 (dd, 1H, J= 11.2, 
7.7 Hz), 3.75 (dd, 1H, J= 11.2, 5.3 Hz), 5.01 (dd, 1H, J= 7.7, 5.3 Hz), 6.97 (tt, 1H, J= 7.3, 1.2 
Hz), 7.20-7.35 (m, 9H). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 35.9, 36.0 55.6, 64.9, 
118.8, 122.0, 126.6, 127.0, 128.1, 128.4, 139.5, 139.9, 156.8, 172.5. - IR: ν = 3382, 3308, 
2462, 2364, 1644, 1598, 1544, 1313, 1243, 1153, 1125, 1078, 1056, 905. - C18H21N3O3 
(327.38): calcd. C 66.04; H 6.47; N 12.84; found C 65.89, H 6.75, N 12.56. 
 
(S)-N-(1-hydroxy-3-phenylpropan-2-yl)-3-(3(2nitrophenyl)ureido) propanamide (58e) 
 
According to the general procedure product 58e was yielded as yellow solid (0.211 g, 0.546 
mmol, 46%) starting from acid 54b (0.300 g, 1.18 mmol) and coupled with (S)-2-amino-3-
phenylpropan-1-ol. 
Rf = 0.31 (DCM/MeOH 95:5). - m.p. 146-147°C - [α]20D = -43.40 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 2.40 (t, 2H, J= 6.6 Hz), 2.72 (dd, 1H, J= 13.7, 8.3), 2.90 (dd, 
1H, J= 13.7, 6.1 Hz), 3.41 (m, 2H), 3.51 (dd, 1H, J= 11.1, 5.6 Hz), 3.56 (dd, 1H, J= 10.6, 5.1 
Hz), 4.14 (m, 1H), 7.13 (m, 2H), 7.23 (m, 4H), 7.61 (ddd, 1H, J= 8.7, 7.2, 1.6), 8.13 (dd, 1H, 
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J= 8.4, 1.6 Hz), 8.35 (dd, 1H, J= 8.6, 1.2 Hz). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 
35.9, 36.2, 36.6, 52.8, 62.8, 121.4, 122.1, 125.1, 125.9, 127.8, 128.9, 134.6, 135.7, 137.1, 
138.4, 155.4, 172.2. - IR: ν = 3371, 3329, 3282, 2368, 1676, 1649, 1585, 1556, 1155, 1116, 
1082, 960, 840. - C19H22N4O5 (355.43): calcd. C 59.06; H 5.74; N 14.50; found C 59.23, H 
6.00, 14.76. 
 
(S)-3-(3-cyclohexylureido)-N-(1-hydroxy-3-methylbutan-2-yl)propanamide (58f) 
 
According to the general procedure product 58f was yielded as white solid (0.688 g, 2.19 
mmol, 99%) starting from acid 54c (0.500 g, 2.3 mmol) and coupled with L-Valinol. 
Rf = 0.44 (DCM/MeOH 95:5). - m.p. 140-141°C - [α]20D = -30. 12 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CD3OD, 25°C): δ = 0.91 (d, 3H, J= 6.7 Hz), 0.94 (d, 3H, J= 6.7 Hz), 1.17 
(m, 3H), 1.34 (m, 3H), 1.60 (dt, 1H, J= 12.6, 3.8 Hz), 1.72 (dt, 1H, J= 13.3, 3.8 Hz), 1.85 (m, 
3H), 2.42 (m, 2H), 3.39 (m, 2H), 3.53 (dd, 1H, J= 11.4, 6.6 Hz), 3.61 (dd, 1H, J= 11.3, 4.4 
Hz), 3.71 (m, 1H). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 17.4, 18.6, 24.6, 25.3, 28.6, 
33.3, 36.1, 36.5, 56.6, 61.9, 158.9, 172.9. - IR: ν = 3312, 3278, 2409, 1623, 1578, 1545, 
1345, 1214, 1123,1076, 965. - C15H29N3O3 (299.41): calcd. C 60.17; H 9.76; N 14.03; found 
C 59.89, H 10.09, 14.33. 
 
(S)-N-(1-hydroxy-3-methylbutan-2-yl)-2-methyl-2-(3-phenylureido) propanamide (58g) 
 
According to the general procedure product 58g was yielded as white solid (0.630 g, 2.04 
mmol, 100%) starting from acid 54d (0.500 g, 2.25 mmol) and coupled with L-Valinol. 
Rf = 0.25 (DCM/MeOH 95:5) - m.p. 135-136°C - [α]20D = -38.27 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CDCl3, 25°C): δ = 0.86 (d, 3H, J= 6.8 Hz), 0.89 (d, 3H, J= 6.7 Hz), 1.52 (s, 3H), 
1.53 (s, 3H), 1.70 (m, 1H), 3.39 (t, 1H, J= 10.2 Hz), 3.70 (m, 2H), 3.98 (bs, 1H), 6.43 (s, 1H), 
6.86 (d, 1H, J= 9.8 Hz), 6.94 (t, 1H, J= 7.2 Hz), 7.15 (t, 2H, 7.6 Hz), 7.28 (d, 2H, 7.7 Hz), 
8.09 (s, 1H). - 
13
C NMR (100.6 MHz, CHCl3, 25°C): δ= 19.2, 19.7, 24.7, 26,9 29.1, 56.8, 
57.9, 64.2, 120.1, 123.0, 128.7, 138.7, 156.1, 177.4. - IR: ν = 3358, 2724, 1649, 1578, 1542, 
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1310, 1150, 1133, 1087, 965. - C16H25N3O3 (307.39): calcd. C 62.52; H 8.20; N 13.67; found 
C 62.22, H 8.06, N 14.01. 
 
(R)-N-(1-hydroxybutan-2-yl)-2-methyl-2-(3-phenylureido)propanamide (58h) 
 
According to the general procedure product 58h was yielded as white solid (0.630 g, 2.04 
mmol, 100%) starting from acid 54d (0.500 g, 2.25 mmol) and coupled with (R)-2-
aminobutan-1-ol. 
Rf = 0.27 (DCM/MeOH 95:5). - m.p. 137-138°C - [α]20D = +39.99 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CD3OD, 25°C): δ = 0.94 (t, 3H, J= 7.6 Hz), 1.46 (m, 1H), 1.50 (s, 6H), 1.62 
(m, 1H), 3.52 (d, 2H, J= 5.4 Hz), 3.81 (m, 1H), 6.97 (t, 1H, J= 7.3 Hz), 7.23 (m, 2H), 7.33 
(dd, 2H, J= 8.5, 1.0 Hz). - 
13
C NMR (100.6 MHz, CHCl3, 25°C): δ= 10.6, 23.4, 24.8, 26.9, 
53.9, 56.7, 65.6, 120.0, 123.0, 128.7, 138.7, 156.0, 177.4. - IR: ν = 3382, 3271, 3133, 2724, 
1648, 1598,1542, 1494, 1312, 1253, 1220, 1168, 1062, 845. - C15H23N3O3 (293.36): calcd. C 
61.41; H 7.90; N 14.32; found C 61.22, H 8.01, N 13.97. 
 
(S)-N-((S)-1-hydroxy-3-methylbutan-2-yl)-4-oxo-3-(3-phenylureido)-4-(pyrrolidin-1-
yl)butanamide (58i) 
 
According to the general procedure product 58i was yielded as yellow pale oil (0.154 g, 0.39 
mmol, 60%) starting from the acid 54e (0.200 g, 0.65 mmol) and coupled with L-valinol. 
Rf = 0.33 (DCM/MeOH 95:5).- [α]20D = -78.04 (c = 0.1, CHCl3) - 
1
H NMR (400 MHz, 
CD3OD, 25°C): δ = 0.91 (d, 3H, J= 6.8 Hz), 0.94 (d, 3H, 6.7 Hz), 1.82-1.93 (m, 2H), 2.00 (m, 
1H), 2.57 (dd, 1H, J= 14.4, 7.4 Hz), 2.72 (dd, 1H, J= 14.4, 6.7 Hz), 3.38-3.60 (m, 4H), 3.69 
(m, 2H), 3.79 (m, 1H), 5.02 (t, 1H, J= 7.2 Hz), 6.98 (m, 1H), 7.24 (m, 2H), 7.33 (m, 2H). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 17.4, 18.6, 23.7, 25.5, 28.5, 38.4, 45.9, 46.5, 48.8, 
56.7, 61.7, 118.8, 122.2, 128.4, 139.2, 155.8, 170.7. - IR: ν = 3310, 3259, 2767, 2456, 2412, 
1665, 1565, 1508, 1459, 1334, 1300, 1211, 1098, 980, 876.  - C20H30N4O4 (390.48): calcd. C 
61.52; H 7.74; N 14.35; found C 61.66, H 7.60, N 14.53. 
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(R)-N-((S)-1-hydroxy-3-methylbutan-2-yl)-4-oxo-3-(3-phenylureido)-4-(pyrrolidin-1-
yl)butanamide (58j) 
 
According to the general procedure product 58j was yielded as yellow pale oil (0.144 g, 0.37 
mmol, 56%) starting from the acid 54f (0.200 g, 0.65 mmol) and coupled with L-valinol. 
Rf = 0.33 (DCM/MeOH 95:5). - [α]20D = -12.35 (c = 0.1, CHCl3) - 
1
H NMR (400 MHz, 
CD3OD, 25°C): δ = 0.89 (d, 3H, J= 6.8 Hz), 0.93 (d, 3H, J= 6.7 Hz), 1.80-1.92 (m, 3H), 2.00 
(m, 2H), 2.58 (dd, 1H, J= 14.3, 6.8 Hz), 2.73 (dd, 1H, J= 14.3, 7.4 Hz), 3.35-3.63 (m, 4H), 
3.70 (m, 2H), 3.82 (m, 1H), 4.99 (t, 1H, J= 7.0 Hz), 6.98 (m, 1H), 7.24 (m, 2H), 7.33 (dd, 2H, 
J= 8.8, 1.2 Hz). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 17.3, 18.6, 23.7, 25.5, 28.5, 
38.3, 45.9, 46.5, 48.7, 56.7, 61.7, 118.7, 122.2, 128.4, 139.2, 155.8, 170.6, 170.8. - IR: ν = 
3300, 3256, 2789, 2481, 2426, 1656, 1599, 1548, 1499, 1315, 1224, 1100, 978, 856. - 
C20H30N4O4 (390.48): calcd. C 61.52; H 7.74; N 14.35; found C 61.84, H 7.70, N 14.39. 
 
(R)-N-(1-hydroxybutan-2-yl)-3-(3-phenylureido)benzamide (58k) 
 
According to the general procedure product 58k was yielded as white solid (0.565 g, 1.72 
mmol, 97%) starting from acid 54g (0.500 g, 1.95 mmol) and coupled with (R)-2-
aminobutan-1-ol. 
Rf = 0.40 (DCM/MeOH 95:5). - m.p. 146-147°C - [α]20D = +42.58 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CD3OD, 25°C): δ = 1.00 (t, 3H, J= 7.5 Hz), 1.56 (m, 1H), 1.76 (m, 1H), 
3.63 (dd, 2H, J= 5.6, 0.9 Hz), 4.03 (m, 2H), 7.03 (t, 1H, J= 7.3 Hz), 7.29 (dd, 2H, J= 8.5, 7.5 
Hz), 7.36 (t, 1H, J= 7.8 Hz), 7.44 (dd, 2H, J= 8.7, 1.2 Hz), 7.48 (dt, 1H, J= 7.7, 1.3 Hz), 7.58 
(ddd, 1H, J= 7.9, 2.2, 1.1 Hz), 7.88 (t, 1H, J= 1.8 Hz), 8.05 (d, 1H, J= 8.3 Hz). - 
13
C NMR 
(100.6 MHz, CD3OD, 25°C): δ= 9.6, 23.66, 53.7, 63.43, 117.9, 119.1, 121.2, 121.9, 122.6, 
128.5, 128.7, 135.6, 138.9, 139.4, 153.9, 169.2. -  IR: ν = 3383, 2724, 1697, 1648, 1542, 
1154, 1069. - C18H21N3O3 (327.38): calcd. C 66.04; H 6.47; N 12.84; found C 65.93, H 6.70, 
N 12.58. 
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(S)-N-(1-hydroxy-3-phenylpropan-2-yl)-3-(3-phenylureido)benzamide (58l) 
 
According to the general procedure product 58l was yielded as white solid (0.689 g, 1.77 
mmol, 100%) starting from acid 54g (0.500 g, 1.95 mmol) and coupled with (S)-2-amino-3-
phenylpropan-1-ol. 
Rf = 0.34 (DCM/MeOH 95:5). - m.p. 157-158°C - [α]20D = -50.29 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 2.87 (dd, 1H, J= 13.7, 8.6 Hz), 3.03 (dd, 1H, J= 13.7, 6.2 Hz), 
3.66 (d, 2H, J= 5.5 Hz), 4.34 (m, 1H), 7.04 (t, 1H, J= 7.5 Hz), 7.17 (m, 1H), 7.29 (m, 6H), 
7.37 (m, 2H), 7.45 (dd, 2H, J= 8.6, 1.0 Hz), 7.56 (dt, 1H, J= 7.0, 2.2 Hz), 7.79 (m, 1H). – 13C 
NMR (100.6 MHz, CD3OD, 25°C): δ= 36.6, 53.6, 62.9, 117.8, 119.0, 121.1, 121.8, 122.6, 
125.9, 128.0, 128.5, 128.6, 129.0, 134.7, 135.5, 138.5, 139.0, 139.3, 153.9, 168.8. - IR: ν = 
3324, 2724, 1739, 1648, 1543, 1310, 1265, 1155, 1069, 876, 840. - C23H23N3O3 (389.45): 
calcd. C 70.93; H 5.95; N 10.79; found C 70.88, H 6.18, N 7.78. 
 
(S)-N-(1-hydroxy-3-methylbutan-2-yl)-3-(3-phenylureido)benzamide (58m) 
 
According to the general procedure product 58m was yielded as white solid (0.578 g, 1.69 
mmol, 96%) starting from acid 54g (0.500 g, 1.95 mmol) and coupled with L-Valinol 
Rf = 0.38 (DCM/MeOH 95:5). - m.p. 167-168°C - [α]20D = -44.37 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 1.00 (d, 3H, J= 6.8 Hz), 1.03 (d, 3H, J= 6.8 Hz), 2.00 (m, 
1H), 3.67-3.76 (m, 2H), 3.91 (m, 1H), 7.03 (t, 1H, J= 7.3 Hz), 7.30 (m, 2H), 7.39 (t, 1H, J= 
7.9 Hz), 7.44 (dd, 2H, J= 8.7, 1.2 Hz), 7.48 (dt, 1H, J= 7.7, 1.3 Hz), 7.58 (ddd, 1H, J= 8.1, 
2.1, 1.0 Hz), 7.88 (t, 1H, J= 1.8 Hz). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 17.8, 18.7, 
28.9, 57.4, 61.7, 117.9, 119.0, 121.2, 121.8, 122.6, 128.4, 128.6, 135.7, 138.9, 139.4, 153.9, 
169.2. - IR: ν = 3266, 3200, 2722, 1656, 1609, 1565, 1501, 1310, 1221, 1167, 1089, 989, 
840. - C19H23N3O3 (341.40): calcd. C 66.84; H 6.79; N 12.31; found C 66.62, H 7.14, N 
12.14. 
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(S)-N-(1-hydroxy-3,3-dimethylbutan-2-yl)-3-(3-phenylureido)benzamide (58n) 
 
According to the general procedure product 58n was yielded as white solid (0.552 g, 1.55 
mmol, 88%) starting from acid 54g (0.500 g, 1.95 mmol) and coupled with (S)-2-amino-3,3-
dimethylbutan-1-ol. 
Rf = 0.37 (DCM/MeOH 95:5). - m.p. 97-98°C - [α]20D = -49.69 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 1.02 (s, 9H), 3.63 (dd, 1H, J= 11.4, 8.8 Hz), 3.68 (dd, 1H, J= 
11.4, 3.5 Hz), 4.04 (dd, 1H, J= 8.8, 3.5 Hz), 7.04 (m, 1H), 7.30 (m, 1H), 7.40 (t, 1H, J= 7.7 
Hz), 7.42-7.50 (m, 3H), 7.59 (ddd, 1H, J= 7.9, 2.2, 1.1 Hz) 7.87 (t, 1H, J= 1.7 Hz) - 
13
C 
NMR (100.6 MHz, CD3OD, 25°C): δ= 26.0, 33.9, 54.4, 60.9, 117.9, 119.1, 121.3, 121.8, 
122.6, 128.5, 128.7, 136.0, 138.9, 139.2, 153.9, 169.9. - IR: ν = 3278, 3204, 2727, 1670, 
1625, 1589, 1553, 1500, 1310, 1233, 1134, 1088, 1047, 840.  - C20H25N3O3 (355.43): calcd. C 
67.58; H 7.09; N 11.82; found C 67.44, H 7.16, N 12.11. 
 
(R)-N-(2-hydroxy-1-phenylethyl)-3-(3-phenylureido)benzamide (58o) 
 
According to the general procedure product 58o was yielded as white solid (0.420 g, 1.12 
mmol, 98%) starting from acid 54g (0.320 g, 1.25 mmol) and coupled with (R)-2-amino-2-
phenylethanol. 
Rf = 0.39 (DCM/MeOH 95:5). - m.p. 112-113°C - [α]20D = -46.89 (c = 0.1, CHCl3) -
 1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 3.87 (d, 2H, J= 6.6 Hz), 5.21 (t, 1H, J= 6.6 Hz), 7.02 (t, 1H, 
J= 7.3 Hz), 7.23-7.45 (m, 10H), 7.51 (d, 1H, J= 7.7 Hz), 7.58 (dd, 1H, J= 8.0, 1.1 Hz), 7.90 
(s, 1H). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 56.4, 64.7, 118.0, 119.1, 121.3, 122.0, 
122.6, 126.6, 127.0, 128.1, 128.5, 128.7, 135.3, 138.9, 139.4, 139.9, 153.9, 168.9. - IR: ν = 
3300, 3205, 2727, 1646, 1621, 1599, 1563, 1348, 1298, 1235, 1175, 1065, 844. - C22H21N3O3 
(375.42): calcd. C 70.38; H 5.64; N 11.19; found C 70.37, H 5.73, N 12.11. 
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(S)-N-(1-hydroxy-3-phenylpropan-2-yl)-3-(3-(2-nitrophenyl)ureido) benzamide (58p) 
 
According to the general procedure product 58p was yielded as yellow solid (0.568 g, 1.47 
mmol, 97%) starting from acid 54h (0.500 g, 1.66 mmol) and coupled with L-Valinol. 
Rf = 0.36 (DCM/MeOH 95:5). - m.p. 140-141°C - [α]20D = -47.64 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 1.00 (d, 1H, J= 6.8 Hz), 1.03 (d, 1H, J= 6.8 Hz), 2.01 (m, 
1H), 3.71 (m, 2H), 3.92 (m, 1H), 7.19 (ddd, 1H, J= 8.4, 7.4, 1.3), 7.42 (t, 1H, J= 7.8 Hz), 7.51 
(dt, 1H, J= 7.8, 1.3 Hz), 7.67 (m, 2H), 7.97 (t, 1H, J= 1.8 Hz), 8.19 (dd, 1H, J= 8.4, 1.4 Hz), 
8.48 (dd, 1H, J= 8.6, 1.2 Hz). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 17.8, 18.7, 28.9, 
57.4, 61.7, 118.2, 121.6, 122.0, 122.3, 125.2, 128.7, 134.7, 135.2, 135.8, 153.2, 169.2. - IR: ν 
= 3296, 3205, 1722, 1697, 1628, 1604, 1565, 1340, 1252, 1194, 1141, 1074, 1028, 846. - 
C19H22N4O5 (355.43): calcd. C 59.06; H 5.74; N 14.50; found C 59.27, H 6.09, 14.83. 
 
1.10.3   General procedure for the cyclization of compounds 58 into the oxazolines Ox 
 
Peptidic precursor 58 (1.0 equiv) was dissolved in THF (0.1M solution) and cooled at -78°C; 
then DAST (2.2 equiv) was added dropwise and the reaction stirred at the same temperature 
for 90 minutes. The mixture was filtered and the solvent evaporated under reduced pressure. 
The product was purified by flash chromatography eluting with MeOH (gradient from 1 to 
5%) in DCM. 
 
(R)-1-(2-(4-ethyl-4,5-dihydrooxazol-2-yl)ethyl)-3-phenylurea (Ox-1) 
 
According to the general procedure product Ox-1 was yielded as pale yellow solid (0.410 g, 
1.57 mmol, 77%) starting from precursor 58a (0.570 g, 2.04 mmol). 
Rf = 0.57 (DCM/MeOH 95:5). - m.p. 68-69°C - [α]20D = +29. 07 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CHCl3, 25°C): δ = 0.91(t, 3H, J= 7.3 Hz), 1.56 (m, 1H), 1.67 (m, 1H), 2.69 (t, 1H, 
J= 5.6 Hz), 3.57 (m, 2H), 4.06-4.20 (m, 2H), 4.63 (t, 1H, J= 8.8 Hz), 6.38 (bs, 1H), 7.02 (t, 
1H, J= 7.7 Hz), 7.25 (m, 2H), 7.39 (d, 2H, J= 7.3 Hz), 7.75 (bs, 1H). - 
13
C NMR (100.6 
MHz, CDCl3, 25°C): δ= 9.8, 24.0, 36.5, 37.3, 53.6, 64.6, 119.6, 122.8, 128.9, 139.2, 156.8, 
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173.0. - IR: ν = 3321, 2725, 1640, 1556, 1309, 1243, 1156, 1070. - C14H19N3O2 (261.32): 
calcd. C 64.35; H 7.33; N 16.08; found C 64.44, H 7.43, N 15.41. 
 
(S)-1-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)ethyl)-3-phenylurea (Ox-2) 
 
According to the general procedure product Ox-2 was yielded as pale yellow solid (0.175g, 
0.541mmol, 53%) starting from precursor 58b (0.350 g, 1.03 mmol). 
Rf = 0.51 (DCM/MeOH 95:5). - m.p. 130-131°C - [α]20D = -44.65 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CHCl3, 25°C): δ = 2.44 (t, 2H, J= 5.8 Hz), 2.64 (dd, 1H, J= 13.7, 7.8 Hz), 2.96 
(dd, 1H, J= 13.7, 5.6 Hz), 3.43-3.62 (m, 2H), 3.98 (t, 1H, J= 7.4 Hz), 4.20 (t, 1H, 8.4 Hz), 
4.29 (m, 1H), 6.06 (bs, 1H), 7.03 (t, 1H, J= 7.3 Hz), 7.13 (m, 2H), 7.16-7.40 (m, 8H), 7.63 
(bs, 1H). - 
13
C NMR (100.6 MHz, CDCl3, 25°C): δ = 28.8, 36.6, 41.6, 66.7, 71.9, 120.5, 
123.3, 126.6, 128.6, 129.1, 129.2, 137.7, 139.0, 156.2, 167.4. - IR: ν = 3331, 2724, 1679, 
1632, 1595, 1565, 1497, 1444, 1349, 1311, 1242, 1191, 1084, 975, 924. - C19H21N3O2 
(323.39): calcd. C 70.57; H 6.55; N 12.99; found C 70.78, H 6.32, N 13.04. 
 
(S)-1-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)ethyl)-3-phenylurea (Ox-3) 
 
According to the general procedure product Ox-3 was yielded as white solid (0.519g, 
1.88mmol, 99%) starting from precursor 58c (0.560 g, 1.91 mmol) 
Rf = 0.59 (DCM/MeOH 95:5). - m.p. 81-81°C - [α]20D = -29.80 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 0.89 (d, 3H, J= 6.8 Hz), 0.94 (d, 3H, J= 6.7 Hz), 1.74 (m, 
1H), 2.52 (m, 2H), 3.49 (m, 2H), 3.91 (m, 1H), 4.07 (t, 1H, J= 7.9 Hz), 4.31 (dd, 1H, J= 9.8, 
8.7 Hz), 6.97 (m, 1H), 7.24 (m, 2H), 7.33 (dd, 2H, J= 8.7, 1.2 Hz). - 
13
C NMR (100.6 MHz, 
CD3OD, 25°C): δ= 17.4, 18.6, 28.6, 36.1, 36.2, 56.6, 61.8, 118.8, 122, 128.4, 139.5, 156.8, 
172.8. - IR: ν = 3205, 2728, 1694, 1639, 1594, 1527, 1380, 1353, 1168, 1077, 1029, 920, 
832. - C15H21N3O2 (273.35): calcd. C 65.43; H 7.69; N 15.26; found C 65.61, H 7.99, 14.61. 
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(R)-1-phenyl-3-(2-(4-phenyl-4,5-dihydrooxazol-2-yl)ethyl)urea (Ox-4) 
 
According to the general procedure product Ox-4 was yielded white solid (0.257g, 0.83 
mmol, 77%) starting from precursor 58d (0.500 g, 1.54 mmol). 
Rf = 0.59 (DCM/MeOH 95:5). - m.p. 122-123°C - [α]20D = +38.08 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CHCl3, 25°C): δ = 2.51 (t, 2H, J= 5.8 Hz), 3.54 (m, 2H), 4.06 (t, 1H, J= 8.3 
Hz), 4.56 (dd, 1H, J= 10.1, 8.6 Hz), 5.09 (t, 1H, J= 9.2 Hz), 6.18 (t, 1H, J= 6.0 Hz), 6.97 (m, 
1H), 7.13-7.36 (m, 10H). - 
13
C NMR (100.6 MHz, CDCl3, 25°C): δ= 28.9, 36.6, 67.7, 69.4, 
120.1, 122.9, 127.8, 128.8, 129.0, 139.1, 141.8, 156.4, 171.8 - IR: ν = 3310, 2726, 1678, 
1620, 1567, 1541, 1310, 1245, 1180, 1076, 978, 845. - C18H19N3O2 (309.36): calcd. C 69.88; 
H 6.12; N 13.58; found C 69.58, H 6.34, N 13.89. 
 
(S)-1-(2-(4-benzyl-4,5-dihydrooxazol-2-yl)ethyl)-3-(2-nitrophenyl)urea (Ox-5) 
 
According to the general procedure product Ox-5 was yielded as yellow solid (0.101g, 
0.274mmol, 50%) starting from precursor 58e (0.210 g, 0.543 mmol). 
Rf = 0.34 (DCM/MeOH 95:5). - m.p. 154-155°C - [α]20D = -42.12 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CDCl3, 25°C): δ = 2.56 (t, 2H, J= 5.7 Hz), 2.78 (dd, 1H, J= 13.7, 7.9 Hz), 
3.08 (dd, 1H, J= 13.7, 5.4 Hz), 3.61 (m, 2H), 4.10 (dd, 1H, J= 8.3, 7.4 Hz), 4.33 (t, 1H, J= 8.9 
Hz), 4.49 (m, 1H), 6.17 (bs, 1H), 7.04 (m, 1H), 7.20-7.35 (m, 5H), 7.58 (ddd, 1H, J= 8.7, 7.3, 
1.6 Hz), 8.16 (dd, 1H, J= 8.4, 1.5 Hz), 8.58 (d, 1H, J= 8.6 Hz), 9.72 (s, 1H). - 
13
C NMR 
(100.6 MHz, CDCl3, 25°C): δ= 28.1, 36.6, 41.5, 66.6, 71.9, 121.3, 121.5, 125.7, 126.7, 128.6, 
129.3, 134.7, 135.8, 137.0, 137.4, 153.9, 172.2. - IR: ν = 3353, 2724, 1651, 1613, 1543, 
1309, 1264, 1140, 1104, 794. - C19H20N4O4 (368.38): calcd. C 61.95 ; H 5.47, N 15.21; found 
C 61.66, H 5.78, N 14.99. 
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(S)-1-cyclohexyl-3-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)ethyl)urea (Ox-6) 
 
According to the general procedure product Ox-6 was yielded as white solid (0.402 g, 1.42 
mmol, 62%) starting from precursor 58f (0.688 g, 2.30 mmol). 
Rf = 0.54 (DCM/MeOH 95:5). - m.p. 103-104°C - [α]20D = -39.45 (c = 0.1, CHCl3)  - 
1
H 
NMR (400 MHz, CDCl3, 25°C): δ = 0.90 (d, 3H, J= 6.8 Hz), 0.98 (d, 3H, J= 6.8 Hz), 1.08-
1.39 (m, 6H), 1.59 (dt, 1H, J= 12.8, 3.8 Hz), 1.71 (m, 2H), 1.77 (m, 1H), 1.92 (m, 2H), 2.50 
(m, 2H), 3.51 (m, 2H), 3.92 (m, 1H), 4.02 (t, 1H, J= 8.1 Hz), 4.32 (dd, 1H, J= 9.5, 8.5 Hz), 
4.61 (d, 1H, J= 7.5 Hz), 5.49 (bs, 1H). - 
13
C NMR (100.6 MHz, CDCl3, 25°C): δ= 18.1, 18.7, 
24.9, 25.6, 28.6, 32.5, 33.9, 36.6, 49.4, 70.3, 71.3, 157.6, 167.4. - IR: ν = 3351, 3305, 2350, 
1669, 1624, 1579, 1532, 1309, 1251, 1167, 1082, 982, 939, 891, 791. - C15H27N3O2 (281.39): 
calcd. C 64.02 ; H 9.67, N 14.93; found C 63.89, H 9.90, N 14.79. 
 
 (S)-1-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)propan-2-yl)-3-phenylurea (Ox-7) 
 
According to the general procedure product Ox-7 was yielded as white solid (0.501 g, 1.73 
mmol, 84%) starting from precursor 58g (0.635 g, 2.06 mmol). 
Rf = 0.50 (DCM/MeOH 95:5). - m.p. 189-190°C - [α]20D = -43.12 (c = 0.1, CHCl3) - 
1
H NMR 
(400 MHz, CD3OD, 25°C): δ = 0.89 (d, 3H, J= 6.7 Hz), 0.95 (d, 3H, J= 6.8 Hz), 1.56 (s, 3H), 
1.59 (s, 3H), 1.82 (m, 1H), 4.00 (ddd, 1H, J= 9.8, 7.2, 5.5 Hz), 4.12 (dd, 1H, J= 8.6, 7.2 Hz), 
4.32 (dd, 1H, J= 9.8, 8.6 Hz), 6.96 (m, 1H), 7.23 (dd, 2H, J= 8.6, 7.5 Hz), 7.31 (dd, 2H, J= 
8.6, 1.2). - 
13
C NMR (100.6 MHz, CD3OD, 25°C): δ= 16.4, 17.5, 25.5, 25.7, 31.9, 51.5, 70.0, 
71.2, 118.6, 121.9, 128.9, 139.4, 155.5, 172.2. - IR: ν = 3338, 2725, 1646, 1600, 1557, 1543, 
1310, 1264, 1152, 1071, 800. - C16H23N3O2 (289.37): calcd. C 66.41; H 8.01, N 14.52; found 
C 66.53, H 8.11, 14.77. 
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 (S)-1-(2-(4-ethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)-3-phenylurea (Ox-8) 
 
According to the general procedure product Ox-8 was yielded as white solid (0.441 g, 1.60 
mmol, 74%) starting from precursor 58h (0.636 g, 2.17 mmol).  
Rf = 0.49 (DCM/MeOH 95:5). - m.p. 122-123°C - [α]20D = +40.82 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CD3OD, 25°C): δ = 0.94 (t, 3H, J= 7.3 Hz), 1.55 (s, 3H), 1.56 (m, 1H), 1.57 
(s, 3H), 1.66 (m, 1H), 4.01 (t, 1H, J= 7.6 Hz), 4.08 (m, 1H), 4.39 (dd, 1H, J= 9.0, 7.8 Hz), 
6.96 (t, 1H, J= 7.3 Hz), 7. 23 (t, 2H, J= 7.9 Hz), 7.30 (dd, 2H, J= 8.8, 1.2 Hz). - 
13
C NMR 
(100.6 MHz, CD3OD, 25°C): δ= 8.3 25.5, 25.6, 27.6, 51.3, 66.8, 72.3, 118.6, 122.0, 128.3, 
139.3, 155.4, 172.2. - IR: ν = 3321, 2725, 1661, 1641, 1596, 1587, 1500, 1302, 1250, 1218, 
1132, 1082, 1068, 979, 955, 924, 843. - C15H21N3O2 (275.35): calcd. C 65.43; H 7.69, N 
15.26; found C 65.57, H 7.66, N 15.37. 
 
1-((S)-3-((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)-1-oxo-1-(pyrrolidin-1-yl) propan-2-yl)-3-
phenylurea (Ox-9) 
 
According to the general procedure product Ox-9 was yielded as yellow solid (0.083 g, 0.22 
mmol, 58%) starting from precursor 58i (0.150 g, 0.38 mmol). 
Rf = 0.43 (DCM/MeOH 95:5). - m.p. 122-123°C - [α]20D = -71.70 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CDCl3, 25°C): δ = 0.84 (d, 3H, J= 6.7 Hz), 0.92 (d, 3H, J= 6.7 Hz), 1.66 m, 
1H), 1.87 (m, 2H), 1.96 (m, 2H), 2.68 (dd, 1H, J= 15.2, 6.4 Hz), 2.82 (dd, 1H, J= 15.2, 8.0 
Hz), 3.49 (m, 2H), 3.78-3.92 (m, 4H), 4.20 (dd, 1H, J= 9.4, 8.2 Hz), 5.20 (m, 1H), 6.88-6.96 
(m, 2H), 7.22 (t, 2H, J= 7.6 Hz), 7.36 (d, 2H, J= 7.6 Hz), 8.26 (s, 1H). - 
13
C NMR (100.6 
MHz, CDCl3, 25°C): δ= 18.3, 18.7, 24.3, 25.9, 31.8, 32,6, 46.3, 47.1, 48.3, 70.3, 72.2, 118.8, 
122.1, 128.7, 139.6, 155.2, 163.7, 170.9. - IR: ν = 3330, 3223, 2721, 1656, 1623, 1567, 1504, 
1398, 1311, 1214, 1200, 1178, 1123, 1083, 1034, 970. - C20H28N4O3 (372.46): calcd. C 64.49; 
H 7.58, N 15.04; found C 64.67, H 7.30, N 14.99. 
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1-((R)-3-((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)-1-oxo-1-(pyrrolidin-1-yl)  propan-2-yl)-3-
phenylurea (Ox-10) 
 
According to the general procedure product Ox-10 was yielded as yellow solid (0.074 g, 0.20 
mmol, 58%) starting from precursor 58j (0.134 g, 0.34 mmol). 
Rf = 0.43 (DCM/MeOH 95:5). - m.p. 126-127°C - [α]20D = -13.76 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CDCl3, 25°C): δ = 0.83 (d, 3H, J= 6.7 Hz), 0.87 (d, 3H, J= 6.7 Hz), 1.65 
(m, 1H), 1.88 (m, 2H), 1.97 (m, 2H), 2.67 (dd, 1H, J= 15.6, 6.6 Hz), 2.81 (dd, 1H, J= 15.6, 
8.3 Hz), 3.42-3.55 (m, 2H), 3.83-3.93 (m, 4H), 4.19 (dd, 1H, J= 8.7, 7.9 Hz), 5.23 (m, 1H), 
6.89 (d, 1H, J= 9.5 Hz), 6.94 (t, 1H, J= 7.3 Hz), 7.21 (t, 2H, J= 7.7 Hz), 7.35 (d, 2H, 7.8 Hz), 
8.35 (s, 1H). - 
13
C NMR (100.6 MHz, CDCl3, 25°C): δ= 18.2, 18.4, 24.3, 25.9, 31.9, 32.4, 
46.3, 47.1, 48.0, 70.2, 72.1, 118.8, 122.0, 128.7, 139.8, 155.1, 163.9, 171.0. - IR: ν = 3312, 
2729, 1678, 1634, 1603, 1593, 1549, 1334, 1212, 1150, 1115, 1084, 1065, 991, 840. - 
C20H28N4O3 (372.46): calcd. C 64.49 ; H 7.58, N 15.04; found C 64.71, H 7.44, N 14.81. 
 
(R)-1-(3-(4-ethyl-4,5-dihydrooxazol-2-yl)phenyl)-3-phenylurea (Ox-11) 
 
According to the general procedure product Ox-11 was yielded as white solid (0.370 g, 1.20 
mmol, 78%) starting from precursor 58k (0.500 g, 1.53 mmol). 
Rf = 0.46 (DCM/MeOH 95:5). - m.p. 147-148°C - [α]20D = +43.30 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CD3OD, 25°C): δ = 0.99 (t, 3H, J= 7.3 Hz), 1.63 (m, 1H), 1.74 (m, 1H), 
4.14 (t, 1H, J= 7.7 Hz), 4.24 (m, 1H), 4.54 (dd, 1H, J= 9.4, 8.2 Hz), 7.02 (m, 1H), 7.29 (m, 
2H), 7.37 (t, 1H, J= 8.2 Hz), 7.43 (dd, 2H, J= 8.7, 1.1 Hz), 7.58 (dt, 1H, J= 7.7, 1.3 Hz), 7.68 
(ddd, 1H, J= 8.1, 2.3, 1.0 Hz), 7,96 (t, 1H, J= 2.0 Hz). ). - 
13
C NMR (100.6 MHz, CD3OD, 
25°C): δ= 8.52, 28.0, 67.1, 72.0, 118.4, 119.0, 122.1, 122.6, 127.8, 128.5, 128,7, 138.9, 
139.6, 153.8, 164.6. - IR: ν = 3309, 3281, 1644, 1612, 1592, 1572, 1448, 1311, 1298, 1237, 
1168, 1080, 1059, 973, 926. - C18H19N3O2 (309.36): calcd. C 69.98; H 6.19, N 13.58; found C 
70.01, H 6.15, N 13.54. 
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(S)-1-(3-(4-benzyl-4,5-dihydrooxazol-2-yl)phenyl)-3-phenylurea (Ox-12) 
 
According to the general procedure product Ox-12 was yielded as white solid (0.518 g, 1.39 
mmol, 78%) starting from precursor 58l (0.693 g, 1.78 mmol). 
Rf = 0.52 (DCM/MeOH 95:5). - m.p. 106-107°C - [α]20D = -37.89 (c = 0.1, CHCl3) - 
 1
H 
NMR (400 MHz, CHCl3, 25°C): δ = 2.64 (dd, 1H, J= 13.7, 9.0 Hz), 3.12 (dd, 1H, J= 13.7, 
5.1 Hz), 4.02 (t, 1H, J= 7.8 Hz), 4.22 (t, 1H, J= 8.8 Hz), 4.47 (m, 1H), 6.95 (t, 1H, J= 7.1 Hz), 
7.11-7.27 (m, 11H), 7.54 (d, 1H, J= 7.1 Hz), 7.94 (d, 2H, J= 8.1 Hz), 8.04 (s, 1H). - 
13
C 
NMR (100.6 MHz, CDCl3, 25°C): δ=41.8, 67.6, 72.0, 119.8, 120.5, 123.0, 123.1, 123.6, 
126.6, 128.1, 128.6, 128.9, 129.0, 129.1, 137.8, 138.2, 138.7, 154.0, 164.4. -  IR: ν = 3353, 
2724, 2360, 1649, 1597, 1555, 1310, 1264, 1201, 1154, 1074, 896, 845. - C23H21N3O2 
(371.43): calcd. C 74.37 ; H 5.70, N 11.31; found C 77.37, H 5.68, N 10.95. 
 
(S)-1-(3-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-3-phenylurea (Ox-13) 
 
According to the general procedure product Ox-13 was yielded as white solid (0.458 g, 1.42 
mmol, 91%) starting from precursor 58m (0.530 g, 1.55 mmol).  
Rf = 0.49 (DCM/MeOH 95:5). - m.p. 138-139°C - [α]20D = -35.05 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CD2Cl2, 25°C): δ = 0.92 (d, 3H, J= 6.8 Hz), 1.01 (d, 3H, J= 6.7 Hz), 1.84 
(m, 1H), 2.15 (bs, 1H), 4.09 (ddd, 1H, J= 9.5, 8.2, 6.4 Hz), 4.16 (t, 1H, 8.2 Hz), 4.43 (dd, 1H, 
J= 9.5, 8.3 Hz), 7.10 (m, 1H), 7.14 (bs, 1H), 7.25 (bs, 1H), 7.28-7.37 (m, 5H), 7.50 (ddd, 1H, 
J= 8.0, 2.1, 0.9 Hz), 7.60 (dt, 1H, J= 7.7, 1.1 Hz), 7.95 (t, 1H, J= 1.7 Hz). - 
13
C NMR (100.6 
MHz, CDCl3, 25°C): δ= 17.6, 18.8, 32.4, 70.6, 71.2, 119.4, 120.8, 123.2, 123.6, 123.9, 128.9, 
129.1, 129.3, 138.0, 138.8, 139.0, 153.6, 165.0. -  IR: ν = 3319, 2725, 1743, 1646, 1595, 
1567, 1309, 1262, 1155, 1069, 801. - C19H21N3O2 (323.39): calcd. C 70.57; H 6.55, N 12.99; 
found C 70.19, H 6.41, N 12.83. 
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 (S)-1-(3-(4-tert-butyl-4,5-dihydrooxazol-2-yl)phenyl)-3-phenylurea (Ox-14) 
 
According to the general procedure product Ox-14 was yielded as white solid (0.436 g, 1.29 
mmol, 83%) starting from precursor 58n (0.552 g, 1.55 mmol). 
Rf = 0.48 (DCM/MeOH 95:5). - m.p. 170-171°C - [α]20D = -47.13 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CD3OD, 25°C): δ = 1.02 (s, 9H), 3.63 (dd, 1H, J= 11.5, 8.9 Hz), 3.88 (dd, 
1H, J= 11.5, 3.4 Hz), 4.04 (dd, 1H, J= 8.9, 3.4 Hz), 7.03 (t, 1H, J= 7.4 Hz), 7.30 (dd, 2H, J= 
8.4, 7.4 Hz), 7.40 (t, 1H, J= 7.7 Hz), 7.44 (m, 2H), 7.48 (ddd, 1H, J= 7.7, 1.7, 1.1 Hz), 7.59 
(ddd, 1H, J= 8.2, 2.2, 1.1 Hz), 7.82 (t, 1H, J= 1.7 Hz)  - 
13
C NMR (100.6 MHz, CDCl3, 
25°C): δ= 25.8, 33.9, 68.8, 75.9, 119.8, 120.6, 123.0, 123.1, 123.6, 128.3,129.0, 138.1, 138.6, 
154.0, 163.7. - IR: ν = 3352, 2724, 2360, 1740, 1647, 1596, 1560, 1309, 1264, 1204, 1154, 
1073, 897, 799. - C20H23N3O2 (337.42): calcd. C 71.19 ; H 6.87, N 12.45; found C 71.44, H 
7.10, N 12.47. 
 
(R)-1-phenyl-3-(3-(4-phenyl-4,5-dihydrooxazol-2-yl)phenyl)urea (Ox-15) 
 
According to the general procedure product Ox-15 was yielded as white solid (0.103 g, 0.29 
mmol, 30%) starting from precursor 58o (0.400 g, 1.06 mmol). 
Rf = 0.45 (DCM/MeOH 95:5). - m.p. 134-135°C - [α]20D = -51.78 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CDCl3, 25°C): δ = 4.25 (t, 1H, J= 8.3 Hz), 4.90 (dd, 1H, J= 10.1, 8.3 Hz), 
5.45 (dd, 1H, J= 10.1, 8.3 Hz), 6.98 (t, 1H J= 7.3 Hz), 7.24-7.31 (m, 3H), 7,34-7.41 (m, 5H), 
7.55 (dd, 2H, J= 8.7, 1.1 Hz), 7.65 (dt, 1H, J= 7.7, 1.3 Hz), 7.73 (ddd, 1H, J= 8.2, 2.3, 1.1 
Hz), 8.23 (t, 1H, J= 1.9 Hz), 8.36 (s, 1H), 8.52 (s, 1H). - 
13
C NMR (100.6 MHz, CDCl3, 
25°C): δ= 69.5, 74.9, 118.2, 118.5, 118.6, 121.5, 121.6, 121.9, 122.1, 126.7, 127.3, 128.1, 
128.5, 128.7, 128.9, 139.9, 140.4, 142.9, 152.5, 164.3. - IR: ν = 3321, 3278, 2725, 1709, 
1656, 1611, 1561, 1311, 1223, 1189, 1063, 970, 840. - C22H19N3O2 (357.41): calcd. C 73.93 ; 
H 5.36, N 11.76; found C 73.57, H 5.63, N 11.46. 
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(S)-1-(3-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-3-(2-nitrophenyl)urea (Ox-16) 
 
According to the general procedure product Ox-16 was yielded as yellow solid (0.441 g, 1.20 
mmol, 82%) starting from precursor 58p (0.565 g, 1.46 mmol). 
Rf = 0.38 (DCM/MeOH 95:5). - m.p. 166-167°C - [α]20D = -49.37 (c = 0.1, CHCl3) - 
1
H 
NMR (400 MHz, CD2Cl2, 25°C): δ = (d, 3H, J= 6.7 Hz), 1.05 (d, 3H, J= 6.7 Hz), 1.84 (m, 
1H), 4.07-4.18 (m, 2H), 4.45 (dd, 1H, J= 9.2, 7.8 Hz), 7.10 (bs, 1H), 7.15 (ddd, 1H, J= 8.4, 
7.2, 1.3 Hz), 7.43 (t, 1H, J= 7.7 Hz), 7.64 (ddd, 1H, J= 7.9, 2.1, 1.0 Hz), 7.68 (ddd, 1H, J= 
8.7, 7.1, 1.6 Hz), 7.72 (dt, 1H, J= 7.7, 1.2 Hz), 8.04 (t, 1H, J= 2.0 Hz), 8.22 (dd, 1H, J= 8.6, 
1.6 Hz), 8.68 (dd, 1H, J= 8.7, 1.1 Hz), 9.94 (bs, 1H). - 
13
C NMR (100.6 MHz, CH2Cl2, 25°C): 
δ= 17.8, 18.6, 32.8, 70.3, 72.5, 119.7, 121.9, 122.1,122.9, 123.4, 125.5, 128.8, 129.1, 135.4, 
136.0, 136.7, 138.4, 151.8, 163.1. - IR: ν = 3339, 3281, 2724, 1650, 1591, 1557, 1309, 1278, 
1155, 1066, 823. - C19H20N4O4 (368.39): calcd. C 61.95; H 5.47, N 15.21; found C 61.71, H 
5.84, N 13.47. 
 
1.10.4  Characterization of metal complexes 
 
Yoe-Jones plot  
 
CuCl2 (2 mg, 0.015 mmol) were transferred in a glass cuvette and 3 mL CH2Cl2 were added.  
A stock solution of (S)-1-(3-(4-isopropyl-4,5-dihydrooxazol-2-yl)phenyl)-3-phenylurea (Ox-
13) (11.52 mg, 0.036 mmol) in 0.5 mL of CH2Cl2 and 15µL of MeOH was prepared and then 
sequentially added in accurately portions with the use of a micropipette up to 2.4 equivalents 
of ligand, performing UV absorption spectrum after each addition. 
UV absorption value at 741 nm (λmax) and the different Ligand/Metal ratio, were plotted in a 
2D graph. 
 
CuCl2 (4 mg, 0.030 mmol) were transferred in a glass cuvette and 3 mL CH2Cl2 were added.  
A stock solution of (S)-4-isopropyl-2-phenyl-4,5-dihydrooxazole (Ox-0) (12.60 mg, 0.078 
mmol) in 0.5 mL of CH2Cl2 was prepared and then sequentially added in accurately portions 
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with the use of a micropipette up to 2.6 equivalents of ligand, performing UV absorption 
spectrum after each addition. 
UV absorption value at 757 nm (λmax) and the different Ligand/Metal ratio, were plotted in a 
2D graph. 
 
Dilution studies - NMR evaluations 
 
(S)-1-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl)ethyl)-3-phenylurea (Ox-3) (100mg, 0.363 
mmol) and PdCl2(CH3CN)2 (47mg, 0.181mmol) were dissolved in 5mL DCM and stirred for 
1 hour at room temperature. Complex was achieved by precipitation with hexane.  
1
H NMR experiments were carried out focusing on the variation of chemical shift of the NH 
signals  upon different concentrations (5, 10, 20 and 40 mM) both in the complex and in the 
free ligand.  
 
1.10.5     General procedure for the asymmetric Friedel-Crafts alkylation of 1H-indole 
with dimethyl-2-benzylidenemalonate 
 
Cu(OTf)2 (0.05 equiv.) and the ligand (0.1 equiv.) were dissolved in the solvent (0.1 M 
solution respect the substrate) and stirred at room temperature for 2 hours. Dimethyl-2-
benzylidenemalonate 59 (1.0 equiv.) was added and the solution was then cooled down to 
15°C. The reaction was stirred for 30 min at 15°C, then added the 1H-indole 60 (1.5 equiv.) 
and stirred maintaining the temperature at 15°C. 
After the reaction was complete (monitored by TLC), the solvent was removed under vacuum 
and the residue was chromatographed on silica gel column with Petroleum ether/Ethyl acetate 
5:1 to afford the final product.  
Spectroscopical data of products were in agreement with the literature
95
 and enantiomeric 
excesses were determined by HPLC equipped with chiral column Chiracel OD-H. 
 
 
 
 
                                                                
95 Y-J. Sun, N. Li, Z-B. Zheng, L. Liu, Y-B. Yu, Z-H. Qin, B. Fua,  Adv. Synth. Catal. 2009, 351, 3113. 
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1.10.6     General procedure for the asymmetric Friedel-Crafts alkylation of 1H-indole 
with trans--nitrostyrene 
 
Zn(OTf)2 (0.05 equiv.) and the ligand (0.1 equiv.) were dissolved in the solvent (0.1 M 
solution respect the substrate) and stirred at room temperature for 2 hours. Trans--
nitrostyrene 62 (1.5 equiv.) was added and then the solution was cooled down (to 15°C or 
0°C). The reaction was stirred for 30 min at the same temperature (15°C or 0°C), then added 
the 1H-indole 60 (1.0 equiv.) and finally stirred maintaining the temperature (15°C or 0°C). 
After the reaction was complete (monitored by TLC), the solvent was removed under vacuum 
and the residue was chromatographed on silica gel column with Petroleum ether/Ethyl acetate 
3:1 to afford the final product.  
Spectroscopical data of products were in agreement with the literature
96
 and enantiomeric 
excesses were determined by HPLC equipped with chiral column Chiracel OD-H. 
 
1.10.7     General procedure for kinetic resolution of 1,2-hydrobenzoin 
 
Ligand (0.1 equiv.) was solved in CH2Cl2 (0.15 M solution respect the substrate) and CuCl2 
(0.05 equiv.) added and  mixture stirred until the solution became clear and then cooled at 
0°C. Substrate 64 (1.0 equiv.), diisopropylethylamine (1.0 equiv.) and acyl chloride (0.5 
equiv.) were added and the reaction stirred for 3 hours at 0°C. The reaction mixture was 
filtered on silica gel washing with CH2Cl2 and the solvent evaporated under reduced pressure. 
Monobenzoylated 65 product was purified by flash chromatography on silica gel eluting with 
Hexane/Ethyl acetate 3:1. Spectroscopical data of products were in agreement with the 
literature
97
 and enantiomeric excesses were determined by HPLC equipped with chiral 
column Chiralpak AS-H . 
 
1.10.8   General procedure for selective desymmetrization of meso-1,2-hydrobenzoin 
 
Ligand (0.1 equiv.) was solved in CH2Cl2 (0.15 M solution respect the substrate) and CuCl2 
(0.05 equiv.) added and the mixture stirred until the solution became clear and then cooled at 
0°C. Substrate 66 (1.0 equiv.), diisopropylethylamine (1.0 equiv.) and acyl chloride (1.0 
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equiv.) were added and the reaction stirred for 3 hours at 0°C. The reaction mixture was 
filtered on silica gel washing with CH2Cl2 and the solvent evaporated under reduced pressure. 
Monobenzoylated 67 product was purified by flash chromatography on silica gel eluting with 
Hexane/Ethyl acetate 3:1. Spectroscopical data of products were in agreement with the 
literature
98
 and enantiomeric excesses were determined by HPLC equipped with chiral 
column Chiralpak AS-H. 
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Chapter 2 
 
Chiral Supramolecular  
Phosphinooxazoline Ligands 
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2.1     Introduction  
 
In the previous chapter the development of the supramolecular version of the 
bis(oxazoline) ligands was introduced. Bis(oxazolines) are homobidentate ligands in the sense 
that the two binding atoms are equal (namely two nitrogen atoms), and such bis(oxazolines) 
are also defined as N,N-ligands. Diphosphorus ligands are also very common (e.g. BINAP, 
DIOP etc.).  
However, in some ligands the two binding atoms are different and these are called 
heterobidentate ligands. A crucial peculiarity of heterobidentate chiral ligands is that, if used 
in metal catalyzed asymmetric transformations, they are able to induce discrimination not just 
through steric factors, but also by the creation of an electronic asymmetry on the metal centre 
thanks to the presence of different donor atoms. The class of ligands that bear phosphorus and 
nitrogen as chelating atoms is the most important and widely used considering the large 
number of works reported in literature. These so called P,N-ligands combine the -acceptor 
character of phosphorus, typically suited for stabilizing a metal centre in a low oxidation 
state, with the -donor ability of nitrogen, that makes the metal susceptible to oxidative 
addition reactions. These important features can play a fundamental role in stabilizing 
intermediate oxidation states and/or geometries during the catalytic cycle.
99
 The electronic 
asymmetry can further be increased by playing on the nature of adjacent atoms at 
phosphorous and/or nitrogen. For instance, bonding the phosphorus directly to a more 
electronegative atom, such as oxygen or nitrogen, it lessens its electron-donating ability and 
in the same time enhances its -acceptor capacity. On the contrary, the presence of an imino 
rather than an amino group results in a nitrogen donor atom of greater -donating capabilities; 
finally resulting in a bigger electronic disparity between the two donor atoms. 
Obviously, all the features above mentioned have prompted, so far, the development of a 
plethora of P,N-ligands successfully applied in a wide range of reactions catalyzed by 
transition metal-complexes.
100
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2.2     Bidentate phosphorus-nitrogen ligands  
 
In 1974 Hayashi and Kumada reported the application of the first bidentate chiral P,N-
ligands.
101
 In particular they developed and applied PPFA and BPPFA, two example of 
ferrocenyl derivatives, in the hydrosilylation of ketones. Although the optical purity was not 
impressive (up to 49% ee), they demonstrated the ability of these ligands to induce 
asymmetry. 
Approximately in the same years, Crabtree showed the ability of iridium towards the 
coordination of one P-ligand and one N-ligand, instead of forming the corresponding 
homocomplexes. The achiral P,N-ligand iridium catalyst was developed while working on the 
iridium analog of Wilkinson's rhodium-based catalyst. In 1977 he reported the first 
application of his catalyst, [Ir(cod)(Py)PCy3]PF6 (68), to the hydrogenation of alkenes.
102
 In 
the catalyst, a nitrogen atom (pyridine) and one phosphorus atom (PCy3) were coordinated in 
cis-configuration around a square planar iridium.  
 
 
 
Crabtree's catalyst immediately showed to be 100 times more active than the Wilkinson's 
catalyst and able to hydrogenate non-functionalized alkenes, even tri- and tetrasubstituted, 
unlike the rhodium catalyst.
103
 
This breakthrough ended in the development by chemists of others catalysts, in particular 
bidentate chiral P,N-ligands for asymmetric applications.  
What makes P,N-ligands iridium complexes particularly attractive for hydrogenation 
reactions is that they either do not require a polar coordinating group next to the unsatured 
bond, in complete contrast to rhodium and ruthenium phosphine catalysts, or that they are 
perfect catalysts for functionalized olefins for which no other suitable chiral catalysts are 
available.
104
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Among the different type of P,N-ligands, mono(oxazoline)-phosphorus ligands are probably 
one of the most common class of ligands used in catalysis. 
Since the ligands we formed belong to this category, a brief overview of this ligand class will 
be discussed here below. 
 
2.3     Mono(oxazoline)-Phosphorous Ligands  
 
Up to now, complexes of these ligands showed good efficiency in several asymmetric 
metal-catalyzed reactions, mainly Ir-catalyzed hydrogenations of unsatured substrates (e.g. 
imines,
105
 unfunctionalyzed olefins,
106
 fluorinated olefins,
107
 allylic alcohols,
108
 allylic 
acetates,
109
 enol phophinates,
110
 ,-unsatured carboxylic acids,111 enamines.112) and Pd-
catalyzed allylic alkylations.
113
 
For convenience, hereafter the ligands will be described spoiled in categories according to the 
nature of phosphorous-derivatives. 
 
2.3.1     Phosphinooxazoline Ligands 
 
Over the last decades, mono(oxazoline)-phosphine ligands, also called 
phosphinooxazolines, have found a good application in metal-catalyzed asymmetric 
transformations. The first example of phosphinooxazoline ligand 69 was introduced by Pfaltz 
in 1993 as efficient ligand for allylic alkylation.
114
 
The ease of accessibility of these molecules from readily available starting materials 
prompted the development of a wide array of phosphinooxazoline ligands similar to 69.  
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Recently, a series of serine-based phosphinooxazoline ligands 70 was synthesized again by 
Pfaltz, and the corresponding iridium complexes were successfully applied in the asymmetric 
hydrogenation of various unfunctionalized olefines and acetophenone-N-phenyl-imine. The 
results showed that these new derivatives were useful substitutes for the standard tert-leucine-
derived PHOX ligands.
115
 
Tietze applied a large library of benzothiophene, thiophene and benzofuran 
phosphinooxazoline ligands 71-75 in Pd-catalyzed alkylation of 1,3-diphenyl-2-propenyl 
acetate with sodium dimethyl malonate with successful in terms of yield and selectivity 
(Scheme 2.1).
116
  
 
 
 
 
Scheme 2.1 
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Thiophene moiety were also used by Cozzi for the development of ligands 76 and 77, which 
proved to be highly active in the iridium-catalyzed asymmetric hydrogenation of olefins and 
imines.
117 
  
 
 
The rule of the rigidity of the linker between N and P coordination atoms was investigated by 
Gilbertson with the development of chiral phosphinooxazolines 78 and 79 based on (1S)-(+)-
ketopinic acid and their application to the asymmetric Pd-catalyzed Heck reaction.
118
 The two 
diastereomer 78b and 79 indicated that the asymmetry of the reaction was induced by the 
chirality of the oxazoline, however, the low enantioselectivity obtained by the corresponding 
acyclic analog 80 highlighted the importance of the rigid bicyclic system for high values of 
enantioselection.  
 
 
 
Ligand 81, a ferrocenyl derivative introduced by Patti, was applied in Pd-catalyzed allylic 
alkylations with good results.
119
  
Following this route Moyano reported an alternative synthesis of the enantiomeric ligand (S)-
81 and the formation of a palladium-allyl complex [(Pd(η3-C3H5)-81)PF6] affording 
enantioselectivity up to 99.6% although with low catalytic activity.
120
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Binaphthyl moiety is a typical backbone for the synthesis of chiral ligands and, of course, it 
has been also used for the development of new classes of phosphinooxazolines.  
Ligands 82 with an axially chirality, were used by Ikeda
121
 for the Pd-catalyzed alkylation of 
1,3-diphenyl-2-propenyl acetate with dimethyl malonate. It is very important to notice that 
the opposite enantioselectivity obtained by the two diastereomers (S,aR)-82a and (S,aS)-82a 
which indicates that the chiral binaphthyl skeleton is the more influential stereogenic unit in 
the structure.  
 
 
 
One of the few examples of a highly enantioselective Rh-catalyzed allylic alkylation was 
reported by Hayashi using ligands 82 high enantio- and regioselectivities.
122
 
Another type of ligands with a stereoaxial chirality, was applied in the Ir-catalyzed 
hydrogenation of -alkylidene succinimides. Ligand 83, with a biphenyl skeleton, afforded 
the hydrogenated products in excellent yields (>99%) and enantioselectivities (up to 99% ee). 
The reactions occured with successful even with very low amount (0.05 mol%) of catalyst 
loading and using only 1 bar of hydrogen pressure (Scheme 2.2).
123
  
 
 
Scheme 2.2 
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Zhou synthesized a wide range of spirophosphinooxazoline ligands 84, reporting applications 
of the corresponding Ir-complexes to hydrogenation of alkenes,
124
 and ,-unsaturated 
carboxylic acids.
125
 
 
 
 
2.3.2     Oxazoline-Phosphonite Ligands 
 
Bidentate chiral P,N-ligands 85 were reported by Gómez and applied in the Pd-catalyzed 
asymmetric allylic alkylation of 1,2-dipheylpropenyl acetate (Scheme 2.1).
126
  
Pfaltz reported the application of ligands 86 to Ir-catalyzed asymmetric hydrogenation of 
unfuctionalized olefins with excellent results in terms of both conversion and 
enantioselectivity. In addition, promising results were also obtained with certain 
functionalized alkenes, furans and benzofurans.
127
 
 
 
 
2.3.3     Oxazoline-Phosphinamine Ligands 
 
Gilbertson synthesized ligands 87-90 to study both the importance of the stereocenter in 
the linker and the activity of diarylphosphino groups directly bonded to a nitrogen atom. 
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These proline-based ligands were tested in the Pd-catalyzed asymmetric alkylation and 
amination,
128 
and in the Ir-catalyzed enantioselective hydrogenation of aromatic olefins.
129 
The influence of the stereogenic proline in the asymmetric induction was demonstrated by the 
much lower ee% achieved with the structurally similar ligand 90 which lacks the rigidity of 
the pyrrolidine ring. 
 
 
 
Iridium-complexes of ligands 91-93 were used in the asymmetric hydrogenation of imines by 
Niedercorn with high conversion and moderate to high enantiomeric excess (Scheme 2.3).
130
  
 
 
Scheme 2.3 
 
Analogs ligands were developed by Chakka, with a family of tetrahydroisoquinoline 
phosphine–oxazoline 94 iridium complexes for the asymmetric hydrogenation of olefins. The 
best results obtained in this study showed 99% of conversions and enantiomeric excesses of 
up to 91%.
131
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Pfaltz reported a series of oxazoline-phosphinamine ligands 95-96 containing a chiral 
oxazoline ring and a bis(N-sulfonylamino)phosphine group embedded in a 
diazaphospholidine ring or in a diazaphosphepine ring derived from TADDOL. The ligands 
were applied in the Pd-catalyzed allylic alkylation and Ir-catalyzed hydrogenation of 
methylstilene.
132
 A broader library of ligands 95 was later employed for iridium-complexes in 
hydrogenation reactions of further unfunctionalized olefins and ,-unsaturated carboxylic 
esters.
133
 
 
 
 
2.3.4      Oxazoline-Phosphoramidate Ligands 
 
Andersson’s group prepared iridium N,P-ligand complexes containing the bidentate 
oxazoline-phosphoramidate ligand 97 for the asymmetric isomerization of allylic alcohols 
(Scheme 2.4).
134
  
 
                                                                
132 R. Hilgraf, A. Pfaltz, Adv. Synth. Cat. 2005, 347, 61. 
133 M. Schönleber, R. Hilgraf, A. Pfaltz, Adv. Synth. Catal. 2008, 350, 2033. 
134 J-Q. Li, B. Peters, P. G. Andersson, Chem. Eur. J. 2011, 17, 11143. 
92 
 
 
Scheme 2.4 
 
The yields were moderate, however, the isomerization of both E- and Z-trisubstituted primary 
allylic alcohols to the corresponding chiral aldehydes was highly enantioselective. 
 
2.3.5      Oxazoline-Phosphite Ligands 
 
A series of ligands easily accessible from hydroxyl–oxazole derivatives 98 and 99 was 
prepared in the group of Andersson and the complexes investigated in the Pd-catalyzed allylic 
substitution reaction of several substrates with different electronic and steric properties. By 
careful selection of the ligand components, high regio- and enantioselectivities (ee values up 
to 96%) and good activities were obtained in a broad range of mono-, di-, and trisubstituted 
linear hindered and unhindered substrates and cyclic substrates. NMR spectroscopic and DFT 
studies on the palladium--allyl intermediates provided a deeper understanding of the effect 
of ligand parameters on the origin of enantioselectivity.
135
 
 
 
 
2.4     Supramolecular P,N-ligands – combinatorial approach 
 
The supramolecular approach discussed in chapter 1 for the formation of SupraBox 
ligands has been extended to the formation of supramolecular phosphinooxazoline ligands. 
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It is based on the combination of two different monodentate ligands, respectively one P-
ligand and one N-ligand, both bearing an urea moiety capable of hydrogen-bonding. 
This approach, better known as combinatorial approach, foresees the simple mixing of 
ligands as an easy and fast way to generate a library of supramolecular bidentate ligands. The 
ease of this approach is an important feature because, despite significant progress in the field 
of theoretical and computational chemistry, there is still no rational way to model the best 
ligand for every given reactions and selectivity problems.  
The combination of two different monodentate ligands was for the first time independently 
reported by Reetz and Feringa, de Vries in 2003 who developed numerous library of 
phosphonites, phosphites and phosphoramidites, forming complexes where two different 
ligands were coordinated to the same metal center and then they investigated their 
applications in various asymmetric transformations, mainly in hydrogenations.
136
 
As already mentioned, the combinatorial approach relies on the addition of two ligands L1 
and L2 to a metal source. In principle the two homocomplexes [ML1L1] and [ML2L2] and the 
heterocomplex [ML1L2] can be formed, and the three of them could be in theory catalytically 
active. So, when the heterocomplex is the most selective species, the homocomplexes lower 
the overall selectivity of the process, unless the catalytic activity of the heterocomplex is 
exceedingly higher. However, in the worst case, is one of the homocomplexes, or even the 
two homocomplexes to be the most active species.  
Under thermodynamic control (fast and reversible ligand exchange), the heterocomplex/ 
homocomplexes ratio often exceed the statistical value (2:1:1), and that the amount of 
heterocomplex can be enhanced by carefully tuning the L1/L2 ratio.
137,138
  
More recently, the concept of supramolecular bidentate ligands emerged as a tool for the 
selective formation of heterocomplexes. This strategy requires that two ligands involved in 
the coordination process possess additional functionalities capable of interact each other 
shifting the equilibrium in the direction of the heterocomplex.
139
  
The systems so created have less degrees of freedom, but still maintaining appeal for a 
combinatorial exploitation, compared to the analogs complexes with monodentate ligands.  
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In fact they combine the most peculiar qualities of monodentate ligands (ease and speed of 
synthesis) with a conformational behavior similar to the classic bidentate ligands.  
 
2.5  Development of a new class of supramolecular bidentate phosphinooxazoline 
ligands 
 
We decided to extend the use the urea functionality as a self-complementary recognition 
motif for the formation of supramolecular bidentate ligands, for the synthesis of the first 
example of supramolecular phosphinoxazolines. 
In analogy to the synthesis of SupraBox, the covalent linker was replaced by hydrogen-bond 
interactions between two urea moieties, connected to the oxazoline ring or to the phosphorus 
atom via different achiral spacers. Transition metal complexes of these phosphinoxazolines 
have been formed and preliminary attempts to apply them for asymmetric transformations 
have been done. In particular, Ir(I)-complexes have been applied in the hydrogenation of 
alkenes. 
 
 
Figure 2.1 
 
2.5.1     Synthesis of the urea-phosphine ligands 
 
All the nitrogen-ligands (Ox-3, Ox-4, Ox-6, Ox-8, Ox-12, Ox-13, Ox-15, Ox-16) were 
synthesized as previously reported in chapter 1. 
Also our phosphorous ligands were synthesized by a few step number synthesis, making them 
suitable for a combinatorial exploitation as well.  
Likewise SupraBox ligands, the phosphorous ligands chosen possess in principle three 
possible tunable sites:  
 the substitution at the phosphorous atom,  
 the spacer,   
 the urea substituents.  
For ligands P-1, P-2, P-3 the synthesis consisted in two straightforward synthetic steps 
(Scheme 2.5 for P-1 and Scheme 2.6 for P-2 and P-3). 
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Scheme 2.5 
 
 
Scheme 2.6 
 
The synthesis for P-4 consisted only in the coupling between the aminophosphane and the 
chiral isocyanate (Scheme 2.7).  
 
 
Scheme 2.7 
 
A small library of 4 ligands, P-1, P-2, P-3 and P-4 was prepared and then the ligands were 
combined with SupraBox ligands in order to form iridium complexes. 
 
 
 
2.5.2     Complexes formation and related complexation studies 
 
First of all, studies to prove the formation of the desired complexes were needed.  
As for SupraBox ligands, we exploited different techniques in order to verify and study the 
complexation.  
We focused the attention on Ir-complexes in order to finally use them in hydrogenation 
reactions of alkenes.  
96 
 
During the determination of the best way for their formation and use, some information 
already known concerning P,N-ligands Ir-complexes have been taken into account. In 
particular, we preserved the electrophilic nature of cationic iridium catalysts and avoided 
coordinating solvents and/or anions in order to prevent catalyst deactivation. 
Dichloromethane and other chlorinated solvents are generally the most viable solvents for 
hydrogenation reactions, presumably since they all have high polarity but negligible 
coordinating power.
140
 Indeed, when hydrogen-bond interactions occur, polar and protic 
solvents can interrupt the formation of these weak interactions. However, fluorinated 
alcohols, such as trifluoroethanol (TFE) or hexafluoroisopropanol (HFIP), which are polar but 
with low hydrogen-bond acceptor properties, typically do not thwart and disturb the self-
assembly of the catalyst. Thus they are sometimes used in the reactions, leading to better 
results than those with the use of dichloromethane as solvent.
141
  
Concerning the couteranion, iridium complexes with bulky, apolar and extremely weakly 
coordinating anions, such as BArF
-
 (Tetrakis[(3,5-trifluoromethyl)phenyl]borate), do not 
suffer from deactivation, due to the formation of hydride species, and are also less sensitive to 
moisture than the corresponding BF4
-
 or PF6
-
.  
 
Few phosphorous-urea ligands P-1 - P-4 were chosen. The spacer turned out to crucial for 
the formation of the heterocomplexes.  
 
 
Indeed, phosphorus ligands possessing a rigid spacer (P-1, P-2 and P-3) were deemed 
suitable for the combination with nitrogen ligands, whereas ligand P-4, with a flexible spacer, 
led to the exclusively formation of the complex arising from ligand P-4 that behaved as a 
P,O-coordinating bidentate ligand,
142
 while leaving the N-ligand not coordinated.  
In Scheme 2.8 are reported the two 
31
P-NMR spectra respectively relative to: 
 the complex formed from 0.5 equiv. of [Ir(cod)Cl]2 and 1 equiv. of ligand P-4. 
 the complex formed from 0.5 equiv. of [Ir(cod)Cl]2 and 2 equiv. of ligand P-4. 
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Scheme 2.8 
 
Considering that the peak of ligand P-4 alone is at  = -21.0 ppm, in the first case the 
complex is formed by ligand P-4 that folds up and acts as P,O-coordinating bidentate ligand 
( = 15.7 ppm). While in the second case the complex consists in two molecules of P-ligand 
coordinated to the metal, therefore the second spectrum is relative to the Ir-homocomplex ( 
= 6.4 ppm). 
Concerning nitrogen ligands, some ligands from SupraBox library were chosen. 
 
 
 
Among them, only those ligands with the linear aliphatic or the aromatic spacers fitted with 
the phosphorous ligands P-1, P-2 and P-3. Indeed nitrogen ligand Ox-8 never led to the 
formation of heterocomplexes.  
98 
 
In order to proceed with the complexation, [Ir(cod)Cl]2 was chosen as iridium(I) source, once 
the preliminary attempts with Chlorobis(cyclooctene)iridium(I)dimer failed.     
Sodium(Tetrakis[(3,5-trifluoromethyl) phenyl]borate) (NaBArF) was chosen as couteranion 
exchanger, and then three phosphorous ligands and seven SupraBox ligands with different 
electronic and steric properties were chosen and combined to finally form seventeen 
heterocomplexes in total. 
Different ligands ratio were tried, and the best conditions found for the complexation were 
Metal/P-ligand/N-ligand in dichloromethane in a 1:1:1 ratio. The three components were 
stirred at room temperature for 2 hours, then NaBArF was added and the resulting solution 
was stirred for an additional hour. Precipitated NaCl was removed by filtration.  
The main problem concerning the complexation was the possible formation of a mixture of 
complexes (i.e. homocomplexes vs heterocomplex).  
In general the equilibrium depends from different factors such as the intrinsic preference of 
the metal and the steric and electronic characteristics of the ligands.  
In our case, the formation of a mixture of mono- and heterocomplexes occurred. These were 
investigated by 
31
P-NMR as a very useful technique. 
 
Ligands combination 
P-homo-/heterocomplex ratio 
(from 
31
P-NMR) 
Conversion into the heterocomplex 
(from 
31
P-NMR) 
P-1/Ox-3 1/2 67% 
P-1/Ox-4 1/3 75% 
P-1/Ox-6 1/0.6 38% 
P-1/Ox-12 1/38 43% 
P-1/Ox-13 1/34 83% 
P-1/Ox-15 0/1 100% 
P-1/Ox-16 0/1 100% 
 
P-2/Ox-3 1/1.5 60% 
P-2/Ox-4 1/3 75% 
P-2/Ox-6 1/0.2 17% 
P-2/Ox-12 1/3.5 72% 
P-2/Ox-13 1/4 80% 
P-2/Ox-15 1/10 88% 
P-2/Ox-16 0/1 100% 
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P-3/Ox-13 1/30 88% 
P-3/Ox-15 1/3.5 63% 
P-3/Ox-16 0/1 100% 
Table 2.1 
 
In the first column of Table 2.1 are reported the various combinations of phosphine and 
oxazoline ligands. 
In the second column the ratio between the peak relative to the P-homocomplex and the peak 
of the heterocomplex. In few cases other peaks were present in the 
31
P-NMR spectrum, but 
these were not further investigated. The third column is relative to the percentage of the 
heterocomplex in relation to the total of the species formed (identified by 
31
P-NMR).  
Here below are reported all the 
31
P-NMR spectra. 
 
 
 
 
Figure 2.2 
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Figure 2.3 
 
 
 
 
Figure 2.4 
 
It is worth noting that, although the heterocomplexes were not always exclusively formed, 
these were the major species in the mixtures. 
In addition, it is interesting to note that the combination with Ox-16 as oxazoline ligand, 
always led to the selective formation of the heterocomplex, regardless of the UreaPhox. This 
behavior was most probably due to an additional interaction occurring between the nitro 
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group and the urea group of phosphorous ligands; although no deeper studies were done to 
confirm this hypothesis.  
On the contrary, the same selection in the exclusively formation of the heterocomplexes was 
not observed when ligand P-3, possessing a nitro group in meta position, was combined with 
various nitrogen ligands. Most likely, in P-3 the NO2-group is too far away from the urea 
moiey of the nitrogen ligand to make this occurrence possible. 
Pivotal for the investigation of the complexation were 
1
H-NMR dilution studies, performed 
with ligand P-1 and ligand Ox-16. The complexation studies were carried out using 
[Ir(cod)Cl]2 as metal precursor, 1 equivalent of ligand P-1 and 1 equivalent of ligand Ox-16 
in CD2Cl2 at room temperature. During these studies signals of  the NHs of the free ligands 
were compared with those of the heterocomplex. 
 
 
 
P-1 HA HB 
    
concentration (mM)    
    
1 4,50 0,00 6,35 0,00 
    
2,5 4,52 0,02 6,38 0,03 
    
5 4,54 0,02 6,42 0,04 
    
10 4,68 0,14 6,83 0,41 
    
         
         
(S) Ox-16 HA HB 
    
concentration (mM)    
    
1 6,99 0,00 9,96 0,00 
    
2,5 7,04 0,05 9,96 0,00 
    
5 7,36 0,37 9,96 0,00 
    
10 7,65 0,61 9,96 0,00 
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Heterocomplex H1 H2 H3 H4 
concentration (mM)        
1 6,73 0,00 8,83 0,00 9,59 0,00 10,00 0,00 
2,5 6,73 0,00 8,83 0,00 9,59 0,00 10,00 0,00 
5 6,73 0,00 8,83 0,00 9,59 0,00 10,00 0,00 
10 6,73 0,00 8,83 0,00 9,59 0,00 10,00 0,00 
 
 
 
 
Dilution studies were performed by comparing signals of the urea protons by 
1
H-NMR in a 
concentration range of 1-10 mM (1 - 2.5 - 5 - 10). 
For both the nitrogen and phosphorus ligands, the urea proton signals showed dependency on 
concentration probably due to the formation of intermolecular hydrogen bonds,
143
 except for 
HB of Ox-16. The heterocomplex, on the other hand, shows four NH proton signals 
completely independent from the concentration. These results support the formation of the 
supramolecular bidentate species through urea hydrogen bonding. 
Besides the 
31
P-NMR spectroscopy, the HR-MS was certain a pivotal technique in order to 
define the occurred complexation and the heterocomplex formation. Hence, all the residues 
were analyzed by FAB-MS and the peaks relative to the heterocomplexes were detected in 
the spectra. 
 
                                                                
143 A. Mulder, J. Huskens, D. N. Reinhoudt, Org. Biomol. Chem. 2004, 2, 3409. 
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2.5.3     Catalytic applications 
 
2.5.3.1     Hydrogenation of alkenes 
 
As we mentioned in the introduction, over the last decades, iridium complexes derived 
from chiral P,N-ligands have emerged as a new class of catalysts that has considerably 
enhanced the scope of asymmetric olefin hydrogenations.
144 
Indeed, in contrast to rhodium 
and ruthenium phosphine catalysts, iridium catalysts do not require a polar coordinating 
group next to the C=C bond for high activity and enantioselectivity. In addition to 
unfunctionalized alkenes, high enantiomeric excesses were also obtained with various 
functionalized olefins for which no suitable chiral catalysts were available before.
145
 
 
Our complexes were therefore tested in the hydrogenation of alkenes. 
The heterocomplexes were prepared as previously mentioned, stirring 0.5 equivalent of 
[Ir(cod)Cl]2, 1.0 equivalent of ligand Ox and 1.0 equivalent of ligand P in CH2Cl2 at room 
temperature for 2 hours. Then NaBArF was added and the resulting mixture were stirred for 
another hour. Finally NaCl was removed by filtration and the solvent evaporated. 
All the residues were analyzed by 
1
H-NMR, 
31
P-NMR and mass spectrometry. 
Not further purifications were done, since the good solubility of the complexes even in apolar 
solvents, caused by the introduction of BArF
-
 as counteranion, made the crystallization 
difficult. 
So, the supramolecular phosphinooxazoline iridium-complexes were subsequently used in 
hydrogenation reactions without further purification.  
As shown in the section before, in some cases a mixture of homo- and heterocomplexes was 
formed. In these circumstances it is crucial to detect the activity of the homocomplexes; 
indeed, if the homocomplexes reveale to be unactive, we would be able to attribute the 
activity of the catalyst solely to the heterocomplexes.  
 
                                                                
144 J. Blankestein, A. Pfaltz, Angew. Chem. Int. Ed. 2001, 40, 4445; D.-R. Hou, J. Reibenspies, T. J. Calacot, K. 
Burgess, Chem. Eur. J. 2001, 24, 5391; G. Menges, A. Pfaltz, Adv. Synth. Catal. 2002, 334, 4044; W-J. Lu, Y-W. 
Chen, X-L. Hou, Angew. Chem. Int. Ed. 2008, 47, 10133; S.-M. Lu, C. Bolm, Angew. Chem. Int. Ed. 2008, 47, 8920; 
A. Franzke, A. Pfaltz, Chem. Eur. J. 2011, 17, 4131. 
145 J. Blankestein, A. Pfaltz, Angew. Chem. Int. Ed. 2001, 40, 4445; A. Pfaltz, J. Blankenstein, R. Hilgraf, E. 
Hörmann, S. McIntyre, F. Menges, M. Schönleber, S. P. Smidt, B. Wüstenberg, N. Zimmermann, Adv. Synth. Catal. 
2003, 345, 33; S. McIntyre, E. Hörmann, F. Menges, S. P. Smidt, A. Pfaltz, Adv. Synth. Catal. 2005, 347, 282; M. G. 
Schrems, E. Neumann, A. Pfaltz, Angew. Chem. 2007, 119, 8422; Angew. Chem. Int. Ed. 2007, 46, 8274; M. 
Diéguez, J. Mazuela, O. Pàmies, J. J. Verendel, P. G. Andersson, Chem. Commun. 2008, 3888; J. Mazuela, J. J. 
Verendel, M. Coll, B. Schäffner, A. Börner, P. G. Andersson, O. Pàmies, M. Diéguez, J. Am. Chem. Soc. 2009, 131, 
12344. 
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Hydrogenation of alpha-methylstylbene 
 
 
For this substrate, different condition were tested. In particular the reactions were initially 
carried out in dichloromethane at room temperature, both at 20 bar H2 and 50 bar H2. Firstly 
the homocomplexes were tested and no conversion was detected. Unfortunately also the use 
of the hetercomplexes led to the recovery of solely the unreacted alkene. The temperature was 
afterward increased at 45°C while the pressure of H2 was holding at 50 bar. Beside the 
heterocomplexes were tested at the same condition but in trifluoroethane as solvent. Once 
again no hydrogenated substrate was recovered. 
Since no conversion was obtained with unfuctionalized alkene 100, we moved onto 
functionalized alkenes. The presence of a functional group in general helps the coordination 
of the substrate to the catalytically active metal center.  
To test our complexes, both benchmark and challenging substrates were chosen. 
 
Hydrogenation of trans-4-phenylpent-3-enoic acid 
 
Entry L1, L2 Additive (1 equiv.) Solvent Conversion
a (%) 
1 P-1/Ox-13 Et3N MeOH - 
2 P-1/Ox-16 Et3N MeOH - 
3 P-1/Ox-13  MeOH 7 
4 P-1/Ox-16  MeOH 8 
5 P-1/Ox-13 Et3N CH2Cl2 - 
6 P-1/Ox-16 Et3N CH2Cl2 - 
7 P-1/Ox-13  CH2Cl2 20 
8 P-1/Ox-16  CH2Cl2 18 
9 P-1/Ox-13 Et3N (CF3)2CHOH - 
10 P-1/Ox-16 Et3N (CF3)2CHOH - 
11 P-1/Ox-4  (CF3)2CHOH 100 
12 P-1/Ox-13  (CF3)2CHOH 98 
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13 P-1/Ox-16  (CF3)2CHOH 100 
14 P-2/Ox-13  (CF3)2CHOH 100 
15 P-2/Ox-16  (CF3)2CHOH 100 
a Calculated on the methylesther from 1H-NMR spectrum after work up with a solution of 
trimethysylyldiazomethano 2M and then CH3COOH 
Table 2.2 
 
Reactions in MeOH as solvent did not proceed. This fact confirms that standard protic 
solvents are not suitable for supramolecular species (entries 3 and 4) hampering H-bond 
interactions. Quite interestingly the use of dichloromethane was not successful and only 
moderate conversions were achieved.  
The addition of TEA as additive, which in other examples reported in the literature used in 
order to deprotect the carboxylic acid functionality helping the coordination to the metal 
center,
146
 in our case did not improve the reactivity. This might be due to the presence of 1 
equivalent of triethylammonium chloride which hampers the formation of the supramolecular 
bidentate complex.  
Very satisfactory results in terms of conversion were achieved when (CF3)2CHOH was the 
solvent used (entries 11 to 15), although racemic products were in all cases invariably 
obtained. 
The lack in enantioselectivity was attributed to the flexibility of the heterocomplexes, 
compared to the classical covalent P,N-ligands, typically creating a 5- or 6-terms iridacycle 
when coordinated to the metal. 
 
Hydrogenation of trans-2-methyl-3-phenylprop-2-en-1-ol 
 
Entry L1, L2 Conversion
a (%) 
1 (P-1)2 100% 
2 (P-2)2 60% 
3 P-1/Ox-3 10% 
4 P-1/Ox-4 10% 
5 P-1/Ox-13 10% 
6 P-1/Ox-15 5% 
                                                                
146 Q.-L. Zhou, Angew. Chem. Int. Ed., 2012, 51, 2708. 
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7 P-1/Ox-16 10% 
8 P-2/Ox-3 5% 
9 P-2/Ox-4 5% 
10 P-2/Ox-13 5% 
11 P-2/Ox-15 5% 
12 P-2/Ox-16 10% 
a Calculated on the methylesther from 1H-NMR spectrum after work up with a solution of 
trimethysylyldiazomethano 2M and then CH3COOH
  
Table 2.3 
 
In these reactions the two phosphorus homocomplexes P-1 and P-2 initially tested, proved to 
be more active than the heterocomplexes. Therefore, the low values of conversion observed 
with the heterocomplex catalysts obtained in mixture with the homocomplexes (entries 3, 4, 
8, 9) could in principle be attributed to the activity of the homocomplexes.  
However, no further investigations were done since was not achieved enantiodiscrimination. 
 
Hydrogenation of alpha-methylcinnamic acid 
 
 
Entry L1, L2 additive (1eq) Temperature H2 pressure Conversion
a (%) 
1  P-1/Ox-4  RT 10 bar 12 
2 P-1/Ox-4 Et3N RT 10 bar - 
3 P-2/Ox-4  RT 10 bar 45 
4 P-2/Ox-4 Et3N RT 10 bar - 
5 P-1/Ox-3  45° C 10 bar 50 
6 P-1/Ox-4  45° C 10 bar 15 
7 P-1/Ox-13  45° C 10 bar 16 
8 P-1/Ox-15  45° C 10 bar 10 
9 P-1/Ox-16  45° C 10 bar 75 
10 P-2/Ox-3  45° C 10 bar 60 
11 P-2/Ox-4  45° C 10 bar 55 
12 P-2/Ox-13  45° C 10 bar 50 
13 P-2/Ox-15  45° C 10 bar 30 
14 P-2/Ox-16  45° C 10 bar 33 
15 (P-1)2  45° C 10 bar 100 
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16 (P-2)2  45° C 10 bar 70 
17 (Ox-4)2  45° C 10 bar 80 
a Calculated on the methylesther from 1H-NMR spectrum after work up with a solution of 
trimethysylyldiazomethano 2M and then CH3COOH 
Table 2.4 
 
Regarding the hydrogenation of substrate 106, first of all two complexes [Ir(P-1/Ox-
4)(cod)]BArF and [Ir(P-2/Ox-4)(cod)]BArF where tested in (CF3)2CHOH at room 
temperature both with (entries 2 and 4) and without 1 equivalent of Et3N (entries 1 and 3) as 
additive. Once again the use of Et3N gave not conversion.  
To increase the final conversion, the reactions were tried at 45°C (entries 6 and 11). At this 
temperature the reactions showed the best results in terms of yield. So other complexes were 
investigated (entries 5, 7, 8, 9, 10, 12, 13, 14).  
Some  homocomplexes were tested as well (entries 15 to 17), and these trials revealed that, 
for this substrate, the homocomplexes behaved as the most active species. 
Consequently, the lower conversions with the use of the two heterocomplexes is either due to 
the lower activity of the pure heterocomplex or, at worst, to the completely inactivity of it.  
The lack in enantioselectivity did not prompt us into further investigations. 
 
Hydrogenation of 2-acetylamino-3-phenyl-acrylic acid methyl ester 
 
Entry L1, L2 Solvent Conversion
a (%) 
1 P-1/Ox-4 CH2Cl2 70 
2 P-1/Ox-16 CH2Cl2 80 
3 P-2/Ox-4 CH2Cl2 85 
4 P-1/Ox-4 (CF3)2CHOH 98 
5 P-1/Ox-16 (CF3)2CHOH 100 
6 P-2/Ox-4 (CF3)2CHOH 100 
a Determined by GC, column Supelco β-dex 225 
Table 2.5 
 
Even for this substrate, (CF3)2CHOH proved to increase the conversion (entries 4 to 6) but, 
once again, these heterocomplexes shown to be not able to induce enantiodiscrimination. 
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Hydrogenation of N-(3,4-dihydronaphthalen-1-yl)acetamide 
 
Entry L1, L2 Conversion
a (%) 
1 P-1/Ox-4 25 
2 P-1/Ox-13 31 
3 P-1/Ox-15 22 
4 P-2/Ox-16 41 
5 P-3/Ox-16 33 
6 (P-1)2 14 
7 (P-2)2 14 
8 (P-3)2 19 
9 (Ox-4)2 33 
10 (Ox-13)2 9 
11 (Ox-15)2 32 
12 (Ox-16)2 18 
a Determined by GC, column Supelco β-dex 225 
Table 2.6 
 
Several heterocomplexes were tested for the hydrogenation of substrate 110, as well as the 
relative homocomplexes. The employment of the heterocomplexes as catalysts did not 
improve the results. 
Once again the conversion into the final product 111 was achieved, revealing that the species 
were active as catalysts but not a discrimination in terms of enantioselectivity was obtained. 
 
Hydrogenation of N-(3,4-dihydronaphthalen-2-yl)benzamide and N-(1-benzyl-3,4-
dihydronaphthalen-2-yl)acetamide 
 
So far our complexes revealed to be in general active for the conversion of the chosen olefins, 
but the lack in enantioselectivity was attributed to the flexibility of our supramolecular 
bidentate ligands compared with the rigid structure of the classical covalent bidentate P,N-
ligand. 
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Therefore, we wanted to see if our complexes could be suitable for the hydrogenation of 
hindered C=C double bonds. The two substrates 112 and 114 following reported were thus 
chosen and tested. 
 
 
 
Various heterocomplexes were used as catalysts as well as the relative homocomplexes. 
The reactions were carried out at room temperature with H2 pressure of 50 bar, but 
unfortunately, the conversion of these bulky substrates was very low. Hence, the two 
substrates revealed to be challenging also for our complexes. 
 
2.6     Conclusions 
 
Novel supramolecular bidentate P,N-ligands were synthesized, in particular 
phosphinooxazoline ligands raised from the hydrogen bond-induced assembly of one 
phosphine ligand and one oxazoline ligand, both bearing an urea functionality. 
Different techniques confirmed the formation of the heterocomplexes, although in some cases 
in mixture with the relative homocomplexes. 
The iridium-complexes resulted often inactive species for hydrogenation reactions of 
unfunctionalized alkenes. Unfortunately not satisfying results in terms of enantioselectivity 
were obtained, probably due to the flexible structure of the supramolecular bidentate ligands. 
However, the predominant, and in some cases exclusive, formation of the heterocomplexes 
achieved with this type of supramolecular interaction, will lead us to further future 
investigations of the complexes in other applications, in particular in allylic alkylations. 
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2.7     Experimental section 
 
General Remarks  
 
All reactions were carried out under a nitrogen atmosphere, using standard Schlenk 
techniques. 
The reactions were performed with distilled solvents. CH2Cl2 and MeOH were distilled from 
CaH2 and TFE and HFIP over molecular sieves under nitrogen.  
Air sensitive liquids and solutions were transferred via a gas-tight syringe or cannula. 
Removal of solvents was accomplished by evaporation on a Buchi rotary evaporator (water 
bath 40°C) or directly from the Schlenk using an oil pump.  
The reactions were monitored by analytical thin-layer chromatography (TLC) using silica gel 
60 F254 pre-coated glass plates (0.25 mm thickness). Visualisation was accomplished by 
irradiation with a UV lamp and/or staining with a potassium permanganate alkaline solution 
or a nynhidrine solution. Flash column chromatography was performed using silica gel (60 Å, 
particle size 40-64 μm) as stationary phase, following the procedure by Still and co-
workers.
147
 
1
H-, 
13
C-  and 
31
P-NMR spectra were recorded measured on a Bruker DRX 
400MHz and Inova 500MHz.  
Chemical shifts are reported in ppm with the solvent reference relative to tetramethylsilane 
(TMS) employed as the internal standard (CDCl3 δ = 7.26 ppm). 
13
C NMR spectra were 
recorded with a 400 MHz spectrometer operating at 100.56 MHz with complete proton 
decoupling. Chemical shifts are reported in ppm relative to TMS with the respective solvent 
resonance as the internal standard (CDCl3, δ = 77.23 ppm). 
31
P NMR spectra were referenced 
to external H3PO4. Chiral GC separations were conducted on Interscience HR-GC apparatus 
with a Supelco β-dex 225 column. High resolution mass spectra were recorded on a JEOL 
JMS SX/S102A four sector mass spectrometer, equipped with ESI or FAB source. Chiral 
HPLC analysis were performed with a Shimadzu instrument equipped with a Diode Array 
detector. 
Commercially available reagents were used as received without, unless indicated otherwise.  
 
 
 
                                                                
147 W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923. 
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2.7.1     Synthesis and characterization of the ligands 
 
Ligands Ox-3, Ox-4, Ox-6, Ox-8, Ox-12, Ox-13, Ox-15, Ox-16 were synthesized according 
to Chapter 1 (Experimental section).  
 
1-(3-(diphenylphosphino)phenyl)urea (P-1) 
 
Compound P-1 was synthesized according to a published procedure.
148
 
Crude yield (
31
P NMR): 96 % - 
1
H NMR (400 MHz, CD2Cl2): δ =
 
4.56 (s, 2H), 6.36 (s, 1H), 
7.02-7.09 (m, 2H), 7.29-7.36 (m, 10H), 7.45-7.46 (m, 1H). -
 31
P NMR (121.2 MHz, CD2Cl2): 
= -4.09. Spectroscopic data of the product were in agreement with the literature. 
 
(R)-1-(2-(diphenylphosphino)ethyl)-3-(1-(naphthalen-1-yl)ethyl)urea (P-2) 
 
Compound P-4 was synthesized according to a published procedure.
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Crude yield (
31
P NMR): 90 % - 
1
H NMR (400 MHz, CD2Cl2): δ =
 
1.4 (d, 3H, J = 6.6 Hz), 2.1 
(m, 2H), 3.1 (m, 2H), 5.15 (m, 1H), 5.42 (d, 1HJ = 7.5 Hz), 5.5 (t, 1H, J = 6.6 Hz). -
 31
P 
NMR (121.2 MHz, CD2Cl2):  
= -21.00. Spectroscopic data of the product were in agreement with the literature. 
 
(R)-1-(3-(diphenylphosphino)phenyl)-3-(1-phenylethyl)urea (P-2) 
 
In a 500 mL flask, meta-iodoaniline (5.48g, 25 mmol) was dissolved in 12.5 mL of HCl in 
H2O (2M). 100mL of water was added to dissolve completely the solid. (R)-(+)-α-
Methylbenzyl isocyanate (4.7mL, 33 mmol) was dissolved in a minimum volume of water 
and was added dropwise to the solution. After 1h stirring at r.t. a white precipitate was filtered 
                                                                
148 P-A. R. Breuil, F. W. Patureau, J. N. H. Reek, Angew. Chem. Int. Ed. 2009, 48, 2162. 
149 J. Meeuwissen, M. Kuil, A. M. van der Burg, A. J. Sandee, J. N. H. Reek, Chem. Eur. J. 2009, 15, 10272. 
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and washed with water. The product was then washed twice with toluene, and dried under 
vacuum to afford the (R)-1-(3-iodophenyl)-3-(1-phenylethyl)urea (yield: 80%). 
(R)-1-(3-iodophenyl)-3-(1-phenylethyl)urea (2.92g, 8 mmol) was dissolved in 20 mL of a 
solution of THF/DMF (3/1), NEt3 (2.20mL, 16 mmol) and Ph2PH (1.39mL, 8 mmol) were 
successively added. Pd(OAc)2 (90mg, 5 mol%) was added under Argon. The black solution 
was refluxed overnight. After cooling to room temperature, the THF was evaporated (crude 
yield 
31
P NMR 90 %). 20 mL of degassed water was added. The product was extracted with 
ethyl acetate. The solvent was evaporated. The crude mixture was dissolved in DCM and 
filtrated over a plug of SiO2. The plug was washed with DCM until the impurities had passed, 
and then was pushed through with ethyl acetate. After evaporation of the solvent the product 
was obtained as a white solid. 
1
H NMR (400 MHz, DMSO): δ = 1.34 (d, 3H, J= 8 Hz), 4.76 (dq, 1H, J=8.0, 16.0 Hz), 6.56 
(d, 1H, J= 8 Hz), 6.73 (t, 1H, J=8.0Hz), 7.17-7.43 (m, 17H),7.47 (d, 1H, J= 12 Hz), 8.43 (s, 
1H) - 
13
C NMR (100.6 MHz, CD2Cl2): δ = 21.4, 56.9, 121.8, 125.9, 126.7, 126.9, 128.5, 
128.6, 128.9, 129.5, 129.7, 133.9, 136.7, 138.4, 139.0, 141.5, 154.3 - 
31
P NMR (121.2 MHz, 
CD2Cl2): = -5.19 - HR-MS: [M+H]
+ m/z:  425.17. 
 
1-(3-(diphenylphosphino)phenyl)-3-(3-nitrophenyl)urea (P-3) 
 
In a 500 mL flask, meta-iodoaniline (5.48g, 25 mmol) was dissolved in 12.5 mL of HCl in 
H2O (2M). 100mL of water was added to dissolve completely the solid. 3-nitro-
phenylisocyanate (5.4g, 33 mmol) was dissolved in a minimum volume of water and was 
added dropwise to the solution. After 1h stirring at r.t. a yellow precipitate was filtered and 
washed with water. The product was then washed twice with toluene, and dried under 
vacuum to afford the 1-(3-iodophenyl)-3-(3-nitrophenyl)urea (yield: 82%). 
1-(3-iodophenyl)-3-(3-nitrophenyl)urea (3 g, 8 mmol) was dissolved in 20 mL of a solution of 
THF/DMF (3/1), NEt3 (2.10mL, 15 mmol) and Ph2PH (1.39mL, 8 mmol) were successively 
added. Pd(OAc)2 (90mg, 0.5 mol%) was added under Argon. The black solution was refluxed 
overnight. After cooling to room temperature, the THF was evaporated (crude yield 
31
P NMR 
92 %). 20 mL of degassed water was added. The product was extracted with ethyl acetate. 
The solvent was evaporated. The crude mixture was dissolved in DCM and filtrated over a 
plug of SiO2. The plug was washed with DCM until the impurities had passed, and then was 
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pushed through with ethyl acetate. After evaporation of the solvent the product was obtained 
as a yellow solid. 
1
H NMR (400 MHz, DMSO): δ = 7.44 (t, 1H, J= 8 Hz), 7.84-7.89 (m, 4H), 7.91-7.95 (m, 
2H),  8.00-8.04 (m, 5H), 8.12-8.20 (m, 3H), 8.27 (d, 1H, J=8.0Hz), 8.41 (dd, 1H, J= 4, 8 Hz), 
9.09 (t, 1H, J= 2 Hz), 9.52 (s, 1H), 9.76 (s, 1H) - 
13
C NMR (100.6 MHz, CD2Cl2): δ = 114.5, 
119.4, 121.8, 125.9, 127.8, 128.6, 128.9, 129.5, 129.7, 129.9, 133.9, 136.7, 136.8, 138.4, 
139.0, 148.5, 153.9 -
 31
P NMR (121.2 MHz, CD2Cl2): = -5.04 - HR-MS: [M+H]
+ m/z: 
442.13. 
 
2.7.2     Synthesis and characterization of metal complexes 
 
2.7.2.1     General procedure for the formation of the homocomplexes  
 
In a dry Schlenk, [Ir(cod)Cl]2 (0.5 equiv.) and the ligand (2 equiv.) were dissolved in CH2Cl2 
and the solution stirred at room temperature for 2 hours. Sodium(Tetrakis[(3,5-
trifluoromethyl) phenyl]borate) was added, leaving the mixture stirring for another hour. The 
mixture was filtered under nitrogen over celite and then the solvent evaporated under 
vacuum. The residue were characterized by 
1
H-, 
31
P-NMR, FAB-MS. 
For each complexes, the comparison between the 
1
H-NMR spectrum of the ligand itself and 
the 
1
H-NMR spectrum of the corresponding Ir-homocomplex is reported. 
 
[Ir(P-1)2(cod)]BArF 
   
 
114 
 
1
H-NMR: comparison between the ligand and homocomplex spectra 
1
H-NMR (400 MHz, CD2Cl2): δ =
 
1.90-2.11 (m, 4H), 2.32-2.40 (m, 4H), 4.25 (bs, 4H), 4.93 
(bs, 4H), 6.90 (bs, 2H), 7.13 (t, 2H, J=7.6 Hz), 7.23-7.32 (m, 4H), 7.39-7.55 (m, 24H), 7.60 
(s, 4H), 7.77 (s, 8H). 
Red powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 942.30 
 
 [Ir(P-2)2(cod)]BArF 
 
 
1
H-NMR: comparison between the ligand and homocomplex spectra 
1
H-NMR (400 MHz, CD2Cl2): δ =
 
1.51 (d, 6H, J=6.9 Hz), 1.86-1.93 (m, 4H), 2.23-2.34 (m, 
4H), 4.18 (bs, 4H), 4.92-4.99 (m, 2H), 4.29 (d, 2H, J=7.4 Hz), 6.78 (t, 2H, J=8.2 Hz), 7.01-
7.08 (m, 4H), 7.14-7.21 (m, 4H), 7.30-7.51 (m, 26H), 7.60 (s, 4H), 7.77 (s, 8H). 
Red powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1149.83 
 
[Ir(P-3)2(cod)]BArF 
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1
H-NMR: comparison between the ligand and homocomplex spectra 
1
H-NMR (400 MHz, DMSO): δ = 1.99-2.08 (m, 4H), 2.35-2.42 (m, 4H), 4.28 (bs, 4H), 6.95 
(t, 2H, J=8.0 Hz), 7.14-7.23 (m, 8H), 7.39-7.44 (m, 8H), 7.48-7.56 (m, 10H), 7.59 (s, 4H), 
7.64 (d, 2H, J=7.7 Hz), 6.69 (d, 2H, J=7.7 Hz), 7.77 (s, 8H), 7.97 (d, 2H, J=8.0 Hz), 8.51-
8.54 (m, 2H). 
Red powder, 
31
P NMR (121.2 MHz, CD2Cl2): =- HR-MS: [M]
+
 m/z: 1183.31 
 
 [Ir(Ox-3)2(cod)]BArF 
      
     
1
H-NMR: comparison between the ligand and homocomplex spectra 
Yellow powderHR-MS: [M]+ m/z: 851.44 
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[Ir(Ox-4)2(cod)]BArF 
 
    
1
H-NMR: comparison between the ligand and homocomplex spectra 
Yellow powder HR-MS: [M]+ m/z: 919.45 
 
[Ir(Ox-6)2(cod)]BArF 
 
   
1
H-NMR: comparison between the ligand and homocomplex spectra 
Yellow powder HR-MS: [M]+ m/z: 865.39 
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[Ir(Ox-12)2(cod)]BArF 
 
      
1
H-NMR: comparison between the ligand and homocomplex spectra 
Yellow powder HR-MS: [M]+ m/z: 1043.44 
 
[Ir(Ox-13)2(cod)]BArF 
 
   
1
H-NMR: comparison between the ligand and homocomplex spectra 
Yellow powderHR-MS: [M]+ m/z: 945.42 
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[Ir(Ox-15)2(cod)]BArF 
 
   
1
H-NMR: comparison between the ligand and homocomplex spectra 
Yellow powder HR-MS: [M]+ m/z: 1015.39  
 
[Ir(Ox-16)2(cod)]BArF 
 
   
1
H-NMR: comparison between the ligand and homocomplex spectra 
Yellow powder HR-MS: [M]+ m/z: 1037.39 
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2.7.2.2     General procedure for the formation of the heterocomplexes  
 
In a dry Schlenk, [Ir(cod)Cl]2 (0.5 equiv.) and the N-ligand (1 equiv.) and the P-ligand (1 
equiv.) were dissolved in CH2Cl2 and the solution stirred at room temperature for 2 hours. 
Sodium(Tetrakis[(3,5-trifluoromethyl) phenyl]borate) was added, leaving the mixture stirring 
for another hour. The mixture was filtered over celite under nitrogen and then the solvent 
evaporated under vacuum. The residue were characterized by 
1
H-, 
31
P-NMR, FAB-MS. 
For each complexes, the comparison between the 
1
H-NMR spectra of the P-ligand, P-ligand 
homocomplex, N-ligand, N-ligand homocomplex and the heterocomplex is reported. 
 
[Ir(P-1)(Ox-3)(cod)]BArF 
 
1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 896.36 
 
[Ir(P-1)(Ox-4)(cod)]BArF 
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1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 930.34 
 
[Ir(P-1)(Ox-6)(cod)]BArF 
 
 
1
H-NMR: comparison of the spectra relative to the: P-ligand, P-ligand homocomplex, N-
ligand, N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 906.41 
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[Ir(P-1)(Ox-12)(cod)]BArF 
 
 
1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 993.36 
 
[Ir(P-1)(Ox-13)(cod)]BArF 
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1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 944.36 
 
[Ir(P-1)(Ox-15)(cod)]BArF 
 
 
1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 978.34 
 
[Ir(P-1)(Ox-16)(cod)]BArF 
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1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 989.34 
 
[Ir(P-2)(Ox-3)(cod)]BArF 
 
 
1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1001.36 
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[Ir(P-2)(Ox-4)(cod)]BArF 
 
 
1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 134.36 
 
[Ir(P-2)(Ox-6)(cod)]BArF 
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1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1010.47 
 
[Ir(P-2)(Ox-12)(cod)]BArF 
 
 
1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1097.37 
 
[Ir(P-2)(Ox-13)(cod)]BArF 
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1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1048.32 
 
[Ir(P-2)(Ox-15)(cod)]BArF 
 
 
1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1082.34 
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[Ir(P-2)(Ox-16)(cod)]BArF 
 
 
1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1093.32 
 
[Ir(P-3)(Ox-13)(cod)]BArF 
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1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1065.32 
 
[Ir(P-3)(Ox-15)(cod)]BArF 
 
 
1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1099.36 
 
[Ir(P-3)(Ox-16)(cod)]BArF 
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1
H-NMR: comparison of the spectra relative to: P-ligand, P-ligand homocomplex, N-ligand, 
N-ligand homocomplex and the heterocomplex  
Orange powder, 
31
P NMR (121.2 MHz, CD2Cl2): = HR-MS: [M]
+
 m/z: 1110.36 
 
Dilution studies - NMR evaluations 
 
The 
1
H NMR dilution experiments were carried out by preparing a sample (0.7 mL) at a 
known concentration: 1, 2.5, 5, 10 mM in CD2Cl2 for Ox-16, P-1, and [Ir(P-1/Ox-
16)(cod)]BArF. The position of the solvent signal was used as a reference for the urea NH 
signal. 
 
2.7.3    Hydrogenation reactions 
 
Substrates 100, 106 and 108 are commercially available. 
 
trans-4-phenylpent-3-enoic acid (102) 
 
Compound 102 was synthesized according to a published procedure.
150
 
1
H NMR (400 MHz, CD3Cl): δ =
 
2.07 (s, 3H),3.31 (d, 2H, J = 7.1 Hz), 5.93 (t, 1H, J = 7.0 
Hz), 7.24–7.26 (m, 1H), 7.32 (t, 2H, J = 7.5 Hz), 7.40 (d, 2H, J = 7.7 Hz). Spectroscopic data 
of the product were in agreement with the literature. 
 
                                                                
150 S. Song, S-F. Zhu, S. Yang, S. Li, Q-L. Zhou, Angew. Chem. Int. Ed. 2012, 51, 2708. 
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trans-2-methyl-3-phenylprop-2-en-1-ol (104) 
 
Compound 104 was synthesized according to a published procedure.
151
 
1
H NMR (400 MHz, CD3Cl): δ =
 
1.90 (s, 3H), 4.18 (s, 2H), 6.53 (s, 1H), 7.20-7.35 (m, 5H). 
Spectroscopic data of the product were in agreement with the literature. 
 
N-(3,4-dihydronaphthalen-1-yl)acetamide (110) 
 
Compound 110 was synthesized according to a published procedure.
152
 
1
H NMR (400 MHz, CD3Cl): δ =
 
2.14 (s, 3H), 5.09 (s, 1H), 5.88 (s, 1H), 6.84 (s, 1H), 7.33-
7.55 (m, 5H). Spectroscopic data of the product were in agreement with the literature.  
 
N-(3,4-dihydronaphthalen-2-yl)benzamide (112) 
 
Compound 112 was synthesized according to a published procedure.
153
 
1
H NMR (400 MHz, CD3Cl): δ =
 
2.55 (t, 2 H, J = 7.7 Hz), 2.93 (t, 2 H, J = 7.7 Hz), 7.07-7.80 
(m, 11 H). Spectroscopic data of the product were in agreement with the literature.  
 
N-(1-benzyl-3,4-dihydronaphthalen-2-yl)acetamide (114) 
 
Compound 114 was synthesized according to a published procedure.
154
 
                                                                
151 L. Cheng-Kun, L. Ta-Jung, J. Org. Chem. 2008, 73, 9527. 
152 D. J. Frank, A. Franzke, A. Pfaltz, Chem. – Eur. J. 2013, 19, 2405. 
153 G. Argouarch, O. Samuel, H. B. Kagan, Eur. J. Org. Chem. 2000, 2885. 
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1
H NMR (400 MHz, CD3Cl): δ =
 
1.90 (s, 3H), 2.62 (t, 2 H, J = 7.7 Hz), 2.93 (t, 2 H, J = 7.7 
Hz), 3.22 (s, 2H) 7.07-7.80 (m, 10 H). Spectroscopic data of the product were in agreement 
with the literature.  
 
 General procedure for the hydrogenation reactions 
 
The hydrogenation experiments were carried out in a stainless steel autoclave (150 mL) 
charged with an insert suitable for 14 reaction vessels (including Teflon mini stirring bars) for 
conducting parallel reactions. In a typical experiment, the reaction vessels were charged with 
substrate, Ir-complex and Et3N, if needed, in dry solvent (so that the concentration of the 
substrate was 0.25 M). Before starting the catalytic reactions, the charged autoclave was 
purged three times with H2, then filled to the required pressure with H2. The reaction was 
stirred at room temperature or 45°C for the time needed  before the H2 pressure was released. 
For some substrate pretreatments were required before the analysis, for some others no 
pretreatments were needed and the solvent was just removed in vacuum. Conversions were 
determined by 
1
H NMR spectroscopy and ee% values were determined using chiral GC or 
HPLC. 
 
ENTRY 
PRODUCT 
Spectral data match those  
previously reported. 
PRETRATMENT SEPARATION METHOD 
1 
 
Adv. Synth. Cat.  2013, 355,  880. 
 
HPLC. Column OJ-H, 
Heptane/IPA 99:1,  
flow 0.7 mL/min 
2 
 
Angew. Chem. Int. Ed.  2012,  51, 
2708. 
Conversion into the 
methylesther by work up 
with a solution of 
trimethysylyldiazomethano 
2M and then CH3COOH 
HPLC. Column OJ-H, 
Heptane/IPA 95:5,  
flow 0.7 mL/min 
3 
 
Tetrahedron, 2011, 67, 5421. 
Conversion into the 
methylesther by work up 
with a solution of 
trimethysylyldiazomethano 
2M and then CH3COOH 
HPLC. Column Chiracel OD-
H, Heptane/IPA 95:5, flow 0.5 
mL/min 
                                                                                                                                                                       
154 P. Dupau, C. Bruneau, P. H. Dixneuf, Adv. Synth. Cat. 2001, 343, 331. 
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4  
Angew. Chem. Int. Ed.  2012,  51, 
8872. 
Conversion into the 
methylesther by work up 
with a solution of 
trimethysylyldiazomethano 
2M and then CH3COOH 
HPLC. Column Chiracel OD-
H, Heptane/IPA 95:5, flow 1.0 
mL/min 
5 
 
Org. lett., 2000, 2, 2431. 
 
GC (column Supelco β-dex 
225) Conditions: 140 °C for 
14 min, then gradient: 
50°C/min to 220 °C;  
tS= 11.56 min, tR = 12.14 min; 
tsubstrate = 10.77 min. 
6 
 
Org. lett., 2007, 9, 1157. 
 
GC (column Supelco β-dex 
225) Conditions: 70°C for 1 
min, then gradient: 10°C/min 
to 160 °C, then 160° for 5.0 
min, then gradient: 4°C/min to 
220 C; tR = 27.78 min, tS = 
27.92 min, tsubstrate= 32.63 min. 
7 
 
Eur. J. Org. Chem, 2000, 16, 2885. 
 
HPLC. Column Chiracel AD, 
Heptane/IPA 90:10, flow 0.6 
mL/min 
8 
 
Adv. Synth. Cat.,2001, 343, 331. 
 
HPLC. Column Chiracel AD, 
Heptane/IPA 90:10, flow 
0.6mL/min 
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Synthesis of polydentate 
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for iron-complexes  
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3.1     Introduction on iron-based catalysis  
 
As we have pointed out so far, transition metal catalysis has a tremendous importance in 
the field of modern synthesis; indeed many processes only take place when metal complexes 
offer new reaction pathways. Nevertheless, the number of industrially implemented catalytic 
processes is still rather limited, and this is even more pronounced in asymmetric catalysis. In 
spite of all advances in the technology, most of the enantiopure compounds are obtained via 
classical resolution of diastereomeric salts. The main reason for this paradox is the high cost 
of the catalysts, classically noble metals such as Rh, Ru, Ir, Pd, Pt, of limited supply. 
It is therefore quite obvious that replacing precious metals with cheap first-row transition 
metals would turn out in a great breakthrough, from both the scientific and the industrial point 
of view.
155
 Among the possible suitable metals, iron plays a special role. In contrast to toxic 
metals (i.e. Cr, Os, Co..), iron is a physiologically and environmentally friendly metal. The 
large abundance of iron in earth’s crust (4.5 wt%, it is the fourth most abundant element and 
the second most common metal in the Earth’s crust, after aluminium) makes it very cheap and 
offers the possibility to engage iron even in stoichiometric manner.  
Despite these obvious advantages, only few iron complexes are nowadays used for synthetic 
applications. Among them, iron carbonyl complexes
156
 and ferrocene derivatives
157
 are the 
most prominent examples.  
At the moment, chemists aim at developing iron-based catalysts not only for hydrogenation 
but also for a variety of organic transformations that can be used in future industrial 
applications. 
To this end, one major obstacle in replacing precious metals with iron stems from the 
difference in electronic structure. Whereas a noble metal like platinum easily undergoes two-
electron redox changes to promote bond-making and breaking events, iron is more prone to 
one-electron redox changes. This tendency, which poses challenges for controlling reactivity 
and stabilising or maintaining the function of the catalyst, can be circumvented by the use of 
“non-innocent” ligands. By confining all redox changes to the ligand, no oxidation state 
change would occur at the metal, thus avoiding the formation of true Fe(0) species, which are 
                                                                
155 Iron Catalysis in Organic Chemistry: Reactions and Applications, Wiley-VCH, 2008; R. H. Morris, Chem. Soc. 
Rev. 2009, 38, 2282; R. M. Bullock, Catalysis without Precious Metals, Wiley-VCH, 2010. 
156 R. Langer, G. Leitus, Y. Ben-David, D. Milstein, Angew. Chem. Int. Ed. 2011, 50, 2120; A. Berkessel, S. Reichau, 
A. von der Höh, N. Leconte, Jörg-M. Neudörlf, Organometallics, 2011, 30, 3880. 
157 S. Fleischer, S. Zhou, K. Junge, M. Beller, Angew. Chem. Int. Ed. 2013, 52, 5120. 
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sometimes detrimental in reduction catalysis, because they can decompose by ligand loss and 
result in deposition of the metal.
158
  
Here below some applications of iron-complexes in catalysis will be highlighted. 
 
3.2.     Iron-catalyzed reduction of C-C multiple bonds (alkenes and alkynes) 
 
Compared to the other transition metals (Pd, Pt, Rh, Ir), iron is significantly less exploited 
for the homogeneous catalysis of organic reactions in general, and of double bond reductions 
in particular. However, given its far lower cost and greater abundance over the more precious 
metals, in recent years there has been a growing scientific effort for developing efficient and 
selective homogeneous iron-catalysts.
155 
Given the indispensability of alkene and alkyne 
hydrogenation in fine and commodity chemical synthesis,
159
 these transformations are 
important targets for the more environmentally benign catalytic methods.  
Complexes 116, 117, 118 are examples of iron catalysts studied by Chirik, Peters and 
Bianchini in the reduction of C-C multiple bonds. Complexes 116 and 117 are extremely air-
sensitive; their synthesis and manipulation must take place under rigorously dry conditions 
and these serious practical limitations have prevented their industrial application; whereas 
complex 118 is reported as exhibiting exceptional thermal and chemical stability. 
 
 
 
In particular, complex 116, used by Chirik,
160
 was suitable for the hydrogenation of several 
types of olefins under very mild conditions, and showed a broad functional group tolerance 
(unsaturated ethers, esters, hydrocarbons, amines). The first mechanism proposed was based 
on a Fe(0)/Fe(II) cycle, but later a combination of spectroscopic techniques and density 
                                                                
158 P. J. Chirik, K. Wieghardt, Science 2010, 327, 794. 
159 J. P. Collman, L. S. Hegedus, J. R. Norton, R. G. Finke, Principles and Applications of Organotransition Metal 
Chemistry; University Science Books: Mill Valley, CA, 1987. 
160 S. C. Bart, E. Lobkovsky, P. J. Chirik, J. Am. Chem. Soc. 2004, 126, 13794; S. C. Bart, K. Chlopek, E. Bill, M. W. 
Bouwkamp, E. Lobkovsky, F. Neese, K. Wieghardt, P. J. Chirik, J. Am. Chem. Soc. 2006, 128, 13901; R. J. Trovitch, 
E. Lobkovsky, E. Bill, P. J. Chirik, Organometallics 2008, 27, 1470; S. K. Russell, J. M. Darmon, E. Lobkovsky, P. 
J. Chirik, Inorg. Chem. 2010, 49, 2782. 
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functional theory calculations established that the formally Fe(0)-compound was actually the 
physical oxidation state of an iron(II)-compound, where the metal transferred two electrons to 
the bis(imino)pyridine ligand.
161
 Therefore, the ligand was supposed to act as a “non-
innocent” ligand, although, up to now, a mechanism that takes into account the “non 
innocent” nature of the ligand is still missing. 
Complexes 117 were introduced for the reduction of alkenes by Peters,
162
 who hypothesized a 
mechanism where, after the coordination and the insertion of the alkene in the Fe-H bond, the 
unusual two-electron redox Fe(II)/Fe(IV) would take place or, alternatively, a σ-bond 
metathesis (Scheme 3.1). 
 
 
Scheme 3.1 
 
Up to date, no methods for the asymmetric hydrogenation of C-C double bonds by 
homogeneous chiral iron catalysts appeared. 
Iron-catalyst 118 was used by Bianchini to promote the reduction of terminal alkynes to the 
corresponding alkenes, although it was not active towards the olefin reduction.
163
 It 
represents, up to now, the only example of well-defined homogeneous iron catalyst for the 
hydrogenation of triple C≡C bonds. 
 
3.3    Iron-catalyzed reduction of C-X multiple bonds (ketones, aldehydes and imines)  
 
The use of iron-catalysts for the reduction of the C=X bond (X = O or NR), has become 
more usual than its use in the C=C or C≡C hydrogenation, also including examples of 
enantioselective catalysts.  
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A key player in this field is certainly Morris, who prepared Fe(II)-complexes 119 bearing 
different bridging diamines, and tested their reactivity in transfer hydrogenation reactions.
164
 
 
 
 
The bigger was the bulkiness of the diamine backbone, the higher were turnover frequency 
(TOF), catalytic activity and enantioselectivity of the complexes.  
The key of the mechanism of these complexes lies in the “non-innocent” nature of the 
P,N,N,P-ligand, whose imino function is partially reduced to generate the catalytically active 
species. Here the diiminodiphosphino ligand, actively participating in the mechanism of C=O 
reduction by mediating the proton transfer, closely resembles the mechanism described by 
Noyori for his Ru(II)-catalyst
165
 (Figure 3.1). 
 
 
Figure 3.1 
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In addition, Morris developed the iron-complexes 120a, b, c, and the related chiral complexes 
(S,S)-120d, e, f.
166
 
 
 
 
Morris had also previously reported the complex (R,R)-121,
167
 which showed higher activity 
and enantioselectivity in the transfer hydrogenation of acetophenone compared to complexes 
120, among which only the two complexes bearing the ethyl group at phosphorus (120c and 
(S,S)-120f) were active.  
In a very recent report, again Morris et al. described the synthesis of a series of iron(II)-
complexes 122 of partially saturated amine(imine)diphosphine (P,NH,N,P) ligands and their 
application to the asymmetric reduction of ketones and imines.
168
 They ended up with the 
choice of selective non symmetrical ligands, after that species 122 revealed to be more 
reactive that the previously studied species 119b. 
 
 
 
Unlike complex 119b,
164,169
 with complex 122 an induction period was not observed, and the 
rate of conversion at the chosen temperature (T = 28 °C) was substantially higher. TOF up to 
6100 s
-1
 with complete conversion were observed, and enantiomeric excess up to 98% for 
ketone reduction and up to 99% for imine reduction were obtained.  
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Also Reiser gave a contribution in iron-based catalysis, describing complex 123 prepared 
from two equivalents of a bis(isonitrile)ligand and FeCl2. This complex showed good activity 
in the transfer hydrogenation of aromatic ketones as well as of heterocaromatic ketones with 
enantioselectivities up to 91%.
170
  
 
 
 
For this complex, a Meerwein-Ponndorf-Verley-type mechanism was proposed on the basis 
of IR and NMR studies. In this process, the formation of an iron hydride does not take place; 
rather, the in situ reduction of the isonitrile ligand to imine occurs, through the extraction of a 
hydride from isopropanol and following  hydride transfer to the substrate. 
Highly effective achiral catalysts for the hydrogenation of ketones, aldehydes and  imines are 
complexes 125, 126 and 127, developed by  Knölker,
171
 Casey,
172
 Milstein
173
 and Beller
174,175
 
respectively. 
 
 
Catalyst 125 is very air- and moisture-sensitive, but three different routes were exploited by 
three research groups for its advantageous in situ formation. Starting from the stable 
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precatalyst 124, Berkessel used photolysis under controlled conditions to remove one CO 
ligand (A),
176
 Renaud treated 124 with trimethylamine N-oxide (B),
177
 while Beller exploited 
the so-called Hieber-base reaction (C)
178,179 
(Scheme 3.2). 
 
 
Scheme 3.2 
 
Complex 126, developed by Milstein and co-workers, catalyzes the hydrogenation of ketones 
under mild conditions making use of a metal-ligand cooperation, based on aromatization-
dearomatization of the heteroaromatic core of the pincer tridentate P,N,P-ligand.
180
 This is an 
example of “non-innocent” ligand behavior, where the ligand assists the metal center by 
undergoing reversible structural changes in the processes of substrate activation and product 
formation. 
In complex 127, in analogy to catalyst 118 proposed by Bianchini,
163
 there is a P4-tetradentate 
ligand. The Fe(II)-complex was developed by Beller for the hydrogenation of allylic 
aldehydes and CO2, and the dehydrogenation of formic acid.
175
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3.4     Iron-catalysts for epoxidation reactions 
 
Asymmetric epoxidation of olefins is one of the most important transformations in organic 
synthesis, since the resulting enantiomerically enriched epoxides are highly useful 
intermediates and building blocks.
181
 Many iron catalysts have been developed for the 
epoxidation of olefins. They can be easily classified in two families: the first one includes the 
iron-porphyrin-based complexes, while the latter the non-heme complexes. 
The iron-porphyrin-based complexes were the first iron-catalysts introduced in the 
epoxidation reaction, with the first example described in 1983 by Groves and Myers.
182
 Later 
on, several research groups developed novel chiral iron complexes of this type for the 
asymmetric epoxidation of olefins.
183
 However, several problems are correlated to the 
metalloporphyrin chemistry. Indeed, the synthesis of the chiral porphyrin core is crucial 
because  the overall conversion is in general very low and the essential extensive purification 
implies great efforts. Moreover, a careful choice of the reaction conditions is needed during 
the linkage of chiral auxiliary. Another important limitation of these methodologies is that the 
oxidant is most often iodosylbenzene, which is not really considered environmentally 
friendly.  
These limitations  have thwarted the development of these porphyrin complexes for 
asymmetric epoxidation. On the other hand, all the features above listed, prompted the design 
of non-porphyrin chiral iron catalysts.  
The first example of chiral non-heme iron complex was reported in 1999 by Francis and 
Jacobsen, who used an elaborate combinatorial screening of 5760 metal-ligand combinations 
to identify three peptide-like ligands suitable for Fe-catalyzed asymmetric epoxidation of 
trans--methylstyrene184 (Scheme 3.3). 
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Scheme 3.3 
  
Some years later, Beller developed simple catalytic systems using commercially available 
enantiopure 1,2-diphenylethylenediamine.
185
 The diamine was monosulfonylated to obtain 
one set of ligands (S,S)-128 and the other free amino group was benzylated to get another set 
of ligands (S,S)-129. These chiral ligands were complexed with ferric chloride and pyridine-
2,6-dicarboxylic acid (Pydic) as a co-ligand. The epoxidation reactions were carried out with 
30% H2O2 at room temperature. 
 
 
 
Ligand (S,S)-129a resulted in the best catalyst, giving excellent results with sterically bulky 
4,4’-disubstituted trans-stilbenes (100% conversion, yield up to 90%, ee up to 91%). 
In 2008, Kwong described a new class of iron catalyst based on sexipyridines for epoxidation 
using H2O2.
186
 Treatment of the ligand with FeCl2 in 1:2 molar ratio afforded the binuclear 
species [Fe2O(130)Cl4], which was isolated as an air-stable solid. The diiron system showed 
good reactivity towards terminal and 1,2-disubstituuted aromatic alkenes, but induced low 
enantioselectivities (31−43%). 
 
                                                                
185 F. G. Gelalcha, B. Bitterlich, G. Anilkumar, M. K. Tse, M. Beller, Angew. Chem., Int. Ed. 2007, 46, 7293; F. G. 
Gelalcha, G. Anilkumar, M. K. Tse, A. Br ckner, M. Beller, Chem.-Eur. J. 2008, 14, 7687. 
186 H-L. Yeung, K-C. Sham, C-S. Tsang, T-C. Lau, H-L. Kwong, Chem. Commun. 2008, 3801. 
144 
 
 
 
Sun developed the chiral iron(II)-complexes 131 using an N4-ligand based on the 
ethylenediamine backbone, and displaying remarkable levels of enantioselectivity in the 
asymmetric epoxidation of ,-enones, using hydrogen peroxide or peracetic acid as the 
oxidant (Scheme 3.4).
187
 
 
 
Scheme 3.4 
 
Very recently, Costas described the use of non-heme iron complexes 132a-g for the 
epoxidation of olefins with H2O2 as the oxidant, and improvement of the enantiomeric excess 
was attained by the use of carboxylic acid as additive, in particular acetic acid.
188
 With cis--
methylstyrene as substrate, the best results were obtained using complex 132a, achieving the 
desired product in 87% yield and 62% ee when the reaction was carried out in the presence of 
a catalytic amount of CH3COOH, in CH3CN, for 30 minutes at -30°C. In the paper was also 
highlighted how electronic effects can be used as powerful tools for controlling the activation 
of H2O2 and O-atom transfer in non-porphyrine iron complexes. 
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The positive role of acetic acid in iron-catalyzed oxidations has been documented for some 
years. Indeed, in many examples its presence has been shown to result in an increase in both 
catalytic activity and selectivity towards epoxidation, and also in the inhibition of cis-
dihydroxilation versus epoxidation.
189
 However, mechanistic interpretation has not been 
provided until recently. 
A rationale for the Fe-catalyzed AcOH-assisted epoxidation of olefins with H2O2 was 
proposed by Que,
190
 involving the intermediacy of an oxocarboxylate-iron(V) species (b) as 
the oxygen atom delivering agent (Scheme 3.5). Species b is formed via acid-assisted 
heterolytic cleavage of the O−O bond in a Fe(III)(OOH)-(HOAc) (a) precursor.  
Experimental spectroscopic evidences in favor of this mechanistic scenario were also recently 
provided by Talsi, Bryliakov and co-workers,
191
 and further computational support for the 
formation and oxidative competence of these species has been built by Rajaraman in a study 
for the ortho-hydroxylation of aromatic compounds by non-heme Fe complexes.
192
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Scheme 3.5 
 
3.5     Polydentate Nx ligands (tri- and tetradentate) for iron-catalyzed reactions  
 
For the applications reported above, the catalysts employed were mainly Fe(II) or Fe(0) 
complexes.  
We focused our attention on Fe(II). Regrettably, Fe(II)-complexes cannot be often considered 
as robust catalysts. Indeed, Fe(II) is very prone to oxidation to Fe(III), and for this reason 
Fe(II)-complexes usually need to be handled under extra-dry and oxygen-free conditions. 
Moreover, NMR spectroscopy, commonly used by chemists as a technique for structural 
characterization, can be rarely used for Fe(II)-complexes, which are in most cases 
paramagnetic. For these the characterization often relies on mass spectrometry (ESI being the 
most suitable ionization methodology) and X-ray diffraction. 
As shown in the sections above, the best way to stabilize the reactive Fe(II) metal centre is 
the use of polydentate ligands, which provide the desired stabilization by means of kinetic 
(steric) and thermodynamic (entropic) effects. 
In particular, we turned our attention to polydentate N-ligands, (tri- and tetradentates), based 
on the following considerations:  
 N-ligands are good sigma-donor ligands and are expected to stabilize the relatively hard 
Fe(II) more efficiently than P-ligands, 
 they are easier to prepare and more stable than P-ligands; indeed these are themselves 
often prone to oxidation, especially in the case of electron-rich phosphines. 
 
 
 
 
147 
 
3.5.1     Tridentate N3-ligands  
 
Among the different types of tridentate nitrogen ligands, we focused our attention on 
scorpionate ligands. 
This new versatile class of ligands appeared in 1966, showing peculiar features typical of 
cyclopentadienyl ligands.
193
 Like the pincer of a scorpion, these tripodal ligands generally 
bind metal centers with nitrogen atoms from two pyrazole rings attached to the central atom 
(e.g. boron); the third pyrazole attached to central atom (e.g. boron) rotates forward like a 
scorpion's tail to "sting" the metal; hence the name of “scorpionates” (Figure 3.2). 
 
Figure 3.2 
 
Over the years, the definition of scorpionates has been extended to tripodal ligands analogs to 
tris(pyrazol-1-yl)borates with different donor groups and bridging atoms. Central atoms other 
than boron, such as carbon, silicon, germanium, tin, aluminium, gallium, indium, phosphorus 
and nitrogen have been reported,
194
 even though the most studied classes of scorpionates are 
the B-centered tris(pyrazol-1-yl)borate derivatives and the C-centered tris(pyrazol-1-yl)alkane 
derivatives.
195
  
The ligand are commonly 6 electron donors and occupy three coordination sites as capping 
ligands when binding to the metal (Figure 3.3). 
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Figure 3.3 
 
Tris(pyrazol-1-yl)borates and tris(pyrazol-1-yl)alkanes have been extensively investigated in 
inorganic, bioinorganic and organometallic chemistry,
196,197
 and numerous reviews on their 
coordination properties with s,p-block elements
198
 and transition metals
195,199
 have been 
reported.
  
In general, independently of the nature of the bridging atom, two families of scorpionate 
ligands may be distinguished, namely homoscorpionates and heteroscorpionates, according 
to the presence of one or more types of metal binding groups, respectively. 
In this chapter we will deal only with the first type, possessing a local C3v symmetry.  
The naming of homoscorpionates follows some general rules.
200
  
When R is H (Figure 3.3), the abbreviation Tp for tris(pyrazol-1-yl)borates and Tm for 
tris(pyrazol-1-yl)methanes is used.  
Then, the substituents are denoted by superscripts. The “default” position in this abbreviation 
system is the 3-position on the pyrazole ring, which is denoted by a superscript “R1”, that is 
Tp
R1. Thus, for instance, hydrotris(3-methylpyrazol-1-yl)borate is denoted as Tp
Me
. The 5-
substituent follows the 3-substituent as a superscript, separated by a comma. For instance, 
hydrotris(3-isopropyl-5-methylpyrazol-1-yl)borate is denoted as Tp
iPr,Me
. When both 3 and the 
5 substituents are identical, the superscript substituent is followed by a 2: for instance 
hydrotris(3,5-dimethylpyrazol-1-yl)borate is Tp
Me2. A substituent in the 4-position is denoted 
as a 4R1 superscript. Thus, hydrotris(3-methyl-4-bromopyrazol-1-yl)borate is Tp
Me,4Br
. All the 
rules described so far are valid for Tm derivatives as well. 
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The coordination properties of scorpionates strictly depend on the steric and electronic effects 
of the substituents on pyrazoles.
201
 In general, scorpionates include a wide set of coordination 
modes in addition to the typical k
3
-N,N’,N’’.202 They can, in fact, behave as tridentate k3-
N,N’, -H donors,203 with a borohydride moiety linked to the metal, as bidentates k2-N,N’204 
or k
2
-N,X-H,
205
 and more rarely, as k
1
 and k
0
 (i.e. as uncoordinated counterion).
206
 Higher 
denticities (k
6
 and occasionally k
4
 and k
5
) are possible in case the substituents in 3-position of 
the pyrazole rings contain additional donor atoms
207
 (Figure 3.4). 
 
 
Figure 3.4 
 
The use of pyrazoles with bulky substituents may prevent the formation of a octahedral 
homoleptic ML2 complexes (L = Tp or Tm) 133, and  rather prefer the formation of a half-
sandwich complex 134. Complexes 133, typical of Tp and Tm derivatives of pyrazoles 
bearing small substituents or without any substituents, are formed in high yields by mixing 
iron(II) salts, as FeCl2, Fe(OAc)2 and Fe(OTf)2, with two equivalents of non-bulky ligands 
(e.g. Tp2Fe and Tp
Me2
2Fe).
208
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Homotris(pyrazol-yl)borates can be synthesized by many different routes,
196
 but most easily 
by reaction of the proper pyrazole with a borohydride anion in the absence of solvent 
(Scheme 3.6). 
 
 
Scheme 3.6 
 
As shown in Scheme 3.6, temperature control steers the reaction to produce selectively only 
one of the above products. A large variety of 1-H pyrazoles may be employed to synthesize 
poly(pyrazolyl)borates by this route, with the exception of those containing functionalities 
incompatible with the borohydride ion.  
Tris(pyrazol-1-yl)methanes are, instead, mainly prepared as shown in Scheme 3.7. 
 
 
Scheme 3.7 
 
Examples of iron complexes with scorpionates already well studied and characterized in 
literature are, for instance, the Fe(II)-complexes 135 (Tp
tBu,Me
FeCl, Tp
Ph,Me
FeCl, Tp
iPr2FeCl) 
obtained from FeCl2 and one equivalent of the Tp ligand.
209
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Oxo-bridged diiron centers, such as Tp2Fe2(μ-O)(μ-O2CCH3) 136, that resembles 
metalloenzymes such as hemerythrin, rubrerythrin, and methane momo-oxygenase, were also 
prepared.
210
 The five-coordinate iron(III) complex Tp
iPr
Fe(OAc) 137 is another example of 
Tp-iron complex, that acts as a mimic for non-heme metalloprotein hemoglobin and 
cytochrome P-450.
211
 
Tris(pyrazol-yl)methane iron complexes have also been studied since they were for the first 
time synthesized by Trofimenko, but not as extensively as the analogous tris(pyrazolyl)borate 
iron complexes.
194
 Iron complexes of Tm ligands, such as [Tm2Fe][X2] 138, where X is: BF4
-
, 
ClO4
-
, OTf
-
, can be formed in high yields using the corresponding iron(II) salts (Fe(BF4)2, 
Fe(ClO4)2, Fe(OTf)2) with two equivalents of Tm ligand. These iron(II) complexes have also 
displayed unusual temperature-dependent spin-state crossover behavior similar to that of their 
Tp2Fe analogs.
212
 
Similarly, Tm-type iron complexes of considerable interest are the facially-capped synthons. 
One example is the complex [Tm
Me2
Fe(NCCH3)3] [(BF4)2] 139.
213
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Our aim was to apply some scorpionate iron complexes as catalysts for the hydrogenation 
of double bonds, for which no examples have been ever reported. 
In order to have active catalyst species, we chose as starting point pyrazoles bearing bulky 
substituent, to avoid the formation of octahedral Tp2Fe or [Tm2Fe][2X
-
] complexes. 
All the chosen pyrazoles are commercially available, except 3-tert-butyl-5-methylpyrazole, 
that was synthetized by a condensation reaction between the corresponding -diketone and 
hydrazine. Tris(pyrazol-yl)borates were prepared through a neat reaction at high temperature, 
from an excess of pyrazoles (more than 3 equivalents) and KBH4. The borates were obtained 
in relatively good yield. Instead, tris(pyrazol-yl)methanes were prepared by reacting 3 
equivalents of the desired pyrazoles in a basic mixture of H2O/CHCl3. Unfortunately the latter 
ligands were obtained in low yield. 
From tris(pyrazol-yl)borates we synthesized two neutral TpFeCl complexes, Tp
tBu,Me
FeCl 144 
and Tp
Ph2FeCl 146, by reaction of 1 equivalent of the chosen KTp ligand with 1 equivalent of 
FeCl2, in THF at room temperature. The cationic complex [Tp
tBu,Me
Fe][BF4] 145 was 
prepared by reaction of the KTp
tBu,Me
 ligand with one equivalent of Fe(BF4)2*6H2O in 
CH3CN at room temperature (Scheme 3.8). 
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Scheme 3.8 
 
In addition, we synthetized also two tris(pyrazol-yl)methane complexes: neutral Tm
Ph
FeCl2 
151, from the corresponding Tm
Ph
 ligand and FeCl2 in THF at room temperature; dicationic 
[Tm
Ph2Fe][2BF4] 152 from Tm
Ph2 ligand, using this time Fe(BF4)2*6H2O as iron(II) source 
(Scheme 3.9). 
 
Scheme 3.9 
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These ligands have been exclusively investigated by us in the hydrogenation reaction of C=C 
and C=N double bonds. 
 
3.5.2     Tetradentate N4-ligands  
 
As tetradentate N4-ligands we prepared a series of derivatives of the complex 153, 
developed by White et al.,
214
 who used it for selective C–H bond oxidations with high chemo- 
and stereoselectivity. Complex 153 was described as an easy-to-prepare air- and moisture-
stable compound.  
 
 
 
Complex 153 has a modular structure that allowed the preparation of the following 
derivatives: 154, 155, 156, 157, 158, that we decided to investigate as catalysts for both the 
hydrogenation and the epoxidation reactions. 
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This class of octahedral complexes consists of an iron(II) coordinated to the tetradentante 
chiral ligand which leaves available two more coordination sites in cis position.
215
 
Their synthesis is shown in Scheme 3.10 and Scheme 3.11. 
 
 
Scheme 3.10 
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Scheme 3.11 
 
Complex 154, the analog of 153 bearing -OMe groups in the ortho position of the pyridine 
rings, was prepared in order to study the effect of the substituent on the activity/selectivity. 
Since 154 showed solubility only in CH3CN, similar complexes with BF4 (155) and BArF 
(156) counteranions were prepared. Indeed, complex 155 showed solubility also in CH3OH, 
while complex 156 is soluble in several common organic solvents (CH3CN, CH3OH, CH2Cl2, 
THF, toluene). 
Complex 157 (Scheme 3.10) was used by Costas et al. as catalyst for the epoxidation of cis-
-methylstyrene, and complex 158 was prepared by us in order to investigate if the 
substituent in the two ortho positions could lead to an increase of activity and/or selectivity, 
as observed by Costas with the correlated meta- or para-OMe derivative.
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3.6     Catalytic applications 
 
3.6.1     Reduction of C=C and C=X double bonds 
 
First of all, we decided to start with the investigation of the complexes as catalysts for the 
hydrogenation of functionalized alkenes. With this aim, we chose a benchmark substrate, 
methyl-2-acetamidoacrylate 163, and then we screened our iron-complexes, both the 
tridentate N3- and the tetradentate N4-ligands.  
 
 
Figure 3.5 
 
The potential reactivity of the two classes of complexes in Figure 3.5 relies for type A in the 
three “free” coordination sites in adjacent position, while for type B in the two “free” 
coordination sites in cis-position. The sites are in principle useful for the H2 activation, in 
order to have the formation of a hypothetic Fe-H bond, and the coordination of the substrate. 
 
 
 
All the reaction were carried out with 5 mol% of catalyst loading, at 50 bar of H2 pressure, at 
25°C, for 18 hours. 
All the scorpionate-complexes were tested, i.e. the neutral complexes of 144, 146, 151 the 
monocationic 145 and the dicationic 152. Unfortunately, neither in CH2Cl2, nor in THF the 
complexes led to any conversion. Together with them, also the neutral dichloro complex of 
the N4-tetradentate ligand, 160, and the hite’s complex 153, were investigated. In this case, 
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not only CH2Cl2 and THF, but also toluene, CH3OH and CH3CN were screened as solvents. 
Regretfully, in all cases only the starting alkene was recovered. 
The following step was to check if complexes with a better solubility (i.e. with 
tetrafluoroborate or tetrakis[3,5-bis(trifluoromethyl)phenyl]borate as counteranion), could 
ride over the lack of reactivity. Hence, again the complexes 144 and 145 were used as 
catalyst, but this time together with an equimolar quantity of AgBArF in order to lead to the 
in situ counteranion exchange (with the precipitation of AgCl) and formation of a cationic 
Fe(II) species, in principle more active thanks to the exchange of the chloride anion with the 
bulky, weakly coordinating, highly lipophilic BArF anion. Besides also the pre-synthesized 
derivatives of complex 153, namely 155 and 156, with respectively BF4
-
 and BArF
-
 as 
counteranion, were tested as for 144 and 145 in CH2Cl2, but also in THF and toluene, due to 
their initial solubility even in the less polar solvents. Here again the conversion still did not 
differ significantly from 0. 
As last attempt on this substrate, the five neutral complexes 144, 146, 151, 160, 162, which 
are the chlorine-derivatives, were investigated in the reaction carried out in CH2Cl2 with the 
addition of a Grignard (EtMgBr), respectively 10 mol% with 144 and 146, and 20 mol% with 
151, 160, 162, in order to form once again a more reactive species in situ, in particular, in this 
case, an iron(0) species.
216
  Regrettably, only the unreacted starting product was recovered. 
 
The possible activity of complex 144 was also investigated with another functionalized 
alkene, 165. 
 
 
 
The reaction was carried out at 50°C, for 18 hours at 50 bar of hydrogen pressure, but neither 
in CH2Cl2 nor in isopropanol, afforded the reduced product 166. 
 
Concerning the reduction of C=X double bonds, very preliminary attempts were made with 
substrate 167, just to test again the reactivity of complex 144. 
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So, the tris(3-tert-butyl-5-methyl-pyrazoyl)borate iron complex was used as catalyst in the 
reaction carried out both in CH2Cl2 and in iPrOH with the addition 50 mol% of a base 
(tBuOK). Unfortunately this complex revealed to be inactive also for the hydrogenation of the 
imine 167. 
 
Then we moved onto ketone transfer hydrogenation, choosing acetophenone 169 as the 
benchmark substrate. 
 
 
 
All the reaction were carried out at 25 °C for 18 hours. Only some complexes of the class of 
N4-tetradentate ligands were used for this reaction. The dicationic catalyst 153 as well as the 
neutral catalyst 160, formed from the same N4-tetradentate ligand, were selected. 
The reactions were carried out in pure iPrOH, with a base/catalyst ratio of 0 (i.e., no base), 
10, 100 and in a mixture of iPrOH/CH3CN 1:2 or iPrOH:CH2Cl2 1:2. No conversion was 
observed, except when the reaction was carried out in iPrOH with a base/catalyst ratio of 100 
(in which case conversion was less than 5%). 
 
3.6.2     Epoxidation 
 
Prompted by recently exiting results reported by Costas,
188
 we were willing to screen our  
N4-tetradentate ligand complexes, in particular those of ligand 161, with two ortho-OMe 
groups on the pyridine rings.  
Costas reported the application of iron(II) bis-triflate complexes where the ligand's pyridine 
rings bear substituents in para-position. For this reason, we prepared complex 158, as 
160 
 
reported in Scheme 3.11, and examined its reactivity in the epoxidation reaction of cis--
methylstyrene 171, the same substrate studied by Costas. 
 
 
Entry Catalyst Conversiona (%) eeb (%) 
1 158 10 5 
2 153 87 19 
3 154 12 5 
a Determined by 1H-NMR and GC 
b Determined by GC, column MEGADEX DACTBSβ  
Table 3.1 
 
The reactions were carried out in the presence of 1 mol% of catalyst, 1.4 equivalent of AcOH, 
and an excess of hydrogen peroxide, at -30 °C for 30 min. 
Besides complex 158, we investigated also complexes 153 and 154, that are the 
bis(hexafluoroantimonate) iron(II)-complexes of ligand 159 and 161. 
Complex 153 gave good results, comparable to the results obtained by Costas with the bis-
triflate complex 157.
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Unfortunately, the introduction of a -OMe group in ortho-position of the pyridine rings led to 
a dramatical drop in terms of conversion and enantioselectivity (entries 1 and 3) and also the 
formation of several unidentified side products. 
Prolonged reaction times, up to 24 hours, did not lead to an improvement in terms of 
conversion and enantiomeric excess. 
 
Then styrene 173 was subjected to the same conditions to test the activity of complexes 157 
and 158.  
 
 
Also for this substrate, complex 157 bearing unsubstituted pyridine rings, revealed to be a 
good catalyst. Indeed very good results in terms of conversion were achieved, although the 
161 
 
enantiomeric excess was low (conversion 100%, ee 8%). On the contrary, complex 158 led 
once again to unsatisfactory results (conversion 10%, ee 0%) and to the formation of several 
unidentified side products.  
 
 
 
Under the same conditions, the epoxidation of chalcone 175 (an ,-unsatured ketone), with 
catalysts 158 led to a mixture of unidentified side products, among which the desired oxide 
product, in very poor amount. This reaction was not further investigated. 
 
 
 
Similarly, ethyl cinnamate was not a good substrate for these catalysts and conditions: both 
complex 157 and 158, were not able to convert substrate 177 into its epoxidation product 178. 
 
3.7     Conclusion 
 
In this chapter we discussed the formation of iron(II)-complexes from polydentate 
nitrogen ligands, suitable for the stabilization of a very unstable Fe(II) towards the oxidation 
to Fe(III). 
Tridentate N3-ligands and tetradentate N4-ligands were prepared and reacted with Fe(II)-
sources and the resulting complexes were subjected to hydrogenation, transfer hydrogenation 
and epoxidation reactions.  
The purification of the complexes was sometimes arduous, because some of them were 
partially soluble even in the most apolar solvents such as hexane and pentane. Moreover, the 
characterization of the complexes was not easy, as little information could be drawn from 
1
H-
NMR spectroscopy (due to the paramagnetism of octahedral iron-complexes) and had to rely 
on mass spectrometry (altough mass spectra were sometimes difficult to interpret). 
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The iron-complexes prepared so far did not afford promising results, probably due to the 
stereoelectronic properties of our ligands since they appeared as not the most suitable 
complexes for these applications.  
Perhaps the substitution of some N-coordinated atoms with phosphines, which in general 
affects the hardness and the capability of accepting π-backdonation from metals in low 
oxidation states, would make the complexes more catalytically active, in particular for 
reduction applications.  
Further studies are currently ongoing in our laboratory to modify the ligand structures and 
achieve conversion and e.e.’s. 
 
3.8    Experimental section 
 
General Remarks  
 
All reactions were carried out under a nitrogen atmosphere, except the synthesis of complexes 
that was performed under argon atmosphere, using standard Schlenk-techniques. 
The reactions were performed with distilled solvents. The solvents for reactions were distilled 
over the following drying agents and transferred under nitrogen: CH2Cl2 (CaH2), MeOH 
(CaH2), CH3CN (CaH2), THF (Na), dioxane (Na), toluene (Na), hexane (Na), Et3N (CaH2). 
Acetophenone and i-PrOH were distilled on CaH2 (a small amount of PPh3 was added when 
distilling isopropanol) and stored over molecular sieves. Et2O and DMF were purchased in 
bottles with crown cap, over molecular sieves, and stored under nitrogen.  
Air sensitive liquids and solutions were transferred via a gas-tight syringe or cannula. 
Removal of solvents was accomplished by evaporation on a Buchi rotary evaporator (water 
bath 40°C) or directly from the Schlenk using an oil pump.  
The reactions were monitored by analytical thin-layer chromatography (TLC) using silica gel 
60 F254 pre-coated glass plates (0.25 mm thickness). Visualisation was accomplished by 
irradiation with a UV lamp and/or staining with a potassium permanganate alkaline solution 
or a nynhidrine solution. Flash column chromatography was performed using silica gel (60 Å, 
particle size 40-64 μm) as stationary phase, following the procedure by Still and co-
workers.
217
 Gas chromatography was performed by a GC instrument equipped with a flame 
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ionization detector, using the chiral capillary column MEGADE  DACTBSβ, diacetyl-t-
butylsilyl-β-cyclodextrin. 
1
H- and 
13
C-NMR spectra were recorded measured on a Bruker DRX 400MHz. Chemical 
shifts are reported in ppm with the solvent reference relative to tetramethylsilane (TMS) 
employed as the internal standard (CDCl3 δ = 7.26 ppm). 
13
C NMR spectra were recorded 
with a 400 MHz spectrometer operating at 100.56 MHz with complete proton decoupling. 
Chemical shifts are reported in ppm relative to TMS with the respective solvent resonance as 
the internal standard (CDCl3, δ = 77.23 ppm).  
High resolution mass spectra were measured with a Fourier Transform Ion Cyclotron 
Resonance (FT-ICR) Mass Spectrometer APEX II & Xmass software (Bruker Daltonics)-4.7 
T Magnet (Magnex) equipped with ESI source. Low resolution mass spectra (MS) were 
acquired either on a Thermo-Finnigan LCQ Advantage mass spectrometer (ESI ion 
source).Chiral HPLC analysis were performed with a Shimadzu instrument equipped with a 
Diode Array detector. Elemental analyses were performed on a Perkin Elmer Series II 
CHNS/O Analyzer 2000. Infrared spectra were recorded on a standard FT/IR spectrometer. 
Commercially available reagents were used as received without, unless indicated otherwise. 
 
3.8.1    Synthesis of the ligands and relative precursors 
 
3-tert-butyl-5-methylpyrazole (140) 
 
Compound 140 was synthesized according to a published procedure.
218,219 
Yield: 75% - 
1
H NMR (400 MHz, CDCl3): δ = 1.30 (s, 9H), 2.27 (s, 3H), 5.87 (s, 1H),  8.80 
(bs, 1H). Spectroscopic data of the product were in agreement with the literature.
220
 
 
Potassium tris(3-tert-butyl-5-methyl-1H-pyrazol-1-yl)hydroborate (142) 
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Ligand 142 was synthesized according to a published procedure.
221
 
Yield: 51% - 
1
H NMR (400 MHz, CDCl3): δ = 1.30 (d, 27H, J = 10.1), 2.37 (s, 3H), 5.80 (d, 
1H, J = 12.6 Hz). Spectroscopic data of the product were in agreement with the literature. 
 
Potassium tris(3,5-diphenyl-1H-pyrazol-1-yl)hydroborate (143) 
 
Ligand 143 was synthesized according to a published procedure.
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Yield: 44% - 
1
H NMR (400 MHz, CD2CO): δ = 6.75 (s, 3 H), 6.95-7.50 (m, 18 H), 7.80-7.95 
(m, 12 H). Spectroscopic data of the product were in agreement with the literature. 
 
Tris(3-phenyl-1H-pyrazol-1-yl)methane (149) 
 
Ligand 149 was synthesized according to a published procedure.
223
 
Yield: 15% - 
1
H NMR (400 MHz, CD2CO): δ = 6.90 (d, 3H, J = 2.4 Hz), 7.35 (tt, 3H, J = 
1.2, 2.8 Hz), 7.38-7.44 (m, 6H), 7.88-7.92 (m, 6H), 8.10 (d, 3H, J = 2.4 Hz), 8.86 (s, 1H). 
Spectroscopic data of the product were in agreement with the literature. 
 
Tris(3,5-diphenyl-1H-pyrazol-1-yl)methane (150) 
 
Ligand 150 was synthesized according to a published procedure.
224
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Yield: 10% - 
1
H NMR (400 MHz, CDCl3): δ = 6.57 (3H, s), 6.81 (d, 6H, J = 7.1 Hz), 7.14 (t, 
6H,  J = 7.7 Hz), 7.22-7.29 (m, 6H), 7.34 (t, 6H, J = 7.5 Hz), 7.80 (d, 6H,  J = 7.0 Hz), 7.82 
(s, 1H). Spectroscopic data of the product were in agreement with the literature. 
 
 (2S,2'S)-1,1'-Bis(pyridin-2-ylmethyl)-2,2'-bipyrrolidine (159) 
 
Ligand 159 was synthesized according to a published procedure.
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Yield: 97% - 
1
H NMR (400 MHz, CDCl3): δ = 1.68-1.91 (m, 8H), 2.14-2.32 (q, 2H, J = 8.6 
Hz), 2.76-2.82 (m, 2H), 2.98-3.08 (m, 2H), 3.53 (d, 2H, J = 14.4 Hz), 4.21 (d, 2H, J = 14.0 
Hz), 7.12 (dd, 2H, J = 7.0, 5.2 Hz), 7.42 (d, 2H, J = 7.8 Hz), 7.61 (td, 2H, J = 7.6, 1.7 Hz), 
8.52 (d, 2H, J = 4.2 Hz). Spectroscopic data of the product were in agreement with the 
literature. 
 
2-(Hydroxymethyl)-6-methoxypyridine   
 
NaBH4 (96%, 0.85 g, 21.6 mmol) was added portionwise to a stirred solution of 6-methoxy-
2-pyridinecarboxaldehyde (1.04 g, 7.37 mmol) in 20 mL MeOH kept at 0 °C. The reaction 
mixture was stirred at RT for 3 hours, then distilled H2O was added and MeOH was 
evaporated. The aqueous layer was extracted with CH2Cl2, the collected organic phases were 
washed with brine, dried with Na2SO4 and filtered. Evaporation of solvents afforded a pale 
yellow liquid in 98% yield, which was used in the following step without further purification.  
1
H NMR (400 MHz, CDCl3): δ = 3.65 (bs, 1H), 3.89 (s, 3H), 4.64 (s, 2H), 6.59 (d, 1H, J = 
8.2 Hz), 6.80 (d, 1H, J = 7.2 Hz), 7.51 (t, 1H, J = 7.7 Hz). Spectroscopic data of the product 
were in agreement with the literature.
226
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2-(Bromomethyl)-6-methoxypyridine   
 
CBr4 (3.61 g, 10.8 mmol) and PPh3 (2.83 g, 10.8 mmol) were added in sequence to a stirred 
solution of 15 (1.00 g, 7.18 mmol) in 18 mL CH2Cl2 kept at 0 °C. Upon addition of the 
triphenylphosphine the solution became purple/brown. The reaction mixture was allowed to 
warm up at room temperature and was stirred for 2 hours, after which period a whitish 
precipitate was present. Solvents were evaporated to give a brown oil, which was purified by 
flash chromatography eluting with hexane/AcOEt 98:2. The product was obtained in 80% 
yield as a colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 3.96 (s, 3H), 4.48 (s, 2H), 6.67 (d, 1H, J = 8.4 Hz), 7.00 (d, 
1H, J = 7.2 Hz), 7.56 (t, 1H, J = 7.8 Hz). Spectroscopic data of the product were in agreement 
with the literature.
227
 
 
(2S,2'S)-1,1'-Bis((6-methoxypyridin-2-yl)methyl)-2,2'-bipyrrolidine (S,S-PDP-OMe)  (161) 
 
NaOH (512 mg, 12.8 mmol) and 2-(bromomethyl)-6-methoxypyridine (1137 mg, 5.6 mmol) 
dissolved in 9 mL CH2Cl2 were added in sequence to a stirred suspension of (S,S)-2,2’-
bipyrrolidine D-tartrate trihydrate (890 mg, 2.6 mmol)  in 9 mL H2O. The obtained biphasic 
mixture was stirred overnight at room temperature, then diluted with 1M NaOH and extracted 
with CH2Cl2. The combined organic phases were dried with Na2SO4, filtered and 
concentrated in vacuo to obtain a sticky yellow oil.  
The crude was purified by flash chromatography eluting  with CH2Cl2/MeOH/aqueous NH3 
(33%) 97:3:2. The collected fractions were combined, diluted with CH2Cl2, washed with 1M 
NaOH and dried with Na2SO4.  Evaporation of solvents afforded the product in 97% yield as 
a pale yellow oil.  
1
H NMR (400 MHz, CDCl3): δ = 7.51 (t, 2H, J = 7.6 Hz), 6.98 (d, 2H, J = 7.2 Hz), 6.57 (d, 
2H, J = 8.0 Hz), 4.14 (d, 2H, J = 14.4 Hz), 3.91 (s, 6H), 3.45 (d, 2H, J = 14.4 Hz), 3.10 (m, 
                                                                
227 C. Derong, J. Huanfeng, Z. Hong, L. Wenjie, Z. Hong, M. Herbert, J. Org. Chem. 2011, 76, 5531. 
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2H), 2.87 (bs, 2H), 2.29 (m, 2H), 1.68-1.90 (m, 8H) - 
13
C NMR (100 MHz, CDCl3): δ = 
163.5, 158.2, 138.8, 115.3, 108.1, 65.2, 60.5, 55.3, 53.4, 26.2, 23.7.  
 
Silver tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
 
(AgBArF)  
 
AgBArF was synthesized according to a published procedure.
228
 
1
H NMR (400 MHz, (CD3)2SO): δ = 7.63 (s, 8H), 7.72 (s, 4H). 
Spectroscopic data of the product were in agreement with the literature. 
 
3.8.2    Synthesis of the complexes 
 
Complex [Tp
tBu,Me
FeCl] (144) 
 
FeCl2 (26 mg, 0.2 mmol) was added to a solution of Tp
tBu,Me
K 142 (100 mg, 0.2 mmol) in 
THF (3 mL). The solution was stirred overnight at room temperature. Filtration over celite 
and removal of solvent under vacuum resulted in a dark yellow residue. Addition of pentane 
caused precipitation of a solid. The solvent was decanted off and the solid dried under high 
vacuum, affording complex 144 in 65% yield as a yellow solid. Spectroscopic data of the 
product were in agreement with the literature.
229
 
1
H NMR (400 MHz, (C6D6): δ = - 11.1 (bs, 27H), 39.7 (bs, 9H), 50.0 (bs, 1H), 63.8 (bs, 3H) - 
MS: [M-Cl]
+ 
m/z: 479.5. 
 
 
  
                                                                
228 E. Buschmann, J. S. Miller, K. Bowman-James, C. N. Miller, Inorg. Synth. 2002, 33, 83. 
229 F. A. Jové, C. Pariya, M. Scoblete, G. P. A. Yap, K. H. Theopold, Chem. Eur. J. 2011, 17, 1310. 
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Complex [Tp
Ph2
FeCl] (146) 
 
FeCl2 (28.4 mg, 0.22 mmol) was added to a solution of Tp
Ph2
K 143 (150 mg, 0.22 mmol) in 
THF (3 mL). The solution was stirred overnight at room temperature. Filtration over celite 
and removal of solvent under vacuum resulted in a pale yellow residue. Addition of pentane 
caused precipitation of a solid. The solvent was decanted off and the solid dried under high 
vacuum, affording complex 146 in 72% yield as a white solid. 
MS: [M-Cl]
+  
m/z: 725.5. 
 
Complex [Tp
tBu,Me
Fe][BF4] (145) 
 
Fe(BF4)2
*
6H2O (174 mg, 0.52 mmol) was added to a solution of Tp
tBu,Me
K 142 (250 mg, 0.52 
mmol) in CH3CN (5 mL). The solution was left to stir overnight. Filtration over celite and 
removal of solvent under vacuum resulted in the complex 145 in 70% yield as a green solid.  
MS: [M(CH3CN)2]
+  
m/z: 561.3 
 
Complex [Tm
Ph
FeCl2] (151) 
 
FeCl2 (52 mg, 0.41 mmol) was added to a solution of Tm
Ph
 149 (180 mg, 0.41 mol) in THF (4 
mL). The solution was left to stir overnight. Removal of solvent under vacuum afforded 
complex 151 in 90% yield as a red solid. 
MS: [M(THF) + H]
+  
m/z: 641.3 
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Complex [Tm
Ph2
Fe][2BF4] (152) 
 
Fe(BF4)2
*
6H2O (40 mg, 0.11 mmol) was added to a solution of Tm
Ph2 150 (70 mg, 0.11 
mmol) in THF (3 mL). The reaction mixture was stirred overnight. Removal of the solvent 
under vacuum resulted in a pale yellow residue. Addition of pentane caused precipitation of a 
solid. The solvent was decanted off and the solid dried under high vacuum, affording 
complex 152 in 90% yield as a white solid. 
MS: [M(THF)2]
++ 
+ MeOH
  
m/z: 451.3 
 
Complex [FeCl2(S,S-PDP)] (160) 
 
Complex 160 was synthesized according to a published procedure.
214 
MS: [M-Cl]
+ 
m/z: 413.3. - C10H11N3O5 (448.1): calcd. C 53.48; H 5.83; N 12.47; found C 
53.14; H 5.95; N 12.45. 
Spectroscopic data of the product were in agreement with the literature. 
 
Complex [Fe(S,S-PDP)(CH3CN)2][(SbF6)2] (153) 
 
Complex 153 was synthesized according to a published procedure.
214 
1
H NMR (400 MHz, CD3CN): δ = 0.1 (bs, 2H), 2.2 (bs, 8H), 3.5 (bs, 2H), 4.5 (bs, 2H), 8.5 
(bs, 4H), 9.7 (bs, 2H), 10.8 (bs, 2H), 16.1 (bs, 2H), 17.0 (bs, 4H), 17.8 (bs, 1H), 43.8 (bs, 2H). 
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MS: [M - CH3CN]
++ 
m/z: 209.5. FT-IR (Nujol): 2308.37 cm
-1
, 2273.66 cm
-1
 (weak, CH3C≡N 
stretching). 
Spectroscopic data of the product were in agreement with the literature.
 
 
Complex [Fe(S,S-PDP)(OTf)2] (157) 
 
A solution of ligand 159 (278 mg, 0.71 mmol) in THF (3.5 mL) was added to a suspension of 
Fe(OTf)2
*
nH2O (85%) (295 mg, 0.84 mmol) in THF (3.5 mL) at room temperature with 
stirring. The mixture was stirred overnight and the solvent removed under vacuum to give a 
light brown powder. The residue was washed with Et2O/hexane 1:1 (2 mL) and then hexane 
(2 mL). The solvent was decanted off and the solid dried under high vacuum, affording 
complex 157 in 25% yield as a yellow solid. 
MS: [M - OTf]
+ 
m/z: 527.3. 
Spectroscopic data of the product were in agreement with the literature.
230 
 
Complex [FeCl2((S,S)-PDP-OMe)]  (162) 
 
FeCl2
*
4H2O (273 mg, 1.37 mmol) was added to a stirred solution of ligand 161 (525 mg, 1.37 
mmol) in 8 mL CH3CN. The yellowish, slightly turbid solution was stirred overnight at room 
temperature. 10 mL Et2O were added and a sticky brown solid precipitated. Solvents were 
decanted off and the residue was dried under high vacuum, then dissolved in CH2Cl2. 
Addition of pentane caused precipitation of a brown solid again. The solvents were decanted 
off and the solid was dried under high vacuum, giving complex 162 in 91% yield.  
MS: [M-Cl]
+ 
m/z: 473.2. 
                                                                
230 K. Suzuki, P. D. Oldenburg, L. Que, Jr., Angew. Chem. Int. Ed. 2008, 47, 1887. 
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Complex [Fe(CH3CN)2(S,S-PDP-OMe)][2SbF6] (154) 
 
Silver hexafluoroantimonate (207 mg, 0.59 mmol) was added to a stirred thick brown solution 
of 162 (150 mg, 0.29 mmol) in 5 mL CH3CN. The reaction mixture became beige and a white 
precipitate formed. The flask was covered with aluminum foil and the mixture was stirred 
overnight at RT. On the next day silver chloride was filtered off under Ar and the clear brown 
filtrate was evaporated to dryness. The residue was re-dissolved in CH3CN, filtered through a 
0.2 μm Acrodisc® LC PVDV syringe filter and concentrated. The filtration/evaporation 
procedure was repeated two more times to ensure no silver salts remains. The last time the 
filtrate was evaporated under N2 stream and then under high vacuum, obtaining a brilliant 
brown solid in 90% yield.  
1
H NMR (400 MHz, CD3CN): δ = 1.82-1.93 (m, 2H), 1.95-2.08 (bs, 8H), 2.10-2.30 (m, 4H), 
2.45 (bs, 2H), 3.50-3.59 (m, 2H), 3.59-3.68 (m, 2H), 3.88 (s, 6H), 4.12 (bs, 2H), 4.67 (d, 2H, 
J = 17.2 Hz), 4.81 (d, 2H, J = 17.2 Hz), 6.99 (d, 2H, J = 9.6 Hz), 7.11 (d, 2H J = 8.0 Hz), 8.02 
(t, 2H, J = 7.4 Hz) - MS: [M-2CH3CN]
2+ 
m/z: 219.5. 
 
Complex [Fe((S,S)-PDP-OMe)(CH3CN)2][2BF4] (155) 
 
A solution of ligand 161 (300 mg, 0.78 mmol) in 10 mL CH3CN was transferred via cannula 
into a stirred solution of iron(II) tetrafluoroborate hexahydrate (273 mg, 0.78 mmol) in 10 mL 
CH3CN. The resulting pale yellow solution was stirred overnight at room temperature, then 
the solvent was evaporated and the yellow residue was washed with Et2O, decanting off the 
solvent via syringe. Drying under high vacuum afforded complex 155 as a yellow-greenish 
solid in 47% yield. 
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1
H NMR (400 MHz, CD2Cl2): δ =  1.3 (bs, 2H), 2.39 (bs, 2H), 2.5-3.2 (m, 10H), 3.0 (bs, 2H), 
4.03 (bs, 8H), 4.6-4.9 (m, 4H), 5.2 (bs, 2H), 6.7 (bs, 2H), 7.4 (bs, 2H), 8.1 (bs, 2H) - MS: [M-
2CH3CN]
2+ 
m/z: 219.3. 
 
Complex [Fe((S,S)-PDP-OMe)(CH3CN)2][2BArF] (156) 
 
METHOD A 
NaBArF (230 mg, 0.26 mmol) was added to a stirred solution of complex 155 (90 mg, 0.13 
mmol) in 10 mL CH2Cl2. The reaction mixture became turbid and, after stirring for 1 hour, 
was filtered through celite under Ar. Evaporation of the filtrate gave complex 156 as a 
whitish solid in 99% yield. 
FT-IR (Nujol): 2306.45 cm
-1
, 2277.52 cm
-1
 (CH3C≡N stretching). 
METHOD B 
AgBArF (381 mg, 0.40 mmol) was added to a stirred thick brown solution of complex 162 
(100 mg, 0.20 mmol) in 8 mL CH3CN. Upon addition the reaction mixture became turbid and 
a white solid precipitated. The reaction mixture was stirred overnight with minimal light 
exposure and the precipitate was then filtered off under Ar. The filtrate was evaporated to 
dryness, the brown residue was taken up with 10 mL CH3CN and filtered through a 0.2 μm 
Acrodisc
® 
LC PVDV syringe filter. The evaporation/filtration procedure was repeated to 
ensure no silver salts remains. Evaporation of solvents afforded complex 156 as a dark brown 
solid in 78% yield.  
 
Complex [Fe((S,S)-PDP-OMe)(OTf)2] (158) 
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A solution of ligand 161 (266 mg, 0.69 mmol) in THF (1.5 mL) was added to a suspension of 
Fe(OTf)2
*
nH2O (85%) (258 mg, 0.73 mmol) in THF (1.5 mL) at room temperature with 
stirring. The mixture was stirred overnight and the solvent removed under vacuum to give a 
light brown powder. The residue was washed with Et2O/hexane 1:1 (2 mL) and then with 
hexane (2 mL). The solvent was decanted off and the solid dried under high vacuum, 
affording complex 157 in 25% yield as a yellow solid. 
MS: [M - OTf]
+ 
m/z: 587.1. 
 
3.8.3    Hydrogenation and epoxidation reactions 
 
 General procedure for the hydrogenation reactions 
 
A Parr multireactor was employed, allowing six reactions in parallel under hydrogen 
pressure. The selected complex (5 mg, 0.05 eq) and the substrate (1 eq) were weighted in 
special glass vessels, which were then purged with nitrogen. Solvent (7 mL) was added via 
syringe, the vessels were placed in the respective autoclaves and purged three times with 50 
bar of hydrogen. The reactions were stirred under hydrogen pressure at the desired 
temperature for a given time and then analyzed for conversion and ee determination, using 
1
H 
NMR, GC or HPLC. 
 
 General procedure for the transfer hydrogenation reactions 
 
A carousel multireactor was employed, allowing eight reactions in parallel under nitrogen 
atmosphere. Under N2 flow, the selected complex (4 mg, 0.05 eq) and the desired base (0.50 
eq) were introduced in special glass vessels, which were then closed with screw caps and 
purged with nitrogen. Distilled isopropanol (2 mL) and acetophenone (10-20 μL, 1 eq) were 
added via syringe and the reactions were stirred under nitrogen at the desired temperature for 
a given time and then analyzed for conversion and ee determination, using 
1
H NMR, GC or 
HPLC. 
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ENTRY 
PRODUCT 
Spectral data match those  
previously reported. 
SEPARATION METHOD 
1 
 
Org. Lett.  2010, 12, 1296. 
GC (column MEGADEX DACTBSβ, diacetyl-tert-
butylsilyl-β-cyclodextrin 0.25 μm; diameter = 0.25 
mm; length = 25 m); carrier: hydrogen; Conditions: 
flow:1 mL/min; 140 °C for 6 min, then gradient 8 
°C/min. tsubstrate = 3.9 min; tR = 5.2 min; tS = 6.0 min 
2 
 
 
Tetrahedron : Asymmetry 2011, 22, 47. 
HPLC. Column Chiralpak AD -H, Heptane/IPA 99:1, 
flow 0.5 mL/min 
3 
 
J. Am. Chem. Soc. 2009, 131, 8358. 
HPLC. Column Chiracel OD, Heptane/IPA 95:5, 
flow 0.5 mL/min 
4 
 
Angew. Chem. Int. Ed. 2012, 51, 12102. 
GC (capillary column: MEGADEX DACTBSβ, 
diacetyl-tert-butylsilyl-β-cyclodextrin, 0.25 μm; 
diameter = 0.25 mm; length = 25 m) carrier: 
hydrogen; Conditions: hydrogen pressure:1 bar; 75 
°C for 5 min, 20 °C/min gradient to 95 °C, 95 °C for 
15 min, then gradient 20 °C/min. tsubstrate = 9.3 min; 
tee1 = 17.5 min; tee2 = 19.8 min. 
 
 General procedure for the epoxidation reactions 
 
A carousel multireactor was employed. To a solution of complex (2-2.5mg, 0.01 eq) in  
CH3CN (3 mL), the substrate (0.11 M, 1 eq) was added and the solution stirred at room 
temperature. The the solution was cooled at -30 ºC, and AcOH was added (28 µL, 1.4 eq.) 
Then, 50 μL of 1:1 v:v acetonitrile:hydrogen peroxide solution 30 % (1.5 equiv.) was added 
by syringe pump over a period of 30 min or through 5 additions of 10 μL each over a period 
of 30 min by micropipette. The solution was further stirred at -30 ºC for 30 minutes. The 
reaction was quickly filtered through a basic alumina plug, which was subsequently rinsed 
with 2 x 1 mL EtOAc. 
1
H-NMR and GC analysis of the solution provided substrate 
conversion and ee%. Spectroscopic data of the products were in agreement with the literature. 
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ENTRY 
PRODUCT 
Spectral data match those  
previously reported. 
SEPARATION METHOD 
1 
 
Angew. Chem. Int. Ed. 2010, 49, 628. 
GC (column MEGADE  DACTBSβ, diacetyl-tert-
butylsilyl-β-cyclodextrin 0.25 μm  diameter = 0.25 
mm; length = 25 m); carrier: hydrogen; Conditions: 
flow:3.5 mL/min; 75 °C for 5 min, then gradient: 3 
°C/min to 90°C, then gradient: 7°C/min to 200°C 
tsubstrate = 3.6 min; tR = 8.1 min; tS = 9.6 min 
2 
 
 
J. Am. Chem. Soc. 1994, 116, 933. 
GC (column MEGADE  DACTBSβ, diacetyl-tert-
butylsilyl-β-cyclodextrin 0.25 μm  diameter = 0.25 
mm; length = 25 m); carrier: hydrogen; Conditions: 
flow:3.5 mL/min; 75 °C for 5 min, then gradient: 3 
°C/min to 90°C, then gradient: 7°C/min to 200°C 
tsubstrate = 2.1 min; tR = 8.6 min; tS = 9.1 min 
3 
 
Org. Lett.  2009, 16, 3622. 
HPLC. 
Column Chiracel OB, 
Heptane/IPA 9:1, flow 1.0 mL/min 
4 
 
J. Org. Chem. 2009, 74, 3986. 
HPLC. 
Column Chiracel OB, 
Heptane/IPA 9:1, flow 1.0 mL/min 
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